122111-03-9 | Gemcitabine HCl

Packsize	Purity	Availability	Price	Discounted Price
1mg	97%	in stock	$6.00	$4.00
100mg	95%	in stock	$6.00	$4.00
250mg	95%	in stock	$9.00	$6.00
1g	95%	in stock	$12.00	$8.00
5g	97%	in stock	$32.00	$22.00
10g	97%	in stock	$59.00	$41.00

Description

• Catalog Number: AB74426
• Chemical Name: Gemcitabine HCl
• CAS Number: 122111-03-9
• Molecular Formula: C9H12ClF2N3O4
• Molecular Weight: 299.6591
• MDL Number: MFCD01735988
• SMILES: OC[C@H]1O[C@H](C([C@@H]1O)(F)F)n1ccc(nc1=O)N.Cl

Computed Properties

• Complexity: 426
• Covalently-Bonded Unit Count: 2
• Defined Atom Stereocenter Count: 3
• Heavy Atom Count: 19
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 2

Literature

• Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways.

  Chemico-biological interactions 20180625

• Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function.

  Toxicology and applied pharmacology 20170201

• Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.

  International journal of cancer 20170101

• Selective GPR55 antagonism reduces chemoresistance in cancer cells.

  Pharmacological research 20160901

• Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs.

  Molecular oncology 20160601

• 14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression.

  Oncotarget 20160405

• The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eµ-MYC driven B-cell lymphoma.

  Oncotarget 20160119

• Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20160115

• The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.

  Oncotarget 20151229

• Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression.

  Clinical lung cancer 20151101

• Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.

  Cancer research 20150915

• A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20150901

• Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines.

  Chemico-biological interactions 20150525

• Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20150501

• Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.

  European journal of haematology 20150301

• Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.

  Molecular pharmacology 20141101

• Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer.

  Molecular carcinogenesis 20140901

• GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.

  Annals of hematology 20140501

• Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor.

  Investigational new drugs 20140401

• Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development.

  Journal of medicinal chemistry 20140227

• Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin.

  Urologia internationalis 20140101

• Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

  Anticancer research 20140101

• Rat N-ERC/mesothelin as a marker for in vivo screening of drugs against pancreas cancer.

  PloS one 20140101

• GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways.

  PloS one 20140101

• Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.

  Toxicology letters 20130912

• Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells.

  Biochemical and biophysical research communications 20130426

• Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma.

  International journal of cancer 20130101

• sVEGF R1 and Tie-2 levels during chemotherapy of lung cancer patients.

  Advances in experimental medicine and biology 20130101

• Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.

  Current pharmaceutical design 20130101

• Enhancement of gene gun-induced vaccine-specific cytotoxic T-cell response by administration of chemotherapeutic drugs.

  Methods in molecular biology (Clifton, N.J.) 20130101

• The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.

  Investigational new drugs 20121201

• Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy.

  Investigational new drugs 20121201

• Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer.

  Medical oncology (Northwood, London, England) 20121201

• Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.

  Medical oncology (Northwood, London, England) 20121201

• Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma.

  Medical oncology (Northwood, London, England) 20121201

• Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer.

  Investigational new drugs 20121201

• Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report.

  Lung cancer (Amsterdam, Netherlands) 20121201

• Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.

  International journal of molecular medicine 20121201

• Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.

  Oncology reports 20121201

• Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.

  International journal of oncology 20121201

• Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice.

  International journal of oncology 20121201

• Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.

  Molecular biology reports 20121201

• Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.

  Cancer 20121115

• Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway.

  Acta histochemica 20121101

• Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.

  Pediatric blood & cancer 20121101

• Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin.

  BJU international 20121101

• Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• Tumor macrophages as a target for Capsaicin mediated immunotherapy.

  Cancer letters 20121101

• High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101

• Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma.

  Surgery 20121101

• Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial.

  International journal of radiation oncology, biology, physics 20121101

• A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.

  Oral oncology 20121101

• UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.

  Journal of cancer research and clinical oncology 20121101

• VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma.

  Annals of hematology 20121101

• Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells.

  Human molecular genetics 20121101

• Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.

  Gynecologic oncology 20121101

• Role of chitosan nanoparticles in the oral absorption of Gemcitabine.

  International journal of pharmaceutics 20121101

• Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival.

  The American journal of pathology 20121101

• The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20121101

• Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.

  Lasers in surgery and medicine 20121101

• Safety and effectiveness of gemcitabine in 260 patients with biliary tract cancer in a Japanese clinical practice based on post-marketing surveillance in Japan.

  Japanese journal of clinical oncology 20121101

• Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.

  British journal of cancer 20121023

• [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20121020

• [A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20121020

• Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection.

  The Journal of biological chemistry 20121012

• Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.

  American journal of clinical oncology 20121001

• Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas.

  American journal of clinical oncology 20121001

• Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.

  American journal of clinical oncology 20121001

• Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review.

  American journal of clinical oncology 20121001

• Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704.

  The pharmacogenomics journal 20121001

• Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study.

  Breast cancer (Tokyo, Japan) 20121001

• A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer.

  International journal of clinical oncology 20121001

• Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.

  Investigational new drugs 20121001

• A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer.

  Investigational new drugs 20121001

• Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum.

  Investigational new drugs 20121001

• Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20121001

• Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy.

  International journal of radiation oncology, biology, physics 20121001

• Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer.

  Pancreas 20121001

• Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer.

  Journal of cancer research and clinical oncology 20121001

• Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma.

  Journal of cancer research and clinical oncology 20121001

• Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.

  Experimental hematology 20121001

• Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma.

  Chinese journal of cancer 20121001

• Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.

  Journal of cancer research and clinical oncology 20121001

• Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine.

  Biochimica et biophysica acta 20121001

• Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20121001

• Localized delivery of chemotherapy to the cervix for radiosensitization.

  Gynecologic oncology 20121001

• [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma].

  Actas urologicas espanolas 20121001

• Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer.

  Japanese journal of clinical oncology 20121001

• Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.

  Molecular medicine reports 20121001

• Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20121001

• Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells.

  Cancer biology & therapy 20121001

• sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR.

  Apoptosis : an international journal on programmed cell death 20121001

• Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121001

• Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20121001

• Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20121001

• Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas.

  Journal of pediatric hematology/oncology 20121001

• Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells.

  Nucleic acid therapeutics 20121001

• Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.

  Clinical breast cancer 20121001

• Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer.

  Asian Pacific journal of tropical medicine 20121001

• Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer.

  British journal of cancer 20120925

• Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

  World journal of gastroenterology 20120921

• [Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120920

• Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120915

• Role of taxanes in pancreatic cancer.

  World journal of gastroenterology 20120907

• FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts.

  World journal of gastroenterology 20120907

• Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.

  Journal of gastrointestinal cancer 20120901

• Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon.

  Annals of hematology 20120901

• Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.

  Acta oncologica (Stockholm, Sweden) 20120901

• Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine.

  Chemical biology & drug design 20120901

• Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20120901

• Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial.

  Gynecologic oncology 20120901

• Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.

  Gastroenterology 20120901

• Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study.

  Lung cancer (Amsterdam, Netherlands) 20120901

• Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120901

• Lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase driven by the hTERT promoter combined with gemcitabine: a potential strategy for cancer therapy.

  International journal of molecular medicine 20120901

• A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer.

  Oncology reports 20120901

• Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.

  International journal of oncology 20120901

• Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.

  International journal of oncology 20120901

• The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models.

  Molecular cancer therapeutics 20120901

• Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120901

• Targeting the MAGE A3 antigen in pancreatic cancer.

  Surgery 20120901

• Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer.

  Japanese journal of clinical oncology 20120901

• The antitumor activity of recombinant antitumor antiviral protein and the associated molecular mechanism in pancreatic tumor cells.

  Cancer biotherapy & radiopharmaceuticals 20120901

• Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20120901

• The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.

  Cancer biology & therapy 20120901

• A retrospective study of S-1 monotherapy as second-line treatment for patients with advanced biliary tract cancer.

  Japanese journal of clinical oncology 20120901

• Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120901

• Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.

  Cancer chemotherapy and pharmacology 20120901

• Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).

  The oncologist 20120901

• Salvage chemotherapy using gemcitabine for taxane/platinum-resistant recurrent ovarian cancer: a single institutional experience.

  Anticancer research 20120901

• Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study.

  Anticancer research 20120901

• Gemcitabine-induced pulmonary toxicity.

  Anticancer research 20120901

• First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820

• [Thermo-chemotherapy of GP or TP for advanced non-small cell lung cancer: a systematic review].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120820

• High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation.

  Clinica chimica acta; international journal of clinical chemistry 20120816

• Occupational exposure to antineoplastic drugs in four Italian health care settings.

  Toxicology letters 20120813

• A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma.

  Investigational new drugs 20120801

• Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer.

  Investigational new drugs 20120801

• Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.

  International journal of cancer 20120801

• Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.

  International journal of cancer 20120801

• Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.

  Journal of cellular and molecular medicine 20120801

• Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer.

  The Journal of surgical research 20120801

• Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma.

  Annals of surgical oncology 20120801

• High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20120801

• Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.

  Journal of surgical oncology 20120801

• Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.

  Journal of surgical oncology 20120801

• Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1.

  Cancer science 20120801

• Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin.

  Journal of magnetic resonance imaging : JMRI 20120801

• Analytical detection and method development of anticancer drug Gemcitabine HCl using gold nanoparticles.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120801

• Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.

  The journal of obstetrics and gynaecology research 20120801

• Induction of pancreatic cancer cell apoptosis and enhancement of gemcitabine sensitivity by RAP80 siRNA.

  Digestive diseases and sciences 20120801

• Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.

  Annals of surgery 20120801

• Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.

  European journal of cancer (Oxford, England : 1990) 20120801

• Sorafenib in locally advanced or metastatic breast cancer.

  Expert opinion on investigational drugs 20120801

• SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine.

  Toxicology and applied pharmacology 20120801

• Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.

  Molecular cancer therapeutics 20120801

• Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.

  Oncology reports 20120801

• Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma.

  The British journal of surgery 20120801

• Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses.

  European journal of immunology 20120801

• Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2.

  Anti-cancer drugs 20120801

• Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks.

  Chinese journal of cancer 20120801

• hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20120801

• Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells.

  Cancer biology & therapy 20120801

• Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines.

  American journal of veterinary research 20120801

• [Soft-tissue sarcoma: recent developments].

  Deutsche medizinische Wochenschrift (1946) 20120801

• [A case of unresectable hilar cholangiocarcinoma successfully treated by gemcitabine and S-1 combination chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120801

• Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation.

  PLoS genetics 20120801

• [The effect of presurgical gemcitabine cisplatin chemotherapy for urothelial carcinoma].

  Hinyokika kiyo. Acta urologica Japonica 20120801

• [A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy].

  Hinyokika kiyo. Acta urologica Japonica 20120801

• Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.

  Cancer letters 20120728

• Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells.

  Gene 20120725

• Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group.

  British journal of cancer 20120724

• Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas.

  British journal of cancer 20120724

• Squalenoylation: a generic platform for nanoparticular drug delivery.

  Journal of controlled release : official journal of the Controlled Release Society 20120720

• Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma.

  International journal of radiation oncology, biology, physics 20120715

• Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

  JAMA 20120711

• Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710

• Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer.

  JOP : Journal of the pancreas 20120710

• Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer.

  International journal of cancer 20120701

• Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy.

  Annals of surgical oncology 20120701

• Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection.

  Annals of surgical oncology 20120701

• Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

  The British journal of nutrition 20120701

• Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo.

  European journal of cancer (Oxford, England : 1990) 20120701

• Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).

  Annals of oncology : official journal of the European Society for Medical Oncology 20120701

• Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.

  International journal of radiation oncology, biology, physics 20120701

• Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer.

  International journal of radiation oncology, biology, physics 20120701

• Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.

  Annals of surgical oncology 20120701

• Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.

  Journal of hepato-biliary-pancreatic sciences 20120701

• Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.

  Journal of hepato-biliary-pancreatic sciences 20120701

• Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial).

  Journal of hepato-biliary-pancreatic sciences 20120701

• Analysis of local control in patients receiving IMRT for resected pancreatic cancers.

  International journal of radiation oncology, biology, physics 20120701

• A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905.

  Lung cancer (Amsterdam, Netherlands) 20120701

• The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice.

  Journal of hepatology 20120701

• A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study).

  Lung cancer (Amsterdam, Netherlands) 20120701

• Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells.

  Pharmaceutical research 20120701

• Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.

  International journal of radiation oncology, biology, physics 20120701

• Role of chemotherapy in treatments for biliary tract cancer.

  Journal of hepato-biliary-pancreatic sciences 20120701

• ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.

  International journal of oncology 20120701

• Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.

  Biochemical pharmacology 20120701

• CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.

  Molecular cancer therapeutics 20120701

• Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors.

  Cancer investigation 20120701

• Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cells.

  International journal of molecular medicine 20120701

• The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer.

  International journal of oncology 20120701

• Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.

  Journal of cutaneous pathology 20120701

• A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.

  Cancer biology & therapy 20120701

• Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120701

• Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer.

  Pancreas 20120701

• Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis.

  Omics : a journal of integrative biology 20120701

• Recurrent lower extremity pseudocellulitis.

  American journal of therapeutics 20120701

• Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.

  Pharmacogenomics 20120701

• Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine.

  Pharmacogenomics 20120701

• Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?

  Pharmacogenomics 20120701

• Systemic therapy of advanced pancreatic cancer: has the landscape changed?

  Clinical advances in hematology & oncology : H&O 20120701

• [Curative effect of 3D-CRT combined with gemcitabine concurrently with addition of Kanglaite Injection in treatment of locally advanced pancreatic].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120701

• Label-free Raman spectroscopy for accessing intracellular anticancer drug release on gold nanoparticles.

  The Analyst 20120621

• Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.

  World journal of gastroenterology 20120621

• Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.

  Cancer 20120615

• Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles.

  International journal of pharmaceutics 20120615

• Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120615

• A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120615

• Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas.

  Journal of medicinal chemistry 20120614

• Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts.

  World journal of gastroenterology 20120614

• A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.

  British journal of cancer 20120605

• A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer.

  Investigational new drugs 20120601

• Cost-effectiveness of gemcitabine + cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer.

  Journal of gastrointestinal cancer 20120601

• Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation.

  Journal of gastrointestinal cancer 20120601

• A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.

  Medical oncology (Northwood, London, England) 20120601

• Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.

  Medical oncology (Northwood, London, England) 20120601

• A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma.

  American journal of clinical oncology 20120601

• Real-world impact of availability of adjuvant therapy on outcomes in patients with resected pancreatic adenocarcinoma: a Canadian Cancer Agency experience.

  American journal of clinical oncology 20120601

• Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells.

  Integrative cancer therapies 20120601

• Multidisciplinary treatment with chemotherapy, targeted drug, and high-intensity focused ultrasound in advanced pancreatic carcinoma.

  Medical oncology (Northwood, London, England) 20120601

• A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.

  Investigational new drugs 20120601

• A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer.

  Investigational new drugs 20120601

• A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer.

  Investigational new drugs 20120601

• A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy.

  Investigational new drugs 20120601

• Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer.

  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20120601

• Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival.

  International journal of radiation oncology, biology, physics 20120601

• Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601

• Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.

  European journal of cancer (Oxford, England : 1990) 20120601

• Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids.

  Cancer letters 20120601

• Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20120601

• Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.

  Cancer letters 20120601

• Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601

• Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway.

  Anti-cancer agents in medicinal chemistry 20120601

• Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.

  Anti-cancer drugs 20120601

• The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum.

  Cancer chemotherapy and pharmacology 20120601

• Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.

  International journal of oncology 20120601

• TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.

  Cancer chemotherapy and pharmacology 20120601

• CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells.

  Oncology reports 20120601

• Neoadjuvant therapy for resectable and borderline resectable adenocarcinoma of the pancreas.

  Current drug targets 20120601

• Conventional chemotherapy of advanced pancreatic cancer.

  Current drug targets 20120601

• Prognostic significance of aquaporins in human biliary tract carcinoma.

  Oncology reports 20120601

• Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120601

• Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20120601

• Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine.

  AJR. American journal of roentgenology 20120601

• Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1.

  Cancer discovery 20120601

• Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120601

• Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20120601

• Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells.

  Anticancer research 20120601

• Gemcitabine-induced severe peripheral edema in a patient with lung cancer.

  Journal of pharmacy practice 20120601

• Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

  Neoplasia (New York, N.Y.) 20120601

• Molecular changes in pancreatic cancer: implications for molecular targeting therapy.

  Acta gastro-enterologica Belgica 20120601

• [Efficacy of gemcitabine and vinorelbine in first-line treatment with advanced non-small cell lung cancer: a multicentre retrospective study].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520

• [Selected arterial infusion chemotherapy combined with target drugs for non-small cell lung cancer with multiple brain metastase].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520

• Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer.

  International journal of pharmaceutics 20120510

• Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.

  Journal of the American Chemical Society 20120509

• [Cerebral infarction after cisplatin-gemcitabine chemotherapy: probable cause-effect].

  Neurologia (Barcelona, Spain) 20120501

• Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome.

  The Journal of dermatology 20120501

• A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.

  Annals of surgical oncology 20120501

• Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine therapy.

  Hepato-gastroenterology 20120501

• Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study.

  Cancer 20120501

• Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case.

  Surgery today 20120501

• Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials.

  Lung cancer (Amsterdam, Netherlands) 20120501

• Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

  Cell death and differentiation 20120501

• Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease.

  Annals of surgical oncology 20120501

• Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma.

  European journal of cancer (Oxford, England : 1990) 20120501

• Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.

  Cancer letters 20120501

• Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies.

  Cancer chemotherapy and pharmacology 20120501

• A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.

  Cancer chemotherapy and pharmacology 20120501

• Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002).

  Cancer chemotherapy and pharmacology 20120501

• Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).

  Cancer chemotherapy and pharmacology 20120501

• Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.

  International journal of oncology 20120501

• Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.

  Journal of cancer research and clinical oncology 20120501

• Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials.

  Cancer chemotherapy and pharmacology 20120501

• RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20120501

• Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120501

• Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine.

  Cancer science 20120501

• Primary hepatocellular carcinoma of the pancreas: a case report and review of the heterogeneous group of pancreatic hepatoid carcinomas.

  Histopathology 20120501

• A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120501

• Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines.

  Gene 20120501

• Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma.

  Acta oncologica (Stockholm, Sweden) 20120501

• Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

  European journal of cancer (Oxford, England : 1990) 20120501

• Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin.

  International journal of antimicrobial agents 20120501

• Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.

  Japanese journal of clinical oncology 20120501

• A Bayesian integrative genomic model for pathway analysis of complex traits.

  Genetic epidemiology 20120501

• Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer.

  Cancer investigation 20120501

• An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer.

  Hepato-gastroenterology 20120501

• Noxa enhances the cytotoxic effect of gemcitabine in human ovarian cancer cells.

  Cancer biotherapy & radiopharmaceuticals 20120501

• Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.

  Pancreas 20120501

• Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports.

  Cancer biology & therapy 20120501

• [Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120501

• The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2.

  Anticancer research 20120501

• Combination therapy with gemcitabine (GEM) and erlotinib (E) in exocrine pancreatic cancer under special reference to RASH and the tumour marker CA19-9.

  Anticancer research 20120501

• Variability of gemcitabine accumulation and its relationship to expression of nucleoside transporters in peripheral blood mononuclear cells.

  Archives of pharmacal research 20120501

• [Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120501

• DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.

  Biochemical and biophysical research communications 20120427

• A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120415

• Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine.

  Investigational new drugs 20120401

• The expression of interferon receptor α/β in human pancreatic cancer in nude mice is essential for tumor response to interferon α treatment.

  The Journal of surgical research 20120401

• A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.

  Investigational new drugs 20120401

• (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts.

  Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20120401

• Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract.

  International journal of cancer 20120401

• A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01.

  Breast cancer research and treatment 20120401

• Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients.

  Cancer chemotherapy and pharmacology 20120401

• Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.

  International journal of oncology 20120401

• Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120401

• Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts.

  Oncology reports 20120401

• Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.

  Molecular therapy : the journal of the American Society of Gene Therapy 20120401

• Discovery of drugs that possess activity against feline leukemia virus.

  The Journal of general virology 20120401

• Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.

  European journal of gastroenterology & hepatology 20120401

• Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma.

  Academic radiology 20120401

• Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

  Antimicrobial agents and chemotherapy 20120401

• A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.

  Pharmacogenetics and genomics 20120401

• A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120401

• Navitoclax (ABT-263) reduces Bcl-x(L)-mediated chemoresistance in ovarian cancer models.

  Molecular cancer therapeutics 20120401

• Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells.

  The FEBS journal 20120401

• Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster.

  Pharmacogenetics and genomics 20120401

• Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120401

• First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120401

• Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120401

• Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine.

  Expert opinion on investigational drugs 20120401

• Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20120401

• Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20120401

• Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer.

  Pancreas 20120401

• Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic.

  Bulletin du cancer 20120401

• [The evaluation of chemotherapy for patients over eighty-years-old].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120401

• Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer.

  World journal of gastroenterology 20120328

• Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

  Cancer cell 20120320

• Intensity-modulated radiotherapy for pancreatic adenocarcinoma.

  International journal of radiation oncology, biology, physics 20120315

• Mutagen-mediated enhancement of HIV-1 replication in persistently infected cells.

  Virology 20120315

• Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.

  British journal of cancer 20120313

• What options are available for refractory pancreatic cancer?

  JOP : Journal of the pancreas 20120310

• Novel agents in early phase clinical studies on refractory pancreatic cancer.

  JOP : Journal of the pancreas 20120310

• Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

  Medical oncology (Northwood, London, England) 20120301

• Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review.

  Medical oncology (Northwood, London, England) 20120301

• Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients.

  Medical oncology (Northwood, London, England) 20120301

• Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer.

  Medical oncology (Northwood, London, England) 20120301

• Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study.

  Medical oncology (Northwood, London, England) 20120301

• Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120301

• Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.

  Analytical and bioanalytical chemistry 20120301

• Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20120301

• Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120301

• Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma.

  Pancreas 20120301

• Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.

  Leukemia & lymphoma 20120301

• Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120301

• RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis.

  Lung cancer (Amsterdam, Netherlands) 20120301

• Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120301

• MicroRNA miR-548d is a superior regulator in pancreatic cancer.

  Pancreas 20120301

• Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.

  Cancer chemotherapy and pharmacology 20120301

• [When should systemic chemotherapy be used for urinary bladder carcinoma?].

  Der Urologe. Ausg. A 20120301

• The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer.

  Journal of cellular biochemistry 20120301

• PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells.

  International journal of oncology 20120301

• Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

  Journal of gastroenterology 20120301

• Metastatic clear cell adenocarcinoma of the urethra in a male patient: report of a case.

  Clinical genitourinary cancer 20120301

• Combination of hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas.

  Pancreas 20120301

• Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.

  International journal of oncology 20120301

• Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

  Cancer prevention research (Philadelphia, Pa.) 20120301

• Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabine.

  The AAPS journal 20120301

• Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.

  Gynecologic oncology 20120301

• Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study.

  Current medical research and opinion 20120301

• Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis.

  Molecular cancer therapeutics 20120301

• Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120301

• A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells.

  Oncology reports 20120301

• Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines.

  Molecular medicine reports 20120301

• Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital.

  Journal of pediatric hematology/oncology 20120301

• Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

  The Lancet. Oncology 20120301

• Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.

  European journal of cancer (Oxford, England : 1990) 20120301

• First-line chemotherapy in epithelial ovarian cancer.

  Clinical obstetrics and gynecology 20120301

• A rational approach to the management of recurrent or persistent ovarian carcinoma.

  Clinical obstetrics and gynecology 20120301

• Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

  The oncologist 20120301

• Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer.

  Asia-Pacific journal of clinical oncology 20120301

• [A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20120301

• Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine.

  Anticancer research 20120301

• Phase II study of panobinostat and bortezomib in patients with pancreatic cancer progressing on gemcitabine-based therapy.

  Anticancer research 20120301

• [A case of pancreatic cancer with liver metastasis controlled effectively by chemotherapy based on chemosensitivity test and stereotactic body radiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• [Successful gemcitabine-nedaplatin therapy in a hemodialysis patient with ureteral carcinoma after bilateral nephroureterectomy].

  Hinyokika kiyo. Acta urologica Japonica 20120301

• Drug interactions: the importance of looking inside cancer cells.

  Cancer discovery 20120301

• nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

  Cancer discovery 20120301

• Developments in metastatic pancreatic cancer: is gemcitabine still the standard?

  World journal of gastroenterology 20120227

• Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma.

  Journal of proteomics 20120216

• Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.

  Cancer 20120215

• Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

  British journal of cancer 20120214

• Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.

  Investigational new drugs 20120201

• Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.

  Investigational new drugs 20120201

• Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report.

  Investigational new drugs 20120201

• Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

  International journal of radiation oncology, biology, physics 20120201

• Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients.

  American journal of clinical oncology 20120201

• Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.

  American journal of clinical oncology 20120201

• Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120201

• Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer.

  International journal of radiation oncology, biology, physics 20120201

• Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.

  Cancer chemotherapy and pharmacology 20120201

• Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

  Cancer chemotherapy and pharmacology 20120201

• The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20120201

• Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model.

  Journal of gastroenterology and hepatology 20120201

• A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20120201

• A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20120201

• The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.

  Cancer chemotherapy and pharmacology 20120201

• Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20120201

• Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function.

  Anti-cancer drugs 20120201

• Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages.

  International journal of oncology 20120201

• A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.

  Anti-cancer drugs 20120201

• HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.

  Cancer letters 20120201

• A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma.

  Gynecologic oncology 20120201

• Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.

  Oncology reports 20120201

• Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management.

  Gynecologic oncology 20120201

• Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).

  Journal of pain and symptom management 20120201

• Targeting quiescent tumor cells via oxygen and IGF-I supplementation.

  Cancer research 20120201

• Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.

  Pharmacogenetics and genomics 20120201

• Biliary-tract cancer: improving therapy by adding molecularly targeted agents.

  The Lancet. Oncology 20120201

• Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

  The Lancet. Oncology 20120201

• Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.

  Urology 20120201

• Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.

  Molecular cancer therapeutics 20120201

• Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells.

  Anticancer research 20120201

• Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120201

• Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.

  BJU international 20120201

• [A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120201

• [A case of a patient with bladder cancer who received warfarin and showed a significantly prolonged PT-INR after gemcitabine and cisplatin combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120201

• EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.

  Journal of controlled release : official journal of the Controlled Release Society 20120130

• Bevacizumab added to neoadjuvant chemotherapy for breast cancer.

  The New England journal of medicine 20120126

• [Phase II trial of improved regimen with gemcitabine in patients with advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120120

• Intravesical gemcitabine for non-muscle invasive bladder cancer.

  The Cochrane database of systematic reviews 20120118

• Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.

  International journal of pharmaceutics 20120117

• A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120115

• Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1.

  Journal of controlled release : official journal of the Controlled Release Society 20120110

• Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110

• Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110

• The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.

  British journal of cancer 20120103

• Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study.

  Veterinary journal (London, England : 1997) 20120101

• A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine.

  Cancer chemotherapy and pharmacology 20120101

• Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.

  Cancer chemotherapy and pharmacology 20120101

• A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).

  Cancer chemotherapy and pharmacology 20120101

• Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells.

  Cancer chemotherapy and pharmacology 20120101

• Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20120101

• Different combination schedules of gemcitabine with endostar affect antitumor efficacy.

  Cancer chemotherapy and pharmacology 20120101

• Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder.

  Cancer 20120101

• Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed.

  Cancer 20120101

• Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation.

  Lung cancer (Amsterdam, Netherlands) 20120101

• Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.

  Journal of neuro-oncology 20120101

• Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.

  Clinical lung cancer 20120101

• A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101

• Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase.

  Pancreas 20120101

• Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer.

  Cancer science 20120101

• Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer.

  Cancer letters 20120101

• ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine.

  Oncology reports 20120101

• A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.

  Molecular cancer therapeutics 20120101

• Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101

• Bevacizumab-induced laryngeal necrosis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120101

• Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120101

• [Population pharmacokinetics of gemcitabine applied to personalize the dosage used in cancer patients].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101

• Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience.

  Neoplasma 20120101

• Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer.

  Annals of surgery 20120101

• The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.

  Pharmacogenetics and genomics 20120101

• Role of myeloid-derived suppressor cells in tumor immunotherapy.

  Immunotherapy 20120101

• Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atoms.

  Translational research : the journal of laboratory and clinical medicine 20120101

• Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis.

  Hepato-gastroenterology 20120101

• Cutaneous presentation of a distant metastasis of malignant phyllodes tumor.

  International journal of dermatology 20120101

• Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review.

  Journal of digestive diseases 20120101

• Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.

  International journal of biological sciences 20120101

• [A case of adenosquamous carcinoma of lower extrahepatic bile duct].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120101

• [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120101

• Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer.

  BMC cancer 20120101

• Gemcitabine: a critical nucleoside for cancer therapy.

  Current medicinal chemistry 20120101

• Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

  PloS one 20120101

• In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells.

  Radiation oncology (London, England) 20120101

• Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20120101

• High-pressure intrapleural chemotherapy: feasibility in the pig model.

  World journal of surgical oncology 20120101

• Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.

  International journal of molecular sciences 20120101

• A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.

  Oncology 20120101

• Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study.

  Neoplasma 20120101

• EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.

  PloS one 20120101

• Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.

  Nucleosides, nucleotides & nucleic acids 20120101

• DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.

  PloS one 20120101

• A phase II study of first-line chemotherapy with weekly carboplatin plus gemcitabine in advanced non-small cell lung cancer.

  Chemotherapy 20120101

• Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.

  Radiation oncology (London, England) 20120101

• Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations.

  Current pharmaceutical design 20120101

• Combination of gemcitabine and carboplatin in urothelial cancer patients unfit for cisplatin due to impaired renal or cardiac function.

  International braz j urol : official journal of the Brazilian Society of Urology 20120101

• Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.

  Cancer genomics & proteomics 20120101

• Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

  PloS one 20120101

• Current approaches to the management of Her2-negative metastatic breast cancer.

  Breast cancer research : BCR 20120101

• Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

  BMC cancer 20120101

• A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes.

  Hematology/oncology and stem cell therapy 20120101

• Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.

  Radiation oncology (London, England) 20120101

• Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization.

  Hepato-gastroenterology 20120101

• Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.

  Internal medicine (Tokyo, Japan) 20120101

• [Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20120101

• Genetic association studies of copy-number variation: should assignment of copy number states precede testing?

  PloS one 20120101

• A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.

  Swiss medical weekly 20120101

• Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.

  PloS one 20120101

• Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature.

  The Pan African medical journal 20120101

• Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20120101

• Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma.

  PloS one 20120101

• Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.

  Chemotherapy 20120101

• FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer.

  PloS one 20120101

• Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.

  International journal of nanomedicine 20120101

• Malignant fibrous histiocytoma of the ovary: a case report.

  European journal of gynaecological oncology 20120101

• Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.

  PloS one 20120101

• Chemotherapy-related thrombocytosis: does it increase the risk of thromboembolism?

  Oncology 20120101

• Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine.

  International journal of nanomedicine 20120101

• Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.

  International journal of clinical and experimental pathology 20120101

• Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.

  BMC cancer 20120101

• [Basic investigation for classification of anticancer drugs by pharmacological effects].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101

• Intermittent chemotherapy is a treatment choice for advanced urothelial cancer.

  Oncology 20120101

• Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.

  PloS one 20120101

• Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy.

  BMC cancer 20120101

• Surface-modified gemcitabine with mucoadhesive polymer for oral delivery.

  Journal of microencapsulation 20120101

• Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.

  Journal of toxicology and environmental health. Part A 20120101

• Efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20120101

• Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.

  PloS one 20120101

• Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20120101

• Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers.

  Journal of translational medicine 20120101

• [Combined effect of gemcitabine and lomustine in mice with intracranial transplanted lymphosarcoma LIO-1].

  Voprosy onkologii 20120101

• Effective use of gemcitabine in the treatment of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas with portal vein tumor thrombus.

  Internal medicine (Tokyo, Japan) 20120101

• Cisplatin-based therapy for the treatment of elderly patients with non-small-cell lung cancer: a retrospective analysis of a single institution.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Gemcitabine-based concurrent chemoradiotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Synergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro.

  PloS one 20120101

• Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.

  PloS one 20120101

• Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.

  Journal of experimental & clinical cancer research : CR 20120101

• Preclinical combination therapy of clofarabine plus radiation.

  Nucleosides, nucleotides & nucleic acids 20120101

• Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin.

  Oncology research 20120101

• Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.

  Onkologie 20120101

• Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma.

  PloS one 20120101

• Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth.

  BMC bioinformatics 20120101

• Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Retrospective study of gemcitabine based chemotherapy for unresectable or recurrent esophagus squamous cell carcinoma refractory to first line chemotherapy.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Involvement of phosphatidylinositol 3-kinase/Akt pathway in gemcitabine-induced apoptosis-like cell death in insulinoma cell line INS-1.

  Biological & pharmaceutical bulletin 20120101

• Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.

  Cancer letters 20111227

• Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells.

  Cancer letters 20111227

• Taxane doublets for metastatic breast cancer: do we need another cytotoxic pair or another approach?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111220

• Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111220

• SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner.

  Cancer research 20111215

• Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.

  Biochemical and biophysical research communications 20111209

• Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.

  Blood 20111208

• A phase I study of topotecan and gemcitabine in advanced solid tumors.

  Investigational new drugs 20111201

• Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.

  Investigational new drugs 20111201

• Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer.

  Medical oncology (Northwood, London, England) 20111201

• Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy.

  Medical oncology (Northwood, London, England) 20111201

• Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism?

  Journal of gastrointestinal cancer 20111201

• Conditions causing gemcitabine crystallization.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20111201

• Phase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumors.

  American journal of clinical oncology 20111201

• Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience.

  Medical oncology (Northwood, London, England) 20111201

• Metachronous multiple adenocarcinomas of the pancreas.

  International journal of clinical oncology 20111201

• Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.

  Nanomedicine : nanotechnology, biology, and medicine 20111201

• Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.

  International journal of radiation oncology, biology, physics 20111201

• Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

  Cancer chemotherapy and pharmacology 20111201

• A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity.

  International journal of clinical oncology 20111201

• Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.

  Cancer chemotherapy and pharmacology 20111201

• Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.

  Nanomedicine : nanotechnology, biology, and medicine 20111201

• A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.

  Cancer chemotherapy and pharmacology 20111201

• Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells.

  International journal of clinical oncology 20111201

• Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational 'SUN' (Survey on the lUng cancer maNagement) study.

  Lung cancer (Amsterdam, Netherlands) 20111201

• In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma.

  Toxicology in vitro : an international journal published in association with BIBRA 20111201

• Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study.

  Journal of aerosol medicine and pulmonary drug delivery 20111201

• Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer.

  Scandinavian journal of urology and nephrology 20111201

• c-Met is a marker of pancreatic cancer stem cells and therapeutic target.

  Gastroenterology 20111201

• A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201

• Chemotherapy in elderly patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20111201

• Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer.

  Oncology reports 20111201

• The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer.

  Journal of cancer research and clinical oncology 20111201

• Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer.

  Expert opinion on drug metabolism & toxicology 20111201

• Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201

• Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer.

  Molecular cancer therapeutics 20111201

• Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.

  Gynecologic oncology 20111201

• Synchronous bilateral urothelial cancer in a kidney recipient.

  International journal of urology : official journal of the Japanese Urological Association 20111201

• High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy.

  International journal of urology : official journal of the Japanese Urological Association 20111201

• Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201

• Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas.

  Veterinary and comparative oncology 20111201

• Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.

  Expert opinion on drug delivery 20111201

• Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.

  Nucleosides, nucleotides & nucleic acids 20111201

• Determination of the phosphorylated metabolites of gemcitabine and of difluorodeoxyuridine by LCMSMS.

  Nucleosides, nucleotides & nucleic acids 20111201

• Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells.

  Nucleosides, nucleotides & nucleic acids 20111201

• [Chemotherapy of metastatic pancreatic adenocarcinoma: challenges and encouraging results].

  Bulletin du cancer 20111201

• [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111201

• Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer.

  Asia-Pacific journal of clinical oncology 20111201

• [First line therapy for local advanced or metastasized urothelial carcinoma: randomized double-blind phase II study to compare gemcitabin and cisplatin in combination with OGX-427 or placebo for advanced transitional cell carcinoma of the bladder (OGX-427 - AB 39/11 of the Working Group Urological Oncology)].

  Der Urologe. Ausg. A 20111201

• [Safety profiles of gemcitabine hydrochloride(GEMZAR®)in Japanese clinical studies].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111201

• Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.

  Anticancer research 20111201

• [Effect of gemcitabine in enhancing the radiosensitivity of HepG2 hepatoma cells and the possible mechanism].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201

• Requirement of nuclear factor κB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis.

  Neoplasia (New York, N.Y.) 20111201

• Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial.

  Chinese medical journal 20111201

• Radiotherapy: the importance of local control in pancreatic cancer.

  Nature reviews. Clinical oncology 20111129

• Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105.

  International journal of radiation oncology, biology, physics 20111115

• Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: Phase I study.

  International journal of radiation oncology, biology, physics 20111115

• Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer.

  International journal of radiation oncology, biology, physics 20111115

• Systemic management strategies for metastatic soft tissue sarcoma.

  Drugs 20111112

• Hand-foot hyperpigmentation skin lesions associated with combination gemcitabine-carboplatin (GemCarbo) therapy.

  American journal of therapeutics 20111101

• Reversible neuropathy after chemotherapy for metastatic adenocarcinoma from an unknown primary tumor to the sural nerve.

  American journal of therapeutics 20111101

• Congenital retroperitoneal vascular anomalies: impact on pelvic surgery.

  Archives of gynecology and obstetrics 20111101

• Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111101

• Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111101

• First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group.

  Cancer chemotherapy and pharmacology 20111101

• A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy.

  Cancer chemotherapy and pharmacology 20111101

• Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20111101

• Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines.

  Lung cancer (Amsterdam, Netherlands) 20111101

• Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.

  International journal of oncology 20111101

• Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence.

  Respirology (Carlton, Vic.) 20111101

• Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.

  Oncology reports 20111101

• The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase.

  Drug metabolism and disposition: the biological fate of chemicals 20111101

• Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology trial AB20/99).

  European urology 20111101

• Ethnic difference in hematological toxicity in patients with non-small cell lung cancer treated with chemotherapy: a pooled analysis on Asian versus non-Asian in phase II and III clinical trials.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101

• Gene set analysis of purine and pyrimidine antimetabolites cancer therapies.

  Pharmacogenetics and genomics 20111101

• Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.

  Molecular cancer therapeutics 20111101

• Acute digital ischemia complicating gemcitabine and carboplatin combination chemotherapy for ovarian cancer.

  Acta obstetricia et gynecologica Scandinavica 20111101

• Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells.

  Molecular bioSystems 20111101

• Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.

  The Journal of urology 20111101

• Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101

• Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101

• Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101

• Locally advanced pancreatic cancer: where should we go from here?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101

• Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival.

  Pancreas 20111101

• [Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20111101

• A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer.

  Cancer investigation 20111101

• Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

  The Lancet. Oncology 20111101

• [Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111101

• Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide.

  Anticancer research 20111101

• Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer.

  Anticancer research 20111101

• [A pilot study of intraperitoneal gemcitabine for reduction of peritoneal dissemination in advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [An example case that chemoradiotherapy was succeeded for unresectable pancreas cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [An operated case of metastasis to the small intestine from lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [Curative resection of gallbladder cancer with simultaneous liver metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A novel gemcitabine delivery system].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [Re-resection for local recurrence in the remnant pancreas after pancreaticoduodenectomy for pancreatic cancer- a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A case of intrahepatic cholangiocarcinoma with invasion to right adrenal gland].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [A randomized controlled trial of the efficacy of combination of gemcitabine and carboplatin or paclitaxel and combination of paclitaxel and carboplatin in the treatment for advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20111101

• [MicroRNA expression pattern in intraductal papillary mucinous neoplasm].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111025

• CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells.

  Life sciences 20111024

• Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma.

  International journal of cancer 20111015

• Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protein kinase.

  Biochemical and biophysical research communications 20111014

• HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.

  Blood 20111013

• A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study).

  British journal of cancer 20111011

• Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

  The Cochrane database of systematic reviews 20111005

• Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.

  Investigational new drugs 20111001

• Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies.

  Investigational new drugs 20111001

• Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness.

  Investigational new drugs 20111001

• A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study.

  American journal of clinical oncology 20111001

• A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981.

  American journal of clinical oncology 20111001

• Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer.

  Critical reviews in oncology/hematology 20111001

• Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer.

  BJU international 20111001

• Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial.

  Cancer chemotherapy and pharmacology 20111001

• Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.

  Cancer chemotherapy and pharmacology 20111001

• Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.

  International journal of clinical oncology 20111001

• Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study.

  International journal of clinical oncology 20111001

• Treatment of borderline cases for curative resection of biliary tract cancer.

  Journal of surgical oncology 20111001

• Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.

  Journal of the American Academy of Dermatology 20111001

• Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT.

  International journal of radiation oncology, biology, physics 20111001

• Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation.

  Biomedical microdevices 20111001

• Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review.

  The Lancet. Oncology 20111001

• Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111001

• Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.

  European urology 20111001

• Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.

  International journal of oncology 20111001

• SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.

  Gynecologic oncology 20111001

• Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.

  Cancer chemotherapy and pharmacology 20111001

• The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.

  Experimental hematology 20111001

• Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.

  Cancer biology & therapy 20111001

• Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.

  Cancer biology & therapy 20111001

• Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer.

  Journal of cancer research and clinical oncology 20111001

• An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.

  Cancer gene therapy 20111001

• Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy.

  Molecular cancer therapeutics 20111001

• FOLFIRINOX: a small step or a great leap forward?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001

• Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.

  Japanese journal of clinical oncology 20111001

• Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells.

  Cancer biotherapy & radiopharmaceuticals 20111001

• Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1.

  Anticancer research 20111001

• Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma.

  Anticancer research 20111001

• [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001

• [Evidences for adjuvant therapy of resected pancreatic cancer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001

• OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.

  Cell death & disease 20111001

• Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.

  Neoplasia (New York, N.Y.) 20111001

• Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide.

  Biochemical and biophysical research communications 20110923

• Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

  Lancet (London, England) 20110917

• Combination chemotherapy for older adults with advanced non-small-cell lung cancer.

  Lancet (London, England) 20110917

• Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110915

• Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110915

• Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

  World journal of gastroenterology 20110907

• Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.

  Medical oncology (Northwood, London, England) 20110901

• A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.

  Journal of gastrointestinal cancer 20110901

• Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.

  Cancer chemotherapy and pharmacology 20110901

• ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478.

  Lung cancer (Amsterdam, Netherlands) 20110901

• Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.

  Lung cancer (Amsterdam, Netherlands) 20110901

• Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection.

  Annals of surgical oncology 20110901

• Gemcitabine-induced acute myositis in a patient with duodenal cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20110901

• Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.

  Journal of hepato-biliary-pancreatic sciences 20110901

• Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20110901

• Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response.

  Cancer immunology, immunotherapy : CII 20110901

• Chemotherapy and targeted therapies for unresectable malignant mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20110901

• Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.

  Gynecologic oncology 20110901

• Triphendiol (NV-196), development of a novel therapy for pancreatic cancer.

  Anti-cancer drugs 20110901

• Chemotherapy only for localized Hodgkin lymphoma.

  Journal of internal medicine 20110901

• Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1.

  Journal of ethnopharmacology 20110901

• A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110901

• Circulating tumor cells count and characterization in a male breast cancer patient.

  Cancer biology & therapy 20110901

• Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110901

• Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20110901

• The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience.

  Anticancer research 20110901

• Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

  Lasers in surgery and medicine 20110901

• [Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied in advanced pancreatic cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20110901

• [Experience with gemcitabine monotherapy in three patients with metastatic urothelial carcinoma].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20110901

• β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction.

  European journal of pharmacology 20110831

• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  The New England journal of medicine 20110825

• Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.

  Cancer 20110815

• Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells.

  International journal of cancer 20110815

• Gemcitabine in elderly patients with advanced pancreatic cancer.

  World journal of gastroenterology 20110814

• Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.

  Journal of the National Cancer Institute 20110803

• A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer.

  Investigational new drugs 20110801

• Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20110801

• Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.

  Cancer chemotherapy and pharmacology 20110801

• Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.

  Lung cancer (Amsterdam, Netherlands) 20110801

• The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status.

  Lung cancer (Amsterdam, Netherlands) 20110801

• The promise of a personalized genomic approach to pancreatic cancer and why targeted therapies have missed the mark.

  World journal of surgery 20110801

• Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.

  Cancer 20110801

• Progressive multifocal leukoencephalopathy following chemotherapy for lung cancer.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110801

• ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration.

  International journal of clinical oncology 20110801

• The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

  International journal of clinical oncology 20110801

• MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.

  Annals of surgical oncology 20110801

• Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy.

  Cancer letters 20110801

• A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells.

  Cancer letters 20110801

• Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer.

  Pancreas 20110801

• Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment.

  European journal of cancer (Oxford, England : 1990) 20110801

• Novel approaches to treatment of leiomyosarcomas.

  Current oncology reports 20110801

• Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.

  Journal of surgical oncology 20110801

• The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110801

• Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer.

  Pancreas 20110801

• Identification of genes associated to 2',2'-difluorodeoxycytidine resistance in HeLa cells with a lentiviral short-hairpin RNA library.

  Biochemical pharmacology 20110801

• Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.

  Expert opinion on drug metabolism & toxicology 20110801

• Emerging pharmacotherapeutic strategies for cholangiocarcinoma.

  Expert opinion on pharmacotherapy 20110801

• Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy.

  Cancer biology & therapy 20110801

• A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.

  Cancer biology & therapy 20110801

• Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil.

  International journal of oncology 20110801

• Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110801

• [New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110801

• Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

  Cancer research 20110801

• Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer.

  Japanese journal of clinical oncology 20110801

• A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.

  Clinical breast cancer 20110801

• Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.

  Cancer biology & therapy 20110801

• [First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO].

  Der Urologe. Ausg. A 20110801

• Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

  The Lancet. Oncology 20110801

• Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study.

  Journal of chemotherapy (Florence, Italy) 20110801

• New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110801

• [A randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patients].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110720

• Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer.

  Cancer 20110715

• Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.

  Cancer research 20110715

• Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the '2011 ASCO Annual Meeting'. Chicago, IL, USA; June 3-7, 2011.

  JOP : Journal of the pancreas 20110708

• Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug.

  The Analyst 20110707

• A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer.

  Cancer chemotherapy and pharmacology 20110701

• Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients.

  Cancer chemotherapy and pharmacology 20110701

• Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).

  Lung cancer (Amsterdam, Netherlands) 20110701

• The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy.

  BJU international 20110701

• Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110701

• Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110701

• A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer.

  Breast cancer (Tokyo, Japan) 20110701

• Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma.

  Gynecologic oncology 20110701

• Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial.

  Breast cancer (Tokyo, Japan) 20110701

• UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity.

  Biochemical pharmacology 20110701

• Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer.

  Anti-cancer drugs 20110701

• Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study.

  Gynecologic oncology 20110701

• Metastatic pancreatic cancer: old drugs, new paradigms.

  Current opinion in oncology 20110701

• NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer.

  World journal of surgery 20110701

• Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL.

  International journal of oncology 20110701

• Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

  European journal of cancer (Oxford, England : 1990) 20110701

• Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1.

  Molecular cancer therapeutics 20110701

• Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children.

  Journal of pediatric hematology/oncology 20110701

• Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110701

• Increased expression of DNA repair genes in invasive human pancreatic cancer cells.

  Pancreas 20110701

• A man with a testicular mass and a colon stenosis. Diagnosis: Metastatic pancreatic adenocarcinoma to the gonads.

  Gastroenterology 20110701

• Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.

  Japanese journal of clinical oncology 20110701

• Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer.

  Pancreas 20110701

• Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.

  BJU international 20110701

• [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110701

• Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110701

• [Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin].

  Hinyokika kiyo. Acta urologica Japonica 20110701

• Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system.

  Anticancer research 20110701

• Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620

• [Gemcitabine in RRM1-negative advanced refractory non-small cell lung cancer (NSCLC): a case report].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110620

• Comment on 'Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer,' i.e., all we are saying is, give C a chance.

  Free radical biology & medicine 20110615

• A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003.

  Cancer 20110615

• Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.

  Investigational new drugs 20110601

• Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors.

  Investigational new drugs 20110601

• Gemcitabine and cisplatin in patients with carcinoma of unknown primary site.

  Medical oncology (Northwood, London, England) 20110601

• Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy.

  Critical reviews in oncology/hematology 20110601

• Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer.

  International journal of radiation oncology, biology, physics 20110601

• A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.

  Cancer chemotherapy and pharmacology 20110601

• Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells.

  Cancer epidemiology 20110601

• Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT.

  Annals of hematology 20110601

• Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110601

• Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy.

  Integrative cancer therapies 20110601

• [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110601

• Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells.

  Cancer science 20110601

• Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells.

  International journal of radiation oncology, biology, physics 20110601

• Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

  Free radical biology & medicine 20110601

• Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.

  Oncology reports 20110601

• [Collecting duct renal cell carcinoma].

  Actas urologicas espanolas 20110601

• Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.

  Laboratory investigation; a journal of technical methods and pathology 20110601

• A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis.

  Japanese journal of clinical oncology 20110601

• Treatment of metastatic renal cell carcinoma and renal pelvic cancer.

  Clinical and experimental nephrology 20110601

• Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110601

• Current treatment options for pancreatic carcinoma.

  Current oncology reports 20110601

• High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells.

  Molecular cancer research : MCR 20110601

• Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110601

• Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: a substudy of the Avastin in Lung trial.

  Asia-Pacific journal of clinical oncology 20110601

• An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia.

  Asia-Pacific journal of clinical oncology 20110601

• Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110601

• Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.

  Drugs in R&D 20110601

• Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110601

• Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.

  Anticancer research 20110601

• Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer.

  Journal of chemotherapy (Florence, Italy) 20110601

• A novel effective therapy for refractory angiosarcoma of the face and scalp.

  Clinical advances in hematology & oncology : H&O 20110601

• [Advances of drug resistance marker of gemcitabine for non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110520

• Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.

  Blood 20110519

• AACR highlights: promise for treating pancreatic cancer.

  Journal of the National Cancer Institute 20110518

• In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles.

  International journal of pharmaceutics 20110516

• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  The New England journal of medicine 20110512

• Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma.

  World journal of gastroenterology 20110507

• A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer.

  Critical reviews in oncology/hematology 20110501

• Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20110501

• The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype.

  Cancer chemotherapy and pharmacology 20110501

• Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.

  Acta oncologica (Stockholm, Sweden) 20110501

• Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.

  Oncology reports 20110501

• An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis.

  Biomaterials 20110501

• Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells.

  International journal of oncology 20110501

• MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110501

• Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20110501

• Nonsurgical therapy of biliary tract cancer.

  Current opinion in gastroenterology 20110501

• Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine.

  Clinics and research in hepatology and gastroenterology 20110501

• Are we making progress in curing advanced cervical cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501

• Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501

• Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

  Annals of surgical oncology 20110501

• Multicystic mesothelioma of the pericardium.

  Pathology international 20110501

• Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.

  Neoplasia (New York, N.Y.) 20110501

• [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110501

• [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110501

• Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501

• Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer.

  Health technology assessment (Winchester, England) 20110501

• Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions.

  Anticancer research 20110501

• Off-label use of oxaliplatin in patients with metastatic breast cancer.

  Anticancer research 20110501

• Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501

• Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501

• Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110501

• [Postoperative adjuvant treatment for pancreatic cancer].

  Nihon Geka Gakkai zasshi 20110501

• [Therapeutic perspectives of cutaneous T-cell lymphoma].

  Annales de dermatologie et de venereologie 20110501

• [Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501

• [Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501

• Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110420

• [Relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110420

• Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane.

  Langmuir : the ACS journal of surfaces and colloids 20110419

• Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives.

  Free radical biology & medicine 20110415

• Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110415

• Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.

  Journal of the American Veterinary Medical Association 20110415

• Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.

  The Cochrane database of systematic reviews 20110413

• Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer.

  American journal of clinical oncology 20110401

• A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.

  American journal of clinical oncology 20110401

• The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth.

  Journal of cellular and molecular medicine 20110401

• Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.

  Cancer chemotherapy and pharmacology 20110401

• A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20110401

• A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas.

  Acta oncologica (Stockholm, Sweden) 20110401

• Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma.

  Acta oncologica (Stockholm, Sweden) 20110401

• Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer.

  Annals of surgical oncology 20110401

• Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy.

  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20110401

• Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.

  Annals of surgical oncology 20110401

• A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study.

  Gynecologic oncology 20110401

• Weekly paclitaxel combining with gemcitabine is an effective and safe treatment for advanced breast cancer patients.

  Japanese journal of clinical oncology 20110401

• Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy.

  European journal of cancer (Oxford, England : 1990) 20110401

• Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.

  Oncology reports 20110401

• The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110401

• Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma.

  Pancreas 20110401

• Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor.

  Molecular cancer therapeutics 20110401

• Effect of its deaminated metabolite, 2',2'-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells.

  Biochemical pharmacology 20110401

• Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells.

  Biochemical and biophysical research communications 20110401

• Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.

  Molecular cancer therapeutics 20110401

• Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells.

  Clinical & experimental metastasis 20110401

• Optimizing pemetrexed-gemcitabine combination in patients with advanced non-small cell lung cancer: a pharmacogenetic approach.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110401

• [Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over].

  Presse medicale (Paris, France : 1983) 20110401

• Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20110401

• Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110401

• Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

  Nature medicine 20110401

• Acute transverse myelopathy probably related to intravenous gemcitabine plus cisplatin.

  The Annals of pharmacotherapy 20110401

• Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells.

  Anticancer research 20110401

• Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation.

  Anticancer research 20110401

• [Second line chemotherapy for pancreatic cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401

• Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.

  Cell death & disease 20110401

• Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells.

  Chinese medical journal 20110401

• E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma.

  Chinese medical journal 20110401

• [Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110401

• In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system.

  Journal of nanoscience and nanotechnology 20110401

• Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.

  British journal of cancer 20110329

• CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.

  Science (New York, N.Y.) 20110325

• [Randomize trial of cisplatin plus gemcitabine with either sorafenib or placebo as first-line therapy for non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110320

• The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.

  International journal of cancer 20110315

• Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies.

  Cancer 20110315

• Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• First-line treatment for advanced pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• Treatment for refractory pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• Novel agents in the management of pancreatic adenocarcinoma: phase I studies. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011.

  JOP : Journal of the pancreas 20110309

• Overall survival of patients with advanced pancreatic cancer improved with an increase in second-line chemotherapy after gemcitabine-based therapy.

  JOP : Journal of the pancreas 20110309

• Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdU.

  ChemMedChem 20110307

• High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy.

  Medical oncology (Northwood, London, England) 20110301

• A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib.

  Medical oncology (Northwood, London, England) 20110301

• Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.

  Cancer chemotherapy and pharmacology 20110301

• A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas.

  Cancer chemotherapy and pharmacology 20110301

• A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.

  Cancer chemotherapy and pharmacology 20110301

• Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine.

  International journal of cancer 20110301

• In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents.

  Cancer chemotherapy and pharmacology 20110301

• Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.

  Cancer chemotherapy and pharmacology 20110301

• Pancreatic cancer cells resistant to chemoradiotherapy rich in 'stem-cell-like' tumor cells.

  Digestive diseases and sciences 20110301

• NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer.

  Surgery 20110301

• Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo.

  International journal of cancer 20110301

• Induction chemotherapy for unresectable urothelial carcinoma of the bladder.

  BJU international 20110301

• Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.

  Annals of surgical oncology 20110301

• Treatment trends in metastatic pancreatic cancer patients: Is it time to change?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110301

• Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experiments.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110301

• Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile.

  International journal of oncology 20110301

• Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd).

  Cancer science 20110301

• Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells.

  Cellular & molecular biology letters 20110301

• High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

  International journal of oncology 20110301

• Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine.

  Respiratory care 20110301

• Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours.

  British journal of clinical pharmacology 20110301

• Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110301

• Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.

  British journal of cancer 20110301

• Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.

  The Lancet. Oncology 20110301

• Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20110301

• How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examination to the advanced stage with multiple liver and bone metastases.

  Pancreas 20110301

• A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).

  Leukemia & lymphoma 20110301

• The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.

  Asia-Pacific journal of clinical oncology 20110301

• Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.

  BJU international 20110301

• Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.

  BJU international 20110301

• RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum.

  Journal of Zhejiang University. Science. B 20110301

• [Signet ring cell carcinoma of the ampulla of Vater].

  Gastroenterologia y hepatologia 20110301

• Connexin-26 is a key factor mediating gemcitabine bystander effect.

  Molecular cancer therapeutics 20110301

• [Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110301

• A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.

  Clinical advances in hematology & oncology : H&O 20110301

• Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.

  Clinical lung cancer 20110301

• Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats.

  Die Pharmazie 20110301

• [Relationship between the protein expression of ERCC1, BRCA, β-tubulin and K-ras and the efficacy and prognosis in advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110301

• [The prognostic significance of human equilibrative nucleoside transporter1 (hENT1) expression in metastatic bladder cancer patients treated with gemcitabine-cisplatin based combination chemotherapy].

  Hinyokika kiyo. Acta urologica Japonica 20110301

• Brief commentary: largest randomized trial of biliary tract cancer treatment with cisplatin plus gemcitabine versus gemcitabine alone: an excellent opportunity to evaluate the prognostic value of tumor marker CA 19-9.

  Clinical colorectal cancer 20110301

• Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics.

  ACS nano 20110222

• Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110220

• A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.

  Cancer 20110215

• Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial.

  Cancer 20110215

• Integrating pharmacogenetics into gemcitabine dosing--time for a change?

  Nature reviews. Clinical oncology 20110208

• Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative study.

  Investigational new drugs 20110201

• Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.

  Investigational new drugs 20110201

• Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan.

  American journal of clinical oncology 20110201

• Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.

  American journal of clinical oncology 20110201

• Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301).

  American journal of clinical oncology 20110201

• Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20110201

• In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects.

  Cancer chemotherapy and pharmacology 20110201

• Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.

  Journal of cancer research and clinical oncology 20110201

• Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.

  Cancer chemotherapy and pharmacology 20110201

• Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice.

  Cancer chemotherapy and pharmacology 20110201

• Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma.

  American journal of clinical oncology 20110201

• Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20110201

• Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].

  Annals of oncology : official journal of the European Society for Medical Oncology 20110201

• Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54).

  European journal of haematology 20110201

• A phase II study of outpatient biweekly gemcitabine-oxaliplatin in advanced biliary tract carcinomas.

  Japanese journal of clinical oncology 20110201

• Chemotherapy for thymic tumors: induction, consolidation, palliation.

  Thoracic surgery clinics 20110201

• A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110201

• Cytotoxic effects of new trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their interaction with antitumoral drugs gemcitabine and paclitaxel on cellular lines of human breast cancer.

  Chemico-biological interactions 20110201

• Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.

  Cancer research 20110201

• Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.

  International journal of oncology 20110201

• Targeted combined aerosol chemotherapy in dogs and radiologic toxicity grading.

  Journal of aerosol medicine and pulmonary drug delivery 20110201

• How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system?

  Journal of molecular graphics & modelling 20110201

• Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.

  Cancer science 20110201

• Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110201

• A phase III randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110201

• Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells.

  Molecular cancer therapeutics 20110201

• Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall.

  Pathology international 20110201

• Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110201

• Response to combined molecular targeting: defining the role of P-STAT3.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110201

• Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities.

  Hepatology (Baltimore, Md.) 20110201

• [Pharmacogenomic research for avoiding adverse reactions by anti-cancer drugs].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110201

• Peritoneal fibrosis leading to small bowel obstruction two years after first-line intraperitoneal chemotherapy for optimally debulked ovarian cancer.

  The Australian & New Zealand journal of obstetrics & gynaecology 20110201

• [AUO-study AB34/09: an open-label, randomised, multicentre, phase II study to evaluate the efficacy of chemotherapy with gemcitabine and cisplatin in combination with the EGF receptor antibody panitumumab (GemCisP) versus GemCis in the first-line therapy of locally advanced/metastatic urothelial carcinoma in patients with wild-type HRAS - PURO].

  Der Urologe. Ausg. A 20110201

• Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot study.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110201

• Relationship between single nucleotide polymorphisms in the deoxycytidine kinase gene and chemosensitivity of gemcitabine in six pancreatic cancer cell lines.

  Chinese medical journal 20110201

• [A case of coexisting malignant mesothelioma and squamous cell carcinoma of the lung].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110201

• [Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110201

• [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110201

• [Contribution of microCT structural imaging to preclinical evaluation of hepatocellular carcinoma chemotherapeutics on orthotopic graft in ACI rats].

  Bulletin du cancer 20110201

• [A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer].

  Hinyokika kiyo. Acta urologica Japonica 20110201

• Treatment of early-stage pancreatic cancer.

  Oncology (Williston Park, N.Y.) 20110201

• Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20110201

• Carboplatin and gemcitabine combination in metastatic triple-negative anthracycline- and taxane-pretreated breast cancer patients: a phase II study.

  Journal of chemotherapy (Florence, Italy) 20110201

• EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.

  Journal of biomedical nanotechnology 20110201

• [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].

  Yao xue xue bao = Acta pharmaceutica Sinica 20110201

• Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

  The New England journal of medicine 20110120

• [A meta-analysis of pemetrexed plus platinum chemotherapy versus gemcitabine plus platinum chemotherapy for advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110120

• Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system.

  Biomacromolecules 20110110

• A rare case of thyroid metastasis from pancreatic adenocarcinoma.

  JOP : Journal of the pancreas 20110105

• Medical therapy for advanced pancreatic cancer: work in progress.

  JOP : Journal of the pancreas 20110105

• The effects of Gemcitabine and Vinorelbine on inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) distribution of MCF-7 breast cancer cells.

  Acta histochemica 20110101

• Successful use of biweekly gemcitabine plus nab-paclitaxel in two male patients with stage iv breast cancer: case reports and review of the literature.

  American journal of therapeutics 20110101

• Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer.

  Cancer chemotherapy and pharmacology 20110101

• Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.

  Cancer chemotherapy and pharmacology 20110101

• Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.

  International journal of radiation oncology, biology, physics 20110101

• Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC).

  Current cancer drug targets 20110101

• Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110101

• Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.

  Biochemical pharmacology 20110101

• The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20110101

• Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells.

  Pancreas 20110101

• Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo.

  Anti-cancer drugs 20110101

• Outcomes and tolerability of systemic chemotherapy for pancreatic or biliary cancer patients aged 75 years or older.

  Japanese journal of clinical oncology 20110101

• Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20110101

• Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.

  European journal of cancer (Oxford, England : 1990) 20110101

• Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.

  Cancer immunology, immunotherapy : CII 20110101

• A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer.

  European journal of cancer (Oxford, England : 1990) 20110101

• Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: results of a phase 2 study.

  Cancer 20110101

• Erlotinib resistance is altered after gemcitabine chemotherapy for recurrent non-small-cell lung cancer.

  Clinical drug investigation 20110101

• Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101

• Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.

  International journal of oncology 20110101

• Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101

• KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.

  Chemotherapy 20110101

• Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

  Molecular cancer therapeutics 20110101

• Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101

• Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20110101

• Interstitial lung disease under erlotinib plus gemcitabine for pancreatic carcinoma: a therapeutic dilemma.

  Pancreas 20110101

• Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma.

  Bioorganic & medicinal chemistry 20110101

• Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer.

  AJR. American journal of roentgenology 20110101

• Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110101

• Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer.

  BMC cancer 20110101

• Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen.

  Ear, nose, & throat journal 20110101

• Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110101

• Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine.

  PloS one 20110101

• Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101

• Mestastatic gastric cancer from malignant fibrous histiocytoma.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101

• [Effectiveness of adjuvant chemotherapy using gemcitabine for resected pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110101

• [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110101

• Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells.

  Archives of medical research 20110101

• Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.

  PloS one 20110101

• Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences.

  Korean journal of radiology 20110101

• A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.

  Journal of hematology & oncology 20110101

• Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial.

  Chemotherapy 20110101

• [Nephropathy following administration of angiogenesis inhibitors].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101

• Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.

  Molecular medicine reports 20110101

• Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report.

  BMC gastroenterology 20110101

• Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.

  BMC cancer 20110101

• Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.

  Journal of veterinary internal medicine 20110101

• Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.

  BMC cancer 20110101

• Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer.

  Hepato-gastroenterology 20110101

• Toxicity profile and adherence to the pharmacotherapeutic regimen of gemcitabine-carboplatin in non-small cell lung cancer.

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101

• [Concurrent versus sequential systemic chemotherapy and whole brain radiation therapy for brain matastases in non-small-cell lung cancer patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110101

• Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.

  Trials 20110101

• Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer.

  Chemotherapy 20110101

• Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression.

  BMC cancer 20110101

• Clusterin confers gemcitabine resistance in pancreatic cancer.

  World journal of surgical oncology 20110101

• Successful treatment with GEMOX in patient with metastatic pancreatic adenosquamous carcinoma.

  Tumori 20110101

• Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells.

  PloS one 20110101

• Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.

  Swiss medical weekly 20110101

• Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer.

  Hepato-gastroenterology 20110101

• GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.

  Hepato-gastroenterology 20110101

• Cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine.

  International journal of molecular sciences 20110101

• Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancer.

  Oncology 20110101

• A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer.

  Oncology 20110101

• Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient.

  Urologia internationalis 20110101

• Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma.

  Oncology 20110101

• Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells.

  PloS one 20110101

• Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study.

  Oncology 20110101

• Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer.

  PloS one 20110101

• Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance.

  Neoplasma 20110101

• Urothelial bladder cancer with cavitary lung metastases.

  Canadian respiratory journal 20110101

• Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.

  BMC pharmacology 20110101

• A conjugate of gemcitabine with bisphosphonate (Gem/BP) shows potential as a targeted bone-specific therapeutic agent in an animal model of human breast cancer bone metastases.

  Oncology research 20110101

• 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma.

  Oncology 20110101

• Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer.

  Tumori 20110101

• Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study.

  BMC cancer 20110101

• Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.

  Radiation oncology (London, England) 20110101

• Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature.

  BMC cancer 20110101

• [Role of gemcitabine in treatment of metastatic breast cancer].

  Voprosy onkologii 20110101

• [Investigation of gemcitabine plus lomustine treatment in mice with transplantable lymphosarcoma LIO-1].

  Voprosy onkologii 20110101

• Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).

  BMC cancer 20110101

• The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.

  Molecular cancer 20110101

• Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01).

  BMC cancer 20110101

• Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.

  Digestion 20110101

• KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy.

  Oncology 20110101

• Dermal fibrosis related to combination chemotherapy with carboplatin and gemcitabine.

  European journal of dermatology : EJD 20110101

• Randomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study).

  Chemotherapy 20110101

• Sarcomatoid peritoneal malignant mesothelioma.

  Internal medicine (Tokyo, Japan) 20110101

• Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma.

  Oncology 20110101

• Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients.

  Hepato-gastroenterology 20110101

• [Peculiarities of urinary bladder cancer tumor cells apoptosis response on neoadjuvant chemotherapy].

  TSitologiia i genetika 20110101

• The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer.

  Advances in surgery 20110101

• HuR's role in gemcitabine efficacy: an exception or opportunity?

  Wiley interdisciplinary reviews. RNA 20110101

• Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.

  Cancer genomics & proteomics 20110101

• Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials.

  Oncology 20110101

• The relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients.

  Biological & pharmaceutical bulletin 20110101

• Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.

  PloS one 20110101

• Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.

  BMC gastroenterology 20110101

• Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck.

  Head & neck oncology 20110101

• Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study.

  Urologia internationalis 20110101

• Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case.

  Hepato-gastroenterology 20110101

• A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.

  Oncology 20110101

• Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.

  PloS one 20110101

• Silencing of X-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer.

  The Journal of international medical research 20110101

• Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.

  Oncology 20110101

• Update on chemotherapy in the treatment of urothelial carcinoma.

  TheScientificWorldJournal 20110101

• Nephrotoxicity of anticancer drugs--an underestimated problem?

  Acta clinica Belgica 20110101

• A case of thyroid metastasis of nasopharyngeal cancer.

  Tumori 20110101

• Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer.

  World journal of surgical oncology 20110101

• [Results of chemotherapy for gynecologic cancer patients in ambulatory care].

  Voprosy onkologii 20110101

• Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study.

  International journal of immunopathology and pharmacology 20110101

• Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study).

  Hepato-gastroenterology 20110101

• Gemcitabine adsorbed onto carbon particles increases drug concentrations at the injection site and in the regional lymph nodes in an animal experiment and a clinical study.

  The Journal of international medical research 20110101

• Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT).

  JPMA. The Journal of the Pakistan Medical Association 20110101

• [Synergism of antitumor activity of gemcitabine and dioxadet in mice with ascitic Ehrlich's tumor].

  Voprosy onkologii 20110101

• HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• BOOP as a rare complication of gemcitabine therapy.

  BMJ case reports 20110101

• [Clinical efficacy and adverse effects of taxol plus carboplatin or gemcitabine plus carboplatin in patients with advanced non-small-cell lung carcinoma].

  Zhonghua yi xue za zhi 20101221

• Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release.

  Angewandte Chemie (International ed. in English) 20101217

• Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3.

  Cancer 20101215

• Pancreatic cancer: will incremental advances begin to make a difference?

  Journal of the National Cancer Institute 20101215

• Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma.

  Cancer letters 20101208

• Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes.

  Investigational new drugs 20101201

• The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.

  Medical oncology (Northwood, London, England) 20101201

• Pharmacogenetics and pharmacoepigenetics of gemcitabine.

  Medical oncology (Northwood, London, England) 20101201

• Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer.

  Medical oncology (Northwood, London, England) 20101201

• A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20101201

• Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study).

  Lung cancer (Amsterdam, Netherlands) 20101201

• Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101201

• High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.

  Cancer investigation 20101201

• Pharmacokinetic study to optimize the intravesical administration of gemcitabine.

  BJU international 20101201

• Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

  Biochimica et biophysica acta 20101201

• Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.

  Japanese journal of clinical oncology 20101201

• Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805).

  Japanese journal of clinical oncology 20101201

• Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites.

  Japanese journal of clinical oncology 20101201

• Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study.

  Japanese journal of clinical oncology 20101201

• Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.

  International journal of clinical oncology 20101201

• Chemoresistance testing of human ovarian cancer cells and its in vitro model.

  Toxicology in vitro : an international journal published in association with BIBRA 20101201

• Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

• Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.

  Gynecologic oncology 20101201

• [Digital necrosis related to gemcitabine].

  Presse medicale (Paris, France : 1983) 20101201

• Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer.

  Biomaterials 20101201

• Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells.

  The Journal of pharmacology and experimental therapeutics 20101201

• CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.

  Cancer biology & therapy 20101201

• Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.

  Clinical and experimental immunology 20101201

• Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101201

• Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.

  Pediatric blood & cancer 20101201

• E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents.

  International journal of oncology 20101201

• Evaluation of the effectiveness of a chemoprevention model of pancreatic adenocarcinoma using protein chip technology.

  International journal of oncology 20101201

• Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

  The Lancet. Oncology 20101201

• [Chemotherapy in gallbladder carcinoma].

  Presse medicale (Paris, France : 1983) 20101201

• Myelinoid bodies in a patient with membranoproliferative glomerulonephritis.

  Pathology 20101201

• A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment.

  Asia-Pacific journal of clinical oncology 20101201

• [Case of intrahepatic cholangiocarcinoma drained through a fistula of the duodenal bulb].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20101201

• Cutaneous metastasis of pancreatic adenocarcinoma after kidney transplant: a case report and review of the literature.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20101201

• A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse.

  Clinical lymphoma, myeloma & leukemia 20101201

• Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.

  The Canadian journal of urology 20101201

• Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol.

  Anticancer research 20101201

• [Emodin enhances antitumor effect of gemcitabine in model of SW1990 cell xenograft on athymic mouse].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20101201

• Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.

  Cancer 20101115

• Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.

  Cancer 20101115

• Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.

  Chemical research in toxicology 20101115

• Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients.

  British journal of cancer 20101109

• Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20101101

• A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

  Cancer chemotherapy and pharmacology 20101101

• Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20101101

• Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation study.

  Lung cancer (Amsterdam, Netherlands) 20101101

• Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations.

  Lung cancer (Amsterdam, Netherlands) 20101101

• A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects.

  Shock (Augusta, Ga.) 20101101

• Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101101

• The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.

  Japanese journal of clinical oncology 20101101

• Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.

  Journal of gastroenterology 20101101

• Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.

  Cancer 20101101

• Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms.

  Molecular therapy : the journal of the American Society of Gene Therapy 20101101

• Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.

  Cancer science 20101101

• The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.

  Journal of hepatology 20101101

• Overcoming platinum resistance in ovarian carcinoma.

  Expert opinion on investigational drugs 20101101

• Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report.

  Pediatric hematology and oncology 20101101

• {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

  Cancer research 20101101

• A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101101

• Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101

• Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer.

  Pancreas 20101101

• Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).

  Gut 20101101

• Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.

  Cancer science 20101101

• Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine.

  British journal of cancer 20101101

• Current status of adjuvant therapy for pancreatic cancer.

  The oncologist 20101101

• CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.

  British journal of cancer 20101101

• Microemulsions for intravesical delivery of gemcitabine.

  Chemical & pharmaceutical bulletin 20101101

• Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).

  Gastroenterologie clinique et biologique 20101101

• Enhanced antitumor effect of coincident intravesical gemcitabine plus BCG therapy in an orthotopic bladder cancer model.

  Urology 20101101

• [Prediction of gemcitabine treatment discontinuation based on platelet count before first administration].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20101101

• Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma.

  Anticancer research 20101101

• Analysis of the cytotoxic activity of carboplatin and gemcitabine combination.

  Anticancer research 20101101

• Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells.

  Anticancer research 20101101

• A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.

  Anticancer research 20101101

• A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.

  Anticancer research 20101101

• XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer.

  Anticancer research 20101101

• [Successful long-term management of hepatic and lymph nodes metastases of ureteral cancer by multimodal treatment including radiofrequency ablation].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20101101

• [Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer].

  Zhonghua fu chan ke za zhi 20101101

• [Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101

• [Locally advanced pancreatic cancer successfully treated by arterial infusion chemotherapy combined with stereotactic radiotherapy--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Two cases of pancreatic cancer with fairly good prognosis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [The case of a person who let to umbilicus metastasis at a year after PD].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Evaluation of systemic chemotherapy for unresectable gallbladder carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [A case of unresectable advanced gallbladder cancer successfully treated by a combined administration of gemcitabine + CDDP].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [A long-term survival case of unresectable intrahepatic cholangiocarcinoma treated with chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.

  Biochemical and biophysical research communications 20101022

• Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020

• Analysis of multi-arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models.

  Statistics in medicine 20101015

• Dose escalation of gemcitabine concomitant with radiation and cisplatin for nonsmall cell lung cancer: a phase 1-2 study.

  Cancer 20101015

• Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.

  Journal of controlled release : official journal of the Controlled Release Society 20101015

• Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.

  Cancer research 20101015

• A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells.

  Bioorganic & medicinal chemistry letters 20101015

• Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.

  Investigational new drugs 20101001

• Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status.

  Critical reviews in oncology/hematology 20101001

• Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer patients.

  American journal of clinical oncology 20101001

• Renal atrophy secondary to chemoradiotherapy of abdominal malignancies.

  International journal of radiation oncology, biology, physics 20101001

• Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.

  International journal of clinical oncology 20101001

• Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis.

  Cancer letters 20101001

• Impact of S-1 on the survival of patients with advanced pancreatic cancer.

  Pancreas 20101001

• A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904).

  Japanese journal of clinical oncology 20101001

• Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.

  Biomaterials 20101001

• A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin.

  Gynecologic oncology 20101001

• A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.

  Clinical breast cancer 20101001

• Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis.

  Lung 20101001

• Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20101001

• Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaïve patients with advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101001

• Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.

  International journal of oncology 20101001

• The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation.

  International journal of oncology 20101001

• Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma.

  International journal of oncology 20101001

• Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature.

  Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20101001

• Chemotherapy: Gemcitabine alone or plus cisplatin for biliary tract cancer?

  Nature reviews. Clinical oncology 20101001

• Intertriginous lymphomatoid drug eruption.

  International journal of dermatology 20101001

• Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer.

  Neoplasia (New York, N.Y.) 20101001

• Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

  Neoplasia (New York, N.Y.) 20101001

• Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review.

  The oncologist 20101001

• [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20101001

• Challenges of drug resistance in the management of pancreatic cancer.

  Expert review of anticancer therapy 20101001

• Simultaneous breast and ovarian metastasis from gallbladder carcinoma.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20101001

• [A case of malignant peritoneal mesothelioma treated effectively with cisplatin and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101001

• [A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101001

• Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity.

  Anticancer research 20101001

• Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin.

  Anticancer research 20101001

• A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer.

  Anticancer research 20101001

• Gemox: a widely useful therapy against solid tumors-review and personal experience.

  Journal of chemotherapy (Florence, Italy) 20101001

• [Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20101001

• Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920

• Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

  JAMA 20100908

• Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway.

  Medical oncology (Northwood, London, England) 20100901

• Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.

  Medical oncology (Northwood, London, England) 20100901

• Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100901

• MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.

  Cancer letters 20100901

• ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100901

• Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.

  European journal of gastroenterology & hepatology 20100901

• Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.

  Laboratory investigation; a journal of technical methods and pathology 20100901

• Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.

  European journal of clinical pharmacology 20100901

• Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901

• Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma.

  Human pathology 20100901

• Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

  Breast cancer research and treatment 20100901

• Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

  Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20100901

• Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901

• Exploiting drug repositioning for discovery of a novel HIV combination therapy.

  Journal of virology 20100901

• Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites.

  Chemosphere 20100901

• Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901

• Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901

• A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.

  Molecular cancer therapeutics 20100901

• Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901

• One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.

  Oncology reports 20100901

• A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients.

  Oncology reports 20100901

• HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients.

  Annals of surgery 20100901

• Finding the tumor copycat: approximating a human cancer.

  Nature medicine 20100901

• Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.

  Neoplasia (New York, N.Y.) 20100901

• [A case of gallbladder cancer which completely responded to gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100901

• [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100901

• [Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100901

• [A phase II study of gemcitabine and carboplatin bi-weekly combination chemotherapy for complete resected non-small-cell lung cancer patients].

  Kyobu geka. The Japanese journal of thoracic surgery 20100901

• [Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)].

  Revue de pneumologie clinique 20100901

• [Granulocyte-colony stimulating factor producing squamous cell carcinoma of the renal pelvis: a case report].

  Hinyokika kiyo. Acta urologica Japonica 20100901

• [A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term].

  Hinyokika kiyo. Acta urologica Japonica 20100901

• Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.

  Anticancer research 20100901

• Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model.

  Anticancer research 20100901

• Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer.

  Anticancer research 20100901

• Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over.

  Anticancer research 20100901

• Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer.

  Cancer letters 20100828

• Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabine.

  Journal of medicinal chemistry 20100826

• Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy.

  British journal of cancer 20100824

• Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.

  International journal of pharmaceutics 20100816

• Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report.

  World journal of gastroenterology 20100814

• Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.

  British journal of cancer 20100810

• Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.

  Journal of aerosol medicine and pulmonary drug delivery 20100801

• A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer.

  American journal of clinical oncology 20100801

• Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy.

  Cancer chemotherapy and pharmacology 20100801

• A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20100801

• 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

  International journal of radiation oncology, biology, physics 20100801

• Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.

  International journal of radiation oncology, biology, physics 20100801

• Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?

  European journal of gastroenterology & hepatology 20100801

• Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

  Cancer treatment reviews 20100801

• Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502.

  Lung cancer (Amsterdam, Netherlands) 20100801

• Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100801

• Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration.

  Annals of surgical oncology 20100801

• Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer.

  International journal of clinical oncology 20100801

• Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.

  International journal of clinical oncology 20100801

• Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.

  Cancer gene therapy 20100801

• Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.

  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20100801

• Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor.

  Acta oncologica (Stockholm, Sweden) 20100801

• Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study.

  Biochimica et biophysica acta 20100801

• A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.

  Gynecologic oncology 20100801

• Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan.

  Japanese journal of clinical oncology 20100801

• Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy.

  European journal of cancer (Oxford, England : 1990) 20100801

• Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.

  Journal of aerosol medicine and pulmonary drug delivery 20100801

• Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.

  Leukemia & lymphoma 20100801

• Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801

• Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801

• Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801

• Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.

  Clinical pharmacokinetics 20100801

• Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

  Molecular cancer therapeutics 20100801

• Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro.

  Journal of digestive diseases 20100801

• Survival analysis of pancreatic and periampullary collision cancers.

  Journal of digestive diseases 20100801

• Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens.

  The Journal of thoracic and cardiovascular surgery 20100801

• Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100801

• A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801

• Gemcitabine-induced acute eosinophilic pneumonia.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801

• Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20100801

• Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.

  Molecular cancer therapeutics 20100801

• Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100801

• Low dose fractionated cisplatin plus gemcitabine for elderly patients with advanced non small cell lung cancer: a retrospective analysis.

  Journal of chemotherapy (Florence, Italy) 20100801

• Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement.

  Analytical chemistry 20100801

• Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.

  Cell cycle (Georgetown, Tex.) 20100801

• [A dialysis patient with advanced lung adenocarcinoma who was safely given biweekly gemcitabine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• [Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• [An effective case of gemcitabine therapy with post-operative peritoneal recurrence of intrahepatic cholangiocarcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• [Rituximab-mediated sensitization of B-NHL cell lines to apoptosis induced by gemcitabine and Navelbine in vitro].

  Zhongguo shi yan xue ye xue za zhi 20100801

• Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy.

  Lung cancer (Amsterdam, Netherlands) 20100801

• Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.

  Lung cancer (Amsterdam, Netherlands) 20100801

• Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20100801

• Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100801

• Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.

  Nanoscale 20100801

• [Efficacy of gemcitabine combined with erlotinib in patients with advanced pancreatic cancer].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801

• [Efficacy and safety of chemotherapy combined with interstitial (125)I seed implantation brachytherapy in unresectable stage IIIa/IIIb non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100801

• Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.

  International journal of cancer 20100715

• Cisplatin plus gemcitabine for biliary tract cancer.

  The New England journal of medicine 20100708

• Cisplatin plus gemcitabine for biliary tract cancer.

  The New England journal of medicine 20100708

• Combinatorial drug conjugation enables nanoparticle dual-drug delivery.

  Small (Weinheim an der Bergstrasse, Germany) 20100705

• Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis.

  Fertility and sterility 20100701

• A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20100701

• Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation.

  International journal of cancer 20100701

• Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20100701

• Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey.

  International journal of radiation oncology, biology, physics 20100701

• Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer.

  Cancer chemotherapy and pharmacology 20100701

• Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100701

• Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100701

• Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.

  Cancer letters 20100701

• Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options.

  BJU international 20100701

• Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20100701

• First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.

  European journal of cancer (Oxford, England : 1990) 20100701

• Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel - pretreated ovarian carcinoma.

  Gynecologic oncology 20100701

• Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase.

  Anti-cancer drugs 20100701

• Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?

  Current hematologic malignancy reports 20100701

• Bladder cancer: can we move beyond chemotherapy?

  Current oncology reports 20100701

• Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial.

  Anti-cancer drugs 20100701

• CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system.

  Leukemia & lymphoma 20100701

• Adenocarcinoma of the small bowel: changes in the landscape?

  Current opinion in oncology 20100701

• Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer.

  Cancer biology & therapy 20100701

• Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas.

  Current opinion in oncology 20100701

• Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.

  Experimental biology and medicine (Maywood, N.J.) 20100701

• 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.

  Cancer 20100701

• Adjuvant chemoradiation therapy in gallbladder cancer.

  Journal of surgical oncology 20100701

• Leveraging combinatorial chemotherapy to improve outcomes in patients with pancreatic cancer.

  Cancer biology & therapy 20100701

• Volumetric modulated arc therapy for advanced pancreatic cancer.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100701

• A Comparison of white and African American outcomes from a three-arm, randomized, phase III multicenter trial of advanced or metastatic non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100701

• Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.

  American journal of veterinary research 20100701

• Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.

  Molecular cancer therapeutics 20100701

• Novel therapies for pancreatic cancer: setbacks and progress.

  Future oncology (London, England) 20100701

• Proton-pump inhibitor as palliative care for chemotherapy-induced gastroesophageal reflux disease in pancreatic cancer patients.

  Journal of palliative medicine 20100701

• [A case of pancreatic cancer treated by gemcitabine with sequential radiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100701

• [Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100701

• Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.

  Anticancer research 20100701

• Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study.

  Anticancer research 20100701

• Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.

  Anticancer research 20100701

• [Vertigo as a symptom of psychosocial pain].

  Wiener medizinische Wochenschrift (1946) 20100701

• [Primary urothelial carcinoma with sarcomatous transformation of the prostate].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100701

• Assessment of pancreatic carcinoma cell chemosensitivity using a three-dimensional culture system.

  Chinese medical journal 20100701

• Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100701

• [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20100701

• Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

  British journal of cancer 20100629

• Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.

  Biochemistry 20100615

• Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

  Cancer research 20100615

• Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case study.

  Medical oncology (Northwood, London, England) 20100601

• Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.

  Investigational new drugs 20100601

• The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100601

• Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20100601

• A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease.

  International journal of radiation oncology, biology, physics 20100601

• Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100601

• Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer.

  The pharmacogenomics journal 20100601

• [Digital ischemia in two patients treated with gemcitabine].

  Journal des maladies vasculaires 20100601

• Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.

  Journal of controlled release : official journal of the Controlled Release Society 20100601

• Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.

  Japanese journal of clinical oncology 20100601

• S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.

  Japanese journal of clinical oncology 20100601

• Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.

  European journal of clinical pharmacology 20100601

• Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients.

  Breast (Edinburgh, Scotland) 20100601

• Gemcitabine and epirubicin plasma concentration-related excretion in saliva in patients with non-small cell lung cancer.

  Therapeutic drug monitoring 20100601

• Novel benzimidazole-pyrimidine conjugates as potent antitumor agents.

  European journal of medicinal chemistry 20100601

• Chemotherapy followed by chemoradiotherapy for locally advanced non-metastatic pancreatic cancer - a new paradigm?

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100601

• Improved survival of left-sided pancreas cancer after surgery.

  Japanese journal of clinical oncology 20100601

• ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial.

  European journal of cancer (Oxford, England : 1990) 20100601

• Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).

  European journal of cancer (Oxford, England : 1990) 20100601

• Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601

• Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.

  Endocrine-related cancer 20100601

• Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100601

• Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.

  Pharmaceutical research 20100601

• Potentiation of gemcitabine by Turmeric Force in pancreatic cancer cell lines.

  Oncology reports 20100601

• Chemoprevention strategies for pancreatic cancer.

  Nature reviews. Gastroenterology & hepatology 20100601

• Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer.

  Current molecular medicine 20100601

• MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

  Cancer research 20100601

• Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.

  Journal of surgical oncology 20100601

• [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].

  Bulletin du cancer 20100601

• Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.

  Nature biotechnology 20100601

• A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer.

  Clinical breast cancer 20100601

• Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells.

  Acta pharmacologica Sinica 20100601

• Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer.

  Acta pharmacologica Sinica 20100601

• Two lung masses with different responses to pemetrexed.

  The Korean journal of internal medicine 20100601

• Salirasib in the treatment of pancreatic cancer.

  Future oncology (London, England) 20100601

• Pasteurella multocida thymidine kinase 1 efficiently activates pyrimidine nucleoside analogs.

  Nucleosides, nucleotides & nucleic acids 20100601

• Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells.

  Nucleosides, nucleotides & nucleic acids 20100601

• Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells.

  Nucleosides, nucleotides & nucleic acids 20100601

• Localizing putative markers in genetic association studies by incorporating linkage disequilibrium into bayesian hierarchical models.

  Human heredity 20100601

• CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy.

  Asia-Pacific journal of clinical oncology 20100601

• Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery.

  Journal of chemotherapy (Florence, Italy) 20100601

• [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100601

• [A case of abdominal wall metastasis from pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100601

• Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer.

  British journal of pharmacology 20100601

• Suppression of renin-angiotensin system and cancer therapy (discussion).

  Nihon rinsho. Japanese journal of clinical medicine 20100601

• Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells.

  Anticancer research 20100601

• Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation.

  International journal of pharmaceutics 20100531

• Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.

  The Journal of biological chemistry 20100528

• Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

  World journal of gastroenterology 20100521

• Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine: the question is still ongoing.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510

• First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20100505

• Options for the treatment of gemcitabine-resistant advanced pancreatic cancer: are we there yet?

  JOP : Journal of the pancreas 20100505

• [Oncological treatment of patients with pancreatic cancer].

  Ugeskrift for laeger 20100503

• Gemcitabine induced digital ischaemia and necrosis.

  European journal of cancer care 20100501

• Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100501

• Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.

  Lung cancer (Amsterdam, Netherlands) 20100501

• Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.

  Cancer chemotherapy and pharmacology 20100501

• Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20100501

• Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer.

  Cancer letters 20100501

• Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature.

  European journal of cancer care 20100501

• ABC transporter gene expression in benign and malignant ovarian tissue.

  Gynecologic oncology 20100501

• The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100501

• Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.

  Pancreas 20100501

• EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer.

  Annals of surgical oncology 20100501

• Pancreatic cancer: progress made.

  Acta oncologica (Stockholm, Sweden) 20100501

• Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20100501

• Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival.

  Japanese journal of clinical oncology 20100501

• Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501

• Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501

• The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma.

  Cancer 20100501

• Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?

  Pediatric blood & cancer 20100501

• Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.

  Journal of cellular biochemistry 20100501

• Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501

• Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

  Leukemia & lymphoma 20100501

• Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.

  Current cancer drug targets 20100501

• Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review).

  Oncology reports 20100501

• Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.

  Oncology reports 20100501

• Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20100501

• Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

  Cancer research 20100501

• Any progress in pancreatic cancer? Well, but progress for Acta Oncologica.

  Acta oncologica (Stockholm, Sweden) 20100501

• Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study.

  Acta oncologica (Stockholm, Sweden) 20100501

• Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.

  Clinical lung cancer 20100501

• Haemolytic uraemic syndrome associated with gemcitabine.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100501

• [A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for bile duct cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100501

• Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.

  Health technology assessment (Winchester, England) 20100501

• Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.

  Health technology assessment (Winchester, England) 20100501

• Pancreatic cancer.

  The New England journal of medicine 20100429

• Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

• Conventional and complementary therapies: a tale of two research standards?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

• Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial.

  Cancer 20100415

• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  Cancer research 20100415

• Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

  The New England journal of medicine 20100408

• A step forward in the treatment of advanced biliary tract cancer.

  The New England journal of medicine 20100408

• Stromal depletion goes on trial in pancreatic cancer.

  Journal of the National Cancer Institute 20100407

• Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial.

  Investigational new drugs 20100401

• Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial.

  Lung cancer (Amsterdam, Netherlands) 20100401

• Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100401

• A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma.

  American journal of clinical oncology 20100401

• Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines.

  Cancer letters 20100401

• Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells.

  Pancreas 20100401

• Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• Survival prediction for pancreatic cancer patients receiving gemcitabine treatment.

  Molecular & cellular proteomics : MCP 20100401

• Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.

  Anti-cancer drugs 20100401

• Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.

  Cancer science 20100401

• An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?

  Anti-cancer drugs 20100401

• Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.

  Cancer chemotherapy and pharmacology 20100401

• Management of borderline resectable pancreatic cancer.

  Surgical oncology clinics of North America 20100401

• Update on adjuvant trials for pancreatic cancer.

  Surgical oncology clinics of North America 20100401

• Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06).

  The Lancet. Oncology 20100401

• Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401

• PARP inhibition: PARP1 and beyond.

  Nature reviews. Cancer 20100401

• Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.

  Journal of clinical gastroenterology 20100401

• Toxicities of gemcitabine in patients with severe hepatic dysfunction.

  The Annals of pharmacotherapy 20100401

• A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy.

  Clinical breast cancer 20100401

• Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

  Cancer research 20100401

• Metronomic chemotherapy for renal cancer in the landscape of targeted therapy.

  The Lancet. Oncology 20100401

• Adjuvant and neoadjuvant therapy in curable pancreatic cancer.

  The Surgical clinics of North America 20100401

• Curative radiation therapy for pancreatic malignancies.

  The Surgical clinics of North America 20100401

• Palliative chemotherapy for pancreatic malignancies.

  The Surgical clinics of North America 20100401

• Evolution of systemic therapy for advanced pancreatic cancer.

  Expert review of anticancer therapy 20100401

• [Cost-effectiveness analysis of chemotherapy with GEM or S-1 for patients with non-resectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100401

• [Influence of gemcitabine on expression of C-myc gene and its apoptosis-inducing effect on HL-60 cells].

  Zhongguo shi yan xue ye xue za zhi 20100401

• [Gemcitabine combined with cisplatin and methylprednisolone sodium succinate in chemotherapy for relapsed or refractory T cell non-Hodgkin lymphoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100401

• A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20100401

• [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20100401

• Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication.

  Virology 20100330

• [A meta analysis of gemcitabine plus platinum chemotherapy compared with single-agent chemotherapy in the treatment of non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100320

• Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100310

• Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer.

  World journal of gastroenterology 20100307

• Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.

  JOP : Journal of the pancreas 20100305

• Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010.

  JOP : Journal of the pancreas 20100305

• Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20100305

• Pulmonary toxicity associated with gemcitabine.

  JOP : Journal of the pancreas 20100305

• External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study.

  International journal of radiation oncology, biology, physics 20100301

• Structural lung damage after chemotherapy fact or fiction?

  Lung cancer (Amsterdam, Netherlands) 20100301

• A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100301

• Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100301

• Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.

  Cancer chemotherapy and pharmacology 20100301

• Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

  Cancer chemotherapy and pharmacology 20100301

• Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.

  International journal of cancer 20100301

• Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301

• A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura).

  Journal of gastrointestinal cancer 20100301

• Functional analysis of LOXL2 in pancreatic carcinoma.

  International journal of colorectal disease 20100301

• Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB.

  Anti-cancer drugs 20100301

• Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival.

  Annals of surgery 20100301

• Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase.

  Cell cycle (Georgetown, Tex.) 20100301

• Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100301

• Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.

  Pancreas 20100301

• Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).

  Medical science monitor : international medical journal of experimental and clinical research 20100301

• Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer.

  Nature reviews. Clinical oncology 20100301

• [Gemcitabine therapy for unresectable pancreatic cancer in elderly patients].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100301

• Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment.

  AAPS PharmSciTech 20100301

• [Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100301

• [A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100301

• [Treatment possibilities in breast cancer progressing after anthracyclines and/or taxanes].

  Magyar onkologia 20100301

• Molecular therapy of pancreatic cancer.

  Minerva endocrinologica 20100301

• [A case of a pulmonary pleomorphic carcinoma with fever which responded well to chemotherapy].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20100301

• Establishment and characterization of multidrug-resistant gastric cancer cell lines.

  Anticancer research 20100301

• Impact of biomarkers on non-small cell lung cancer treatment.

  Targeted oncology 20100301

• Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.

  World journal of gastroenterology 20100227

• Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.

  Biochemical pharmacology 20100215

• Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report.

  Journal of medicine and life 20100215

• Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.

  World journal of gastroenterology 20100214

• INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model.

  Investigational new drugs 20100201

• Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial.

  Investigational new drugs 20100201

• A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.

  Investigational new drugs 20100201

• A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer.

  Cancer chemotherapy and pharmacology 20100201

• A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.

  Cancer chemotherapy and pharmacology 20100201

• A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20100201

• Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer.

  Molecular therapy : the journal of the American Society of Gene Therapy 20100201

• Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201

• Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20100201

• Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging.

  Molecular pharmaceutics 20100201

• Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model.

  International journal of colorectal disease 20100201

• Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.

  Cancer chemotherapy and pharmacology 20100201

• Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.

  Cancer science 20100201

• In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy.

  Cancer investigation 20100201

• A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer.

  European journal of cancer (Oxford, England : 1990) 20100201

• High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine.

  Therapeutic drug monitoring 20100201

• Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumour.

  European journal of cancer (Oxford, England : 1990) 20100201

• Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1.

  International journal of oncology 20100201

• Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase?

  Oncology reports 20100201

• A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer.

  Molecular cancer therapeutics 20100201

• Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers.

  Cancer research 20100201

• Transverse leukonychia (Mees' lines) associated with docetaxel.

  The Journal of dermatology 20100201

• Fixed-dose-rate gemcitabine: a viable first-line treatment option for advanced pancreatic and biliary tract cancer.

  The oncologist 20100201

• [Cerebral vasculitis associated with gemcitabine].

  Der Urologe. Ausg. A 20100201

• Efficient syntheses of clofarabine and gemcitabine from 2-deoxyribonolactone.

  Nucleosides, nucleotides & nucleic acids 20100201

• Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.

  Internal medicine journal 20100201

• Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.

  Biochemical pharmacology 20100115

• A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group.

  Cancer 20100115

• [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20100115

• Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.

  World journal of gastroenterology 20100114

• [Efficacy study of single-agent gemcitabine versus gemcitabine plus carboplatin in untreated elderly patients with stage IIIb/IV non-small-cell lung cancer].

  Zhonghua yi xue za zhi 20100112

• Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses.

  British journal of cancer 20100105

• Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer.

  Urologic oncology 20100101

• Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials.

  Lung cancer (Amsterdam, Netherlands) 20100101

• Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study.

  Cancer chemotherapy and pharmacology 20100101

• Metastatic pancreatic adenocarcinoma: current standards, future directions.

  American journal of therapeutics 20100101

• Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.

  European radiology 20100101

• Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2.

  Biochemical pharmacology 20100101

• Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100101

• Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG).

  Breast cancer research and treatment 20100101

• Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers.

  Japanese journal of clinical oncology 20100101

• Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.

  Anti-cancer drugs 20100101

• Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study.

  Acta oncologica (Stockholm, Sweden) 20100101

• The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.

  Current drug targets 20100101

• Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme.

  Cancer chemotherapy and pharmacology 20100101

• Acute aortic dissection during sorafenib-containing therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial.

  Anti-cancer drugs 20100101

• Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101

• Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100101

• Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.

  Acta pharmacologica Sinica 20100101

• Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100101

• Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101

• Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data.

  Applied health economics and health policy 20100101

• The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106.

  Molecular cancer therapeutics 20100101

• Vesicular phospholipid gels.

  Methods in molecular biology (Clifton, N.J.) 20100101

• Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.

  Zeitschrift fur Gastroenterologie 20100101

• Memoirs of differential radiation doses: Gemcitabine induced radiation recall.

  Acta oncologica (Stockholm, Sweden) 20100101

• [Combination chemotherapy with gemcitabine and paclitaxel in a hemodialysis patient with metastatic urothelial carcinoma].

  Hinyokika kiyo. Acta urologica Japonica 20100101

• [Effects of gemcitabine and pemetrexed on the proliferation of pancreatic cancer cell lines BXPC-3 and PANC-1 in vitro].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100101

• Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells.

  Biological & pharmaceutical bulletin 20100101

• A randomized controlled pilot trial of 'Feiji Recipe' on quality of life of non-small cell lung cancer patients.

  The American journal of Chinese medicine 20100101

• Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells.

  Anticancer research 20100101

• Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors.

  Anticancer research 20100101

• [A case of refractory pulmonary peripheral T cell lymphoma successfully treated with Cisplatin Plus Gemcitabine Plus Solumedrol].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20100101

• Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer.

  Onkologie 20100101

• Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial.

  Cancer journal (Sudbury, Mass.) 20100101

• Bacillus Calmette-Guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study.

  Urologia internationalis 20100101

• Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer.

  Journal of experimental & clinical cancer research : CR 20100101

• What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies.

  Reviews on recent clinical trials 20100101

• Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.

  PloS one 20100101

• [Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100101

• Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya.

  Oncology 20100101

• RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.

  Journal of hematology & oncology 20100101

• A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer.

  Hematology/oncology and stem cell therapy 20100101

• Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.

  Urologia internationalis 20100101

• Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101

• Phase I trial of gemcitabine dose escalation with concurrent radiotherapy for patients with locally advanced pancreatic cancer.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101

• Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.

  BMC cancer 20100101

• A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors.

  Chemotherapy 20100101

• [New data on pancreatic cancer].

  Onkologie 20100101

• Immunoglobulin E-mediated severe anaphylaxis to paclitaxel.

  Journal of investigational allergology & clinical immunology 20100101

• Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: a prospective randomized trial in Algeria.

  Journal of cancer research and therapeutics 20100101

• Analysis of chemiotherapeutic protocols efficiency in therapy of advanced non small cell lung cancer.

  Medicinski arhiv 20100101

• A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.

  Oncology 20100101

• Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.

  BMC genomics 20100101

• Ovarian metastasis following gallbladder carcinoma: a case report.

  European journal of gynaecological oncology 20100101

• Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy.

  Molecular cancer 20100101

• Treatment of metachronous and simultaneous liver metastases of pancreatic cancer.

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20100101

• The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.

  Medicina (Kaunas, Lithuania) 20100101

• Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.

  Biological & pharmaceutical bulletin 20100101

• Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation.

  European journal of medical research 20100101

• Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells.

  Chemotherapy 20100101

• Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells.

  BMC cancer 20100101

• In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells.

  BMC cancer 20100101

• [Specific features of toxicological profile of gemcitabine, an antitumour agent from the group of anti-metabolites].

  Sudebno-meditsinskaia ekspertiza 20100101

• The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy.

  Journal of experimental therapeutics & oncology 20100101

• Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion.

  Asian Pacific journal of cancer prevention : APJCP 20100101

• Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma.

  Tumori 20100101

• Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer.

  Chemotherapy 20100101

• Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101

• Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report.

  BMC cancer 20100101

• Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.

  Tumori 20100101

• Treatment effect or secret nature: long-term remissions in metastatic pancreatic cancer.

  Onkologie 20100101

• Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract.

  Onkologie 20100101

• Gemcitabine in arterial injection chemotherapy for pancreatic cancer does not cause catheter obstruction or any other complication.

  Hepato-gastroenterology 20100101

• Curcumin and gemcitabine in patients with advanced pancreatic cancer.

  Nutrition and cancer 20100101

• [The role of membrane transporters in cellular resistance of pancreatic carcinoma to gemcitabine].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20100101

• Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases.

  Oncology 20100101

• Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

  BMC cancer 20100101

• The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.

  Molecular cancer 20100101

• The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer.

  Chemotherapy 20100101

• Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy.

  BMC medical genetics 20100101

• Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.

  PloS one 20100101

• Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.

  Asian Pacific journal of cancer prevention : APJCP 20100101

• pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.

  PloS one 20100101

• Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.

  PloS one 20100101

• Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature.

  Tumori 20100101

• [Neuroendocrine small-cell bladder cancer: our experience].

  Urologia 20100101

• Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells.

  Tumori 20100101

• An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.

  Tumori 20100101

• Acute liver failure secondary to gemcitabine.

  BMJ case reports 20100101

• Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation.

  Journal of molecular biology 20091211

• Drug compendia in oncology: are they flawed?

  Journal of the National Cancer Institute 20091202

• The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.

  Medical oncology (Northwood, London, England) 20091201

• Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20091201

• Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.

  International journal of radiation oncology, biology, physics 20091201

• A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20091201

• Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20091201

• Phase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies.

  American journal of clinical oncology 20091201

• Ceramide metabolism determines glioma cell resistance to chemotherapy.

  Journal of cellular physiology 20091201

• Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201

• [Virchow's node as the form of onset of squamous cell carcinoma of the pancreas].

  Gastroenterologia y hepatologia 20091201

• Second-line therapy for advanced pancreatic cancer: a review of the literature and future directions.

  Cancer treatment reviews 20091201

• Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study.

  Gynecologic oncology 20091201

• Phase II trial of weekly gemcitabine and split-dose cisplatin for advanced non-small-cell lung cancer.

  Japanese journal of clinical oncology 20091201

• Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer.

  Japanese journal of clinical oncology 20091201

• IR spectroscopy reveals effect of non-cytotoxic doses of anti-tumour drug on cancer cells.

  Analytical and bioanalytical chemistry 20091201

• Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I study.

  Gynecologic oncology 20091201

• Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201

• Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201

• Third-line chemotherapy in advanced non-small cell lung cancer: identifying the candidates for routine practice.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201

• Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.

  British journal of cancer 20091201

• Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre randomised phase II study.

  British journal of cancer 20091201

• Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091201

• Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.

  Annals of surgery 20091201

• Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091201

• [Analysis of factors associated with quality of life for older adult patients with non-small cell lung cancer receiving outpatient gemcitabine therapy as an alternative inpatient therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091201

• [Clinical evaluation of calculating carboplatin doses using modification of diet in renal disease (MDRD) estimate and adverse events].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091201

• The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201

• Second and third line treatment in advanced non-small cell lung cancer.

  Discovery medicine 20091201

• Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors.

  Anticancer research 20091201

• Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer.

  Anticancer research 20091201

• Weekly epirubicin as salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer.

  Journal of chemotherapy (Florence, Italy) 20091201

• [The effect of thalidomide in preventing delayed nausea and vomiting induced by GP regimen of chemotherapy for non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20091201

• Efficiency and tolerance of aranose combinations with cisplatin and gemcitabine in experimental lung cancer.

  Bulletin of experimental biology and medicine 20091201

• Adaptive group sequential design for phase II clinical trials: a Bayesian decision theoretic approach.

  Statistics in medicine 20091130

• Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.

  Journal of medicinal chemistry 20091126

• Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer 'unfit' for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Call for clarity in the reporting of benefit associated with anticancer therapies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• What does similarity mean in clinical trials?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical development.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment.

  Cancer letters 20091118

• A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer.

  British journal of cancer 20091117

• Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice.

  Journal of controlled release : official journal of the Controlled Release Society 20091116

• CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

  International journal of cancer 20091115

• A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy.

  World journal of gastroenterology 20091107

• Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20091101

• Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20091101

• Experimental study of combination therapy with S-1 against pancreatic cancer.

  Cancer chemotherapy and pharmacology 20091101

• Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20091101

• Intermediate dose gemcitabine-cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting--a new standard of care in relapsed or refractory Hodgkin lymphoma?

  Annals of hematology 20091101

• Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO).

  Thrombosis research 20091101

• Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.

  Cancer gene therapy 20091101

• [Sudden blindness following combination chemotherapy with Cisplatin and Gemcitabine].

  Presse medicale (Paris, France : 1983) 20091101

• Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells.

  Biochemical pharmacology 20091101

• Pemetrexed in the treatment of advanced non-squamous lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20091101

• Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.

  Japanese journal of clinical oncology 20091101

• Enterocolitis related to chemotherapy with gemcitabine and cisplatin in patient with transitional cell carcinoma of ureter.

  European journal of cancer care 20091101

• OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.

  Cardiovascular and interventional radiology 20091101

• Lysosomal ceramide mediates gemcitabine-induced death of glioma cells.

  Journal of molecular medicine (Berlin, Germany) 20091101

• Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101

• Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer.

  Urology 20091101

• Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment.

  Japanese journal of clinical oncology 20091101

• Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer.

  Cancer investigation 20091101

• Editorial comment.

  Urology 20091101

• Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer.

  Onkologie 20091101

• [Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20091101

• [A case of adenocarcinoma of the lung with a long-term therapeutic effect due to S-1 administered as the sixth regimen].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [Two cases of inoperable advanced bileduct cancer treated effectively with a gemcitabine/cisplatin combination].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091101

• [The possibility of local control of cancer by neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case of postoperative multiple liver metastases of pancreatic cancer successfully treated by combination chemotherapy with weekly high-dose 5-FU hepatic arterial infusion plus systemic infusion of gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case of long-term survival for advanced gallbladder cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [The effectiveness of reduction surgery and gemcitabine for multiple bowel obstructions due to peritoneal dissemination of pancreatic carcinoma with liver metastasis--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case report of un-resectable pancreas body carcinoma successfully treated by chemoradiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case of postoperative brain metastasis originated from pancreatic cancer which was successfully treated by resection and postoperative irradiation].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• Bacterial deoxyribonucleoside kinases are poor suicide genes in mammalian cells.

  Nucleosides, nucleotides & nucleic acids 20091101

• Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091020

• Cap-dependent translation blockade and fixed dose-rate gemcitabine: interaction in an in vitro bioreactor system.

  Cancer letters 20091018

• CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone.

  British journal of cancer 20091006

• Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin.

  British journal of cancer 20091006

• Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.

  Investigational new drugs 20091001

• Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma.

  Investigational new drugs 20091001

• A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20091001

• Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.

  Cancer chemotherapy and pharmacology 20091001

• A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies.

  Cancer chemotherapy and pharmacology 20091001

• In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.

  Cancer chemotherapy and pharmacology 20091001

• Treatment of disseminated paraganglioma with gemcitabine and docetaxel.

  Pediatric blood & cancer 20091001

• Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics.

  Acta biomaterialia 20091001

• A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312.

  American journal of clinical oncology 20091001

• Characterizing DNA methylation patterns in pancreatic cancer genome.

  Molecular oncology 20091001

• Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.

  Pancreas 20091001

• Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer.

  Pancreas 20091001

• Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension.

  Anti-cancer drugs 20091001

• Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration.

  Annals of oncology : official journal of the European Society for Medical Oncology 20091001

• Simultaneous quantification of 2',2'-difluorodeoxycytidine and 2',2'-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20091001

• Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091001

• Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel.

  Journal of pediatric hematology/oncology 20091001

• Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.

  Pancreas 20091001

• Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.

  AJR. American journal of roentgenology 20091001

• Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?

  Clinical colorectal cancer 20091001

• HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment.

  Expert review of anticancer therapy 20091001

• Novel agents for the treatment of adenocarcinoma of the pancreas.

  Expert review of anticancer therapy 20091001

• [Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091001

• [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091001

• [A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091001

• [A case of interstitial pneumonia induced by gemcitabine hydrochloride for unresectable bile duct cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091001

• Downsizing to resectability of a large solid and cystic papillary tumor of the pancreas by single-agent chemotherapy.

  Journal of pediatric surgery 20091001

• Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.

  International journal of clinical oncology 20091001

• Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens.

  International journal of clinical oncology 20091001

• Low-dose gemcitabine efficacious in three patients with tumor-stage mycosis fungoides.

  Clinical lymphoma & myeloma 20091001

• [Complementary treatment for pancreas cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091001

• Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.

  Pancreas 20091001

• A case of unresectable gallbladder cancer responding to gemcitabine after metallic biliary stent implantation.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20091001

• Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma.

  World journal of gastroenterology 20090928

• A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity.

  Statistics in medicine 20090920

• A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

  British journal of cancer 20090915

• [Effect of human telomerase reverse transcriptase gene antisense oligonucleotide on sensitivity of gemcitabine in pancreatic cancer cell].

  Zhonghua yi xue za zhi 20090915

• Different impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090910

• Metastatic pancreatic adenocarcinoma and renal cell carcinoma treated with gemcitabine and sunitinib malate. A case report.

  JOP : Journal of the pancreas 20090904

• Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.

  JOP : Journal of the pancreas 20090904

• A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20090901

• Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20090901

• Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer.

  Cancer chemotherapy and pharmacology 20090901

• A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.

  Cancer chemotherapy and pharmacology 20090901

• A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03.

  Hematological oncology 20090901

• Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.

  Leukemia research 20090901

• Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases.

  The British journal of dermatology 20090901

• Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study.

  European journal of cancer (Oxford, England : 1990) 20090901

• Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.

  Gastroenterology 20090901

• A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2.

  Japanese journal of clinical oncology 20090901

• Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090901

• A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion.

  European journal of cancer (Oxford, England : 1990) 20090901

• Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.

  European urology 20090901

• Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090901

• Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901

• Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901

• Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).

  Expert opinion on investigational drugs 20090901

• Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090901

• Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.

  Journal of drug targeting 20090901

• Brief report of biweekly pemetrexed and gemcitabine in elderly patients with non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090901

• Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis.

  Pathology international 20090901

• Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature.

  The oncologist 20090901

• Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro.

  Acta pharmacologica Sinica 20090901

• Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer.

  The oncologist 20090901

• Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20090901

• Optimisation of replication-selective oncolytic adenoviral mutants in combination with chemotherapeutics.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090901

• Gemcitabine for the treatment of metastatic breast cancer.

  Health technology assessment (Winchester, England) 20090901

• [The inhibition of the Sonic Hedgehog (SHh) pathway improves the effects of chemotherapy in a model of ductal carcinoma of the pancreas in mice].

  Bulletin du cancer 20090901

• [Bemusement and strategy on the efficacy of clinical application of targeted anticancer drugs].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090901

• [Relationship between the level of RRM1 expression and the sensitivity to gemcitabine in the esophageal squamous cell carcinoma cell lines].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090901

• Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study.

  British journal of cancer 20090818

• The role of apoptotic cell death in the radiosensitising effect of gemcitabine.

  British journal of cancer 20090818

• Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression.

  British journal of cancer 20090818

• Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

  International journal of cancer 20090815

• Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

  Cancer research 20090815

• Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.

  Oncogene 20090813

• Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810

• Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehicles.

  Chemical communications (Cambridge, England) 20090807

• Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.

  Cancer immunology, immunotherapy : CII 20090801

• Selective pulmonary artery perfusion for the treatment of primary lung cancer: Improved drug exposure of the lung.

  Lung cancer (Amsterdam, Netherlands) 20090801

• A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20090801

• Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours.

  BJU international 20090801

• Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.

  Biochimica et biophysica acta 20090801

• Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.

  American journal of clinical oncology 20090801

• Generating genome-scale candidate gene lists for pharmacogenomics.

  Clinical pharmacology and therapeutics 20090801

• Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.

  The Prostate 20090801

• Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090801

• Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.

  Cancer science 20090801

• Acute rhabdomyolysis as a complication of paclitaxel-gemcitabine chemotherapy for ovarian cancer.

  European journal of obstetrics, gynecology, and reproductive biology 20090801

• Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study.

  Pancreas 20090801

• Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysis.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090801

• The usefulness of perfusion-weighted magnetic resonance imaging in advanced pancreatic cancer.

  Pancreas 20090801

• A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.

  Cell cycle (Georgetown, Tex.) 20090801

• Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities.

  Oncology reports 20090801

• Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.

  Pharmacogenetics and genomics 20090801

• An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer.

  Surgery 20090801

• Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090801

• Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.

  Clinical breast cancer 20090801

• Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma.

  Anticancer research 20090801

• Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.

  Anticancer research 20090801

• Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction.

  Anticancer research 20090801

• Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.

  Anticancer research 20090801

• [A case of unresectable advanced pancreatic cancer treated by gemcitabine-based chemotherapy following cancer pain alleviation by low-dose matrix-type transdermal fentanyl].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer.

  Journal of the National Medical Association 20090801

• Gemcitabine: new indication. Relapsed ovarian cancer: simply more toxic. Increases haematologic toxicity but not overall survival.

  Prescrire international 20090801

• Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case.

  The Tokai journal of experimental and clinical medicine 20090720

• Development of a sensitive and selective LC-MS/MS method for simultaneous determination of gemcitabine and 2,2-difluoro-2-deoxyuridine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090715

• Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

  Cancer research 20090715

• Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.

  Cancer research 20090715

• Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.

  JOP : Journal of the pancreas 20090706

• Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.

  JOP : Journal of the pancreas 20090706

• Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.

  JOP : Journal of the pancreas 20090706

• Sirolimus can reverse resistance to gemcitabine, capecitabine and docetaxel combination therapy in pancreatic cancer.

  JOP : Journal of the pancreas 20090706

• Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial.

  Breast cancer research and treatment 20090701

• Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.

  Cancer chemotherapy and pharmacology 20090701

• Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20090701

• A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.

  Cancer chemotherapy and pharmacology 20090701

• A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.

  Cancer chemotherapy and pharmacology 20090701

• Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.

  Biomaterials 20090701

• Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.

  International immunopharmacology 20090701

• Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1.

  Molecular pharmacology 20090701

• Impact of rhenium-188, gemcitabine, and 5-fluorouracil on cholangiocellular carcinoma cells: an in vitro study.

  Cardiovascular and interventional radiology 20090701

• Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.

  Cancer biology & therapy 20090701

• Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• Epigenetic modulation and attacking the hedgehog pathway: potentially synergistic therapeutic targets for pancreatic cancer.

  Cancer biology & therapy 20090701

• Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma.

  American journal of hematology 20090701

• Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701

• High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701

• Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine.

  Molecular cancer therapeutics 20090701

• Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.

  Oncology reports 20090701

• 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.

  Cancer research 20090701

• Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.

  Cancer research 20090701

• 'The best-laid plans ... often go awry ...'.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701

• Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.

  Annals of surgery 20090701

• Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.

  Neoplasia (New York, N.Y.) 20090701

• Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.

  Anticancer research 20090701

• [A squamous cell lung cancer patient who developed immune hemolytic anemia after gemcitabine and docetaxel administration].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090701

• [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090701

• Mass flows of X-ray contrast media and cytostatics in hospital wastewater.

  Environmental science & technology 20090701

• Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study.

  British journal of cancer 20090616

• Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma.

  Cancer 20090615

• Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

  Science (New York, N.Y.) 20090612

• Cancer. Breaching the cancer fortress.

  Science (New York, N.Y.) 20090612

• Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.

  Cancer chemotherapy and pharmacology 20090601

• A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20090601

• Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial.

  International journal of radiation oncology, biology, physics 20090601

• Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090601

• Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.

  Lung cancer (Amsterdam, Netherlands) 20090601

• Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20090601

• Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.

  Cancer chemotherapy and pharmacology 20090601

• Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.

  Cancer treatment reviews 20090601

• A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090601

• A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.

  European journal of cancer (Oxford, England : 1990) 20090601

• Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.

  Chest 20090601

• Re: Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20090601

• A landmark point analysis with cytotoxic agents for advanced NSCLC.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090601

• A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).

  The Journal of urology 20090601

• Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090601

• Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy.

  International journal of oncology 20090601

• Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition.

  Biochemical pharmacology 20090601

• Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer.

  American journal of clinical oncology 20090601

• Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090601

• Gemcitabine and capecitabine chemotherapy in Japanese patients with immunotherapy-resistant renal cell carcinoma.

  International journal of urology : official journal of the Japanese Urological Association 20090601

• The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.

  Cancer research 20090601

• Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer.

  Recent patents on anti-cancer drug discovery 20090601

• Sarcoidosis as a diagnostic pitfall of pancreatic cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090601

• Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.

  Molecular cancer research : MCR 20090601

• Malignant solitary fibrous tumor with superior vena cava syndrome.

  General thoracic and cardiovascular surgery 20090601

• [Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090601

• A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine.

  Gan to kagaku ryoho. Cancer & chemotherapy 20090601

• [A case of advanced ampullary carcinoma successfully resected after primary chemotherapy with s-1 and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090601

• Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines.

  Journal of chemotherapy (Florence, Italy) 20090601

• Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma.

  International journal of clinical oncology 20090601

• Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20090601

• Gemcitabine: cutaneous, hepatic and vascular disorders.

  Prescrire international 20090601

• Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards.

  Analytical chemistry 20090515

• A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.

  Breast cancer research and treatment 20090501

• A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20090501

• Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.

  Lung cancer (Amsterdam, Netherlands) 20090501

• The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells.

  Pancreas 20090501

• Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104).

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• Gemicitabine resistence and mesenchymal phenotype.

  Annals of surgical oncology 20090501

• Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.

  Liver international : official journal of the International Association for the Study of the Liver 20090501

• Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis.

  Cancer 20090501

• MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.

  Gynecologic oncology 20090501

• Drosophila melanogaster deoxyribonucleoside kinase activates gemcitabine.

  Biochemical and biophysical research communications 20090501

• Identification of a predictive biomarker for hematologic toxicities of gemcitabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501

• Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501

• Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501

• Synthesis of potent antitumor and antiviral benzofuran derivatives.

  Bioorganic & medicinal chemistry letters 20090501

• AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells.

  Molecular cancer therapeutics 20090501

• Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor.

  Southern medical journal 20090501

• Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells.

  Molecular cancer therapeutics 20090501

• Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma.

  Annals of surgery 20090501

• Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090501

• XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.

  Acta biochimica et biophysica Sinica 20090501

• Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature.

  Journal of pediatric surgery 20090501

• MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.

  Molecular cancer therapeutics 20090501

• Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer.

  Molecular cancer therapeutics 20090501

• Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20090501

• A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer.

  Anticancer research 20090501

• Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I study.

  Anticancer research 20090501

• Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

  Anticancer research 20090501

• Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report.

  European journal of cancer care 20090501

• [Seven cases of gemcitabine-induced lung injury during treatment for pancreatic or biliary tract cancers].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090501

• Thrombotic microangiopathy associated with gemcitabine: rare but real.

  Expert opinion on drug safety 20090501

• [Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090501

• Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090415

• FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090415

• A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090415

• Gemcitabine impacts histological structure of mice testis and embryonic organs.

  Pakistan journal of biological sciences : PJBS 20090415

• Retention studies of 2'-2'-difluorodeoxycytidine and 2'-2'-difluorodeoxyuridine nucleosides and nucleotides on porous graphitic carbon: development of a liquid chromatography-tandem mass spectrometry method.

  Journal of chromatography. A 20090410

• Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090410

• Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.

  British journal of cancer 20090407

• Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20090401

• Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer.

  Pancreas 20090401

• Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer.

  Pancreas 20090401

• The integration of chemoradiation in the care of patient with localized pancreatic cancer.

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20090401

• Gemcitabine, irinotecan and celecoxib in patients with biliary cancer.

  Anti-cancer drugs 20090401

• Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.

  Japanese journal of clinical oncology 20090401

• A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.

  Pancreas 20090401

• Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.

  Molecular cancer therapeutics 20090401

• Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer.

  Molecular cancer therapeutics 20090401

• First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype.

  Expert review of anticancer therapy 20090401

• Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.

  Expert review of anticancer therapy 20090401

• Novel therapeutic agents for osteosarcoma.

  Expert review of anticancer therapy 20090401

• [A case of drug induced interstitial pneumonitis after gemcitabine treatment for pancreatic carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090401

• Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: a case report.

  The Journal of reproductive medicine 20090401

• [Phalanges necrosis--a rare manifestation of 'hand-foot' syndrome induced by gemcitabine used in the second--line therapy for progressive ovarian cancer. A case report].

  Ginekologia polska 20090401

• Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.

  British journal of cancer 20090324

• Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320

• Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320

• Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320

• Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320

• Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.

  Brain research 20090319

• Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.

  Cancer biology & therapy 20090315

• Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.

  Cancer research 20090315

• Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310

• Pancreatic cancer: translating lessons from mouse models.

  JOP : Journal of the pancreas 20090309

• Advancements in the management of pancreatic cancer.

  JOP : Journal of the pancreas 20090309

• Therapeutic tools in pancreatic cancer.

  JOP : Journal of the pancreas 20090309

• Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy.

  Cancer chemotherapy and pharmacology 20090301

• Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition.

  Cancer chemotherapy and pharmacology 20090301

• Selective pulmonary artery perfusion followed by blood flow occlusion: new challenge for the treatment of pulmonary malignancies.

  Lung cancer (Amsterdam, Netherlands) 20090301

• Liver perfusion chemotherapy with 5-Fluorouracil followed by systemic gemcitabine administration for resected pancreatic cancer: preliminary results of a prospective phase 2 study.

  Pancreas 20090301

• Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531).

  Annals of oncology : official journal of the European Society for Medical Oncology 20090301

• A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.

  European journal of cancer (Oxford, England : 1990) 20090301

• Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer.

  Cell biology international 20090301

• Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.

  Gynecologic oncology 20090301

• A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090301

• Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models.

  International journal of oncology 20090301

• The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.

  The oncologist 20090301

• Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090301

• Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine.

  Pancreas 20090301

• Chemotherapy-related posterior reversible leukoencephalopathy syndrome.

  Nature clinical practice. Neurology 20090301

• Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.

  The Korean journal of internal medicine 20090301

• [Thrombotic microangiopathy under an effective treatment with gemcitabine].

  Zeitschrift fur Gastroenterologie 20090301

• Second-line therapy in refractory pancreatic cancer. results of a phase II study.

  Onkologie 20090301

• [Biological basis of chemo-radiotherapy associations].

  Bulletin du cancer 20090301

• Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: a single-institution review of two different regimens.

  Clinical lung cancer 20090301

• Palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin as first-line treatment following gemcitabine monotherapy for patients with transitional cell carcinoma of the urothelium.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20090301

• Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.

  Ai zheng = Aizheng = Chinese journal of cancer 20090301

• Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.

  British journal of cancer 20090224

• Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.

  Biochemistry 20090217

• Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series.

  Cancer 20090215

• Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo.

  World journal of gastroenterology 20090214

• Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry.

  Journal of chromatography. A 20090213

• Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells.

  Cancer letters 20090208

• Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma.

  Chinese medical journal 20090205

• Gemcitabine-induced retinopathy in a diabetic patient.

  Acta ophthalmologica 20090201

• Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.

  Investigational new drugs 20090201

• An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20090201

• Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer.

  Journal of pain and symptom management 20090201

• Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.

  Cancer chemotherapy and pharmacology 20090201

• A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090201

• Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090201

• Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.

  BJU international 20090201

• Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.

  World journal of urology 20090201

• Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.

  Annals of surgical oncology 20090201

• [Medical-oncological aspects in the treatment of pancreatic cancer].

  Der Radiologe 20090201

• Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201

• A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

  Molecular cancer therapeutics 20090201

• Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.

  American journal of clinical oncology 20090201

• Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.

  Clinical nephrology 20090201

• Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.

  Molecular cancer therapeutics 20090201

• Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines.

  Anti-cancer drugs 20090201

• [Retrospective analysis of uracil/tegafur, cyclophosphamide and gemcitabine compared with gemcitabine monotherapy in unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• [Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].

  Gastroenterologia y hepatologia 20090201

• Intra-arterial chemotherapy with gemcitabine and cisplatin for patients with recurrence of transitional cell carcinoma confined to the pelvis.

  Journal of chemotherapy (Florence, Italy) 20090201

• Clinical utility of CA-125 for maintenance therapy in the treatment of advanced stage ovarian carcinoma.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090201

• [Effects of magnetic gemcitabine stealth nano-liposomes on the characteristics of breast cancer cell line MCF-7].

  Yao xue xue bao = Acta pharmaceutica Sinica 20090201

• Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay.

  Oncogene 20090129

• Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090120

• Synergistic effects of acyclic retinoid and gemcitabine on growth inhibition in pancreatic cancer cells.

  Cancer letters 20090118

• Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090115

• Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

  British journal of cancer 20090113

• A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.

  British journal of cancer 20090113

• Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110

• Cisplatin and gemcitabine in the management of metastatic penile cancer.

  Urologic oncology 20090101

• A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.

  Cancer chemotherapy and pharmacology 20090101

• Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: a multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20090101

• Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20090101

• Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20090101

• XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy.

  Urologic oncology 20090101

• Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20090101

• A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites.

  Cancer chemotherapy and pharmacology 20090101

• siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.

  Digestive diseases and sciences 20090101

• Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090101

• Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090101

• Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.

  Thorax 20090101

• Lung cancer and renal insufficiency: prevalence and anticancer drug issues.

  Lung 20090101

• Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy.

  Radiology 20090101

• Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

  Gastroenterology 20090101

• CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines.

  British journal of haematology 20090101

• Personalized medicine for pancreatic cancer: a step in the right direction.

  Gastroenterology 20090101

• S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer.

  Japanese journal of clinical oncology 20090101

• Gemcitabine-induced acute coronary syndrome: a case report.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20090101

• Cutaneous vasculitis associated with gemcitabine therapy.

  Clinical and experimental dermatology 20090101

• Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.

  Radiology 20090101

• Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy.

  The British journal of radiology 20090101

• RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ('ping-pong trial') followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090101

• Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090101

• Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors.

  Pharmacogenomics 20090101

• Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

  Journal of immunology (Baltimore, Md. : 1950) 20090101

• Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy.

  Journal of perinatology : official journal of the California Perinatal Association 20090101

• Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.

  Cancer research 20090101

• Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.

  Molecular cancer therapeutics 20090101

• Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.

  Molecular cancer therapeutics 20090101

• [Feasibility and response of gemcitabine and carboplatin biweekly combination chemotherapy for patients with postoperative recurrence non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090101

• Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090101

• Combined gemcitabine and carboplatin therapy for carcinomas in dogs.

  Journal of veterinary internal medicine 20090101

• Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib.

  Clinical genitourinary cancer 20090101

• Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions.

  Scandinavian journal of gastroenterology 20090101

• Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients.

  World journal of surgical oncology 20090101

• Adjuvant chemoradiotherapy for high-risk pancreatic cancer.

  Singapore medical journal 20090101

• Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors.

  PloS one 20090101

• A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene.

  Blood cells, molecules & diseases 20090101

• Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer.

  Oncology 20090101

• Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic function.

  Clinical pharmacokinetics 20090101

• Chemotherapy and quality of life in NSCLC PS 2 patients.

  Acta oncologica (Stockholm, Sweden) 20090101

• Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.

  Clinical lung cancer 20090101

• Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis.

  Journal of hematology & oncology 20090101

• Tolerability of gemcitabine and carboplatin doublet therapy in cats with carcinomas.

  Journal of veterinary internal medicine 20090101

• Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study.

  Oncology 20090101

• Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with chemotherapy.

  Oncology 20090101

• Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma.

  Journal of translational medicine 20090101

• The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery.

  Journal of hepato-biliary-pancreatic surgery 20090101

• Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.

  Anti-cancer drugs 20090101

• Gemcitabine and carboplatin treatment in advanced NSCLC: a retrospective evaluation including elderly patients.

  Tumori 20090101

• Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer.

  Chemotherapy 20090101

• Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.

  BMC cancer 20090101

• [Gallbladder cancer staging with 18F-FDG PET-CT].

  Revista espanola de medicina nuclear 20090101

• Identification of genomic alterations associated with the aggressiveness of pancreatic cancer using an ultra-high-resolution CGH array.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20090101

• Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

  PloS one 20090101

• The 'win-win' initiative: a global, scientifically based approach to resource sparing treatment for systemic breast cancer therapy.

  World journal of surgical oncology 20090101

• Medical management of pancreatic adenocarcinoma.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20090101

• Effect of combined treatment methods on quality of life in patients with pancreatic cancer.

  American journal of therapeutics 20090101

• Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs.

  European journal of drug metabolism and pharmacokinetics 20090101

• Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer.

  Neoplasma 20090101

• Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.

  Journal of experimental & clinical cancer research : CR 20090101

• Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor.

  Molecular cancer 20090101

• Clinical pharmacology and pharmacogenetics of gemcitabine.

  Drug metabolism reviews 20090101

• Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.

  Journal of translational medicine 20090101

• Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.

  Cutaneous and ocular toxicology 20090101

• Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer.

  Journal of experimental & clinical cancer research : CR 20090101

• Current oncological treatment of patients with pancreatic cancer in germany: results from a national survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society.

  Oncology 20090101

• Phase I study of prolonged-infusion gemcitabine combined with cyclophosphamide in patients with metastatic carcinoma of the breast: tolerability of an optimal dose schedule.

  Oncology 20090101

• Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients for unresectable biliary carcinoma.

  Hepato-gastroenterology 20090101

• Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.

  Radiation oncology (London, England) 20090101

• Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.

  Molecular cancer 20090101

• Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.

  BMC cancer 20090101

• Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.

  Molecular pharmaceutics 20090101

• Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.

  BMC cancer 20090101

• Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas.

  Cancer journal (Sudbury, Mass.) 20090101

• Clinical impact of radiotherapy for locally advanced pancreatic cancer.

  Journal of gastroenterology 20090101

• Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

  Oncology 20090101

• Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?

  Oncology 20090101

• Cancer of unknown primary site in which tumor marker-oriented chemotherapy was effective and pancreatic cancer was finally confirmed at autopsy.

  Internal medicine (Tokyo, Japan) 20090101

• Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

  Clinical & experimental metastasis 20090101

• Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancer.

  Oncology research 20090101

• A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke.

  Renal failure 20090101

• IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101

• Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome?

  Journal of clinical apheresis 20090101

• Management of elderly patients with advanced non-small cell lung cancer in Turkey.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

  PloS one 20090101

• [Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].

  Anais brasileiros de dermatologia 20090101

• Docetaxel and gemcitabine in the treatment of metastatic breast carcinoma: a dose finding study.

  Tumori 20090101

• Gemcitabine-induced supraventricular tachycardia.

  Tumori 20090101

• Important role of gemcitabine in the treatment of classic Kaposi's sarcoma.

  Tumori 20090101

• Splenic artery used for replaced common hepatic artery reconstruction during pancreatoduodenectomy--a case report.

  Chirurgia (Bucharest, Romania : 1990) 20090101

• Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.

  PloS one 20090101

• [Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis].

  Casopis lekaru ceskych 20090101

• A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer.

  Oncology 20090101

• [Final results of cooperative studies of dicarbamine used as a hemoprotector in combination chemotherapy for cancer].

  Voprosy onkologii 20090101

• Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.

  Molecular cancer 20090101

• Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.

  Drug metabolism and pharmacokinetics 20090101

• Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.

  Hematology/oncology and stem cell therapy 20090101

• The effects of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin in superficial bladder cancer: a preliminary study.

  The Journal of international medical research 20090101

• Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.

  Nutrition and cancer 20090101

• Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey.

  Tumori 20090101

• Enhancing apoptosis and overcoming resistance of gemcitabine in pancreatic cancer with bortezomib: a role of death-associated protein kinase-related apoptosis-inducing protein kinase 1.

  Tumori 20090101

• Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy.

  World journal of gastroenterology 20081221

• Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.

  Journal of the National Cancer Institute 20081217

• Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081215

• Adjuvant chemoradiation for pancreatic cancer: few good data, much debate.

  Journal of the National Cancer Institute 20081203

• A heavily pretreated patient with recurrent clear cell adenocarcinoma of the ovary in whom carcinomatous peritonitis was controlled successfully by salvage therapy with gemcitabine.

  Archives of gynecology and obstetrics 20081201

• RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.

  Journal of cellular and molecular medicine 20081201

• A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.

  Cancer chemotherapy and pharmacology 20081201

• Does saturable formation of gemcitabine triphosphate occur in patients?

  Cancer chemotherapy and pharmacology 20081201

• Gemcitabine at fixed dose-rate in patients with advanced soft-tissue sarcomas: a mono-institutional phase II study.

  Cancer chemotherapy and pharmacology 20081201

• Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20081201

• Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20081201

• Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20081201

• Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20081201

• Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20081201

• Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy.

  Interactive cardiovascular and thoracic surgery 20081201

• Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

  Journal of surgical oncology 20081201

• Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.

  Gynecologic oncology 20081201

• Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer.

  Annals of surgical oncology 20081201

• Results of surgical treatment after neoadjuvant chemotherapy for stage III non-small cell lung cancer.

  World journal of surgery 20081201

• Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder.

  The Journal of urology 20081201

• A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.

  Cancer 20081201

• Personalized medicine in advanced non-small-cell lung cancer: reality or wishful thinking?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081201

• Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.

  The Lancet. Oncology 20081201

• Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.

  American journal of clinical oncology 20081201

• Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial.

  Annals of surgery 20081201

• Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy.

  International journal of clinical oncology 20081201

• [Gemcitabine treatment in patients with stage IV pancreatic cancer and prognostic factors for survival of patients with stage IVb(a retrospective survey at 15 hospitals in Niigata Prefecture)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081201

• [A long survival case of unresectable pancreatic cancer by chemoradiotherapy with gemcitabine as key drug].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081201

• Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience.

  Radiation medicine 20081201

• New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20081201

• Management of a patient with borderline resectable pancreatic cancer. Case report and review.

  Oncology (Williston Park, N.Y.) 20081130

• A patient with unresectable advanced pancreatic cancer achieving long-term survival with gemcitabine chemotherapy.

  World journal of gastroenterology 20081128

• Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib.

  European journal of medical research 20081124

• The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines.

  International journal of cancer 20081115

• Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response.

  Cancer 20081115

• Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma.

  Cancer 20081115

• Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081115

• Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours.

  British journal of cancer 20081104

• Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20081103

• Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20081103

• Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20081103

• Tumor resensitization to erlotinib following brief substitution of cetuximab.

  Cancer chemotherapy and pharmacology 20081101

• Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.

  Cancer chemotherapy and pharmacology 20081101

• [Acral necrosis in metastatic ovarian carcinoma. A single episode of Moschowitz syndrome during gemcitabine chemotherapy].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20081101

• Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20081101

• Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20081101

• mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids.

  American journal of respiratory cell and molecular biology 20081101

• Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study.

  Critical reviews in oncology/hematology 20081101

• Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy.

  Annals of surgical oncology 20081101

• Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumours.

  European journal of cancer (Oxford, England : 1990) 20081101

• Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).

  European journal of cancer (Oxford, England : 1990) 20081101

• A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer.

  Cancer 20081101

• Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer.

  Cancer 20081101

• A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.

  Cancer 20081101

• Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms.

  Anti-cancer drugs 20081101

• Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.

  Japanese journal of clinical oncology 20081101

• Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.

  Pancreas 20081101

• Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081101

• Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081101

• Gemcitabine: vascular toxicity and prothrombotic potential.

  Expert opinion on drug safety 20081101

• [Efficacy of whole body gamma-knife radiotherapy combined with thermochemotherapy on locally advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20081101

• Bortezomib is ineffective in an orthotopic mouse model of pancreatic adenocarcinoma.

  Molecular cancer therapeutics 20081101

• [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• Adrenal metastasis of breast cancer with involvement of the inferior vena cava.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081101

• [Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20081101

• [Metastases from urethelial carcinoma: role of chemotherapy].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20081101

• [A case report of intra-operative radiotherapy and gemcitabine for unresectable pancreatic body cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [A phase I study of combination-therapy with gemcitabine and epitope peptides derived from human vascular endothelial growth factor receptor for unresectable or recurrent pancreas cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081101

• Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases.

  International journal of cancer 20081015

• Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.

  Cancer research 20081015

• Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081015

• A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.

  Cancer chemotherapy and pharmacology 20081001

• Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil.

  Investigational new drugs 20081001

• Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20081001

• Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20081001

• A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?

  Investigational new drugs 20081001

• Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20081001

• A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20081001

• Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study.

  Lung cancer (Amsterdam, Netherlands) 20081001

• Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer.

  Breast (Edinburgh, Scotland) 20081001

• Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.

  Japanese journal of clinical oncology 20081001

• Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.

  Cancer investigation 20081001

• HER-2-positive metastatic breast cancer: trastuzumab and beyond.

  Expert opinion on pharmacotherapy 20081001

• Borderline resectable pancreatic cancer: on the edge of survival.

  Cancer control : journal of the Moffitt Cancer Center 20081001

• Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network.

  Cancer control : journal of the Moffitt Cancer Center 20081001

• The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.

  Oncology reports 20081001

• Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy.

  Pancreas 20081001

• Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081001

• A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081001

• A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081001

• Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival.

  Cancer research 20081001

• Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review.

  Health technology assessment (Winchester, England) 20081001

• A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) Trial.

  American journal of clinical oncology 20081001

• [An autopsy case of pancreatic cancer with poor performance status due to peritonitis carcinomatosa treated successfully with continuous infusion of low-dose 5-FU with octreotide].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20081001

• Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.

  Molecular cancer therapeutics 20081001

• [Two cases of advanced biliary tract cancer successfully treated with gemcitabine combination chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081001

• Prometheus' spirit: quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy.

  Singapore medical journal 20081001

• A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.

  Clinical breast cancer 20081001

• Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.

  Clinical breast cancer 20081001

• Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma.

  Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20081001

• In vivo chemotherapeutic profile of human gallbladder small cell carcinoma.

  Biomedical research (Tokyo, Japan) 20081001

• Patient challenges trust's right to deprive her of NHS treatment for buying drugs privately.

  BMJ (Clinical research ed.) 20080930

• Breathless beyond obvious.

  BMJ (Clinical research ed.) 20080917

• Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.

  British journal of cancer 20080916

• Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma.

  Cancer 20080915

• Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer.

  World journal of gastroenterology 20080914

• Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

  Cancer cell 20080909

• Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.

  World journal of gastroenterology 20080907

• Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer.

  British journal of cancer 20080902

• Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.

  Cancer chemotherapy and pharmacology 20080901

• A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20080901

• Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.

  Cancer chemotherapy and pharmacology 20080901

• A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20080901

• A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20080901

• An iatrogenic hepatic subcapsular biloma successfully treated by percutaneous drainage and endoscopic biliary stenting.

  Endoscopy 20080901

• Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM).

  Pharmaceutical research 20080901

• Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080901

• Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines.

  Molecular pharmacology 20080901

• Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.

  Drug metabolism and disposition: the biological fate of chemicals 20080901

• Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays.

  Gynecologic oncology 20080901

• A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents.

  The Journal of urology 20080901

• Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond.

  Current opinion in supportive and palliative care 20080901

• Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma.

  International journal of oncology 20080901

• Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.

  Oncology reports 20080901

• Novel therapies in peripheral T-cell lymphomas.

  Current oncology reports 20080901

• Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.

  Cancer research 20080901

• Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901

• Docetaxel as second line therapy in advanced non-small cell lung cancer-the dose and combination may matter!

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901

• Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080901

• Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis.

  Molecular cancer therapeutics 20080901

• AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.

  Molecular cancer therapeutics 20080901

• [A case of elderly non-small cell lung cancer effectively treated by combined chemotherapy of gemcitabine and S-1].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080901

• Craniocervical paraganglioma with numerous pulmonary metastases--case report.

  Neurologia medico-chirurgica 20080901

• S-phase cell-specific modification by gemcitabine of PFGE-analyzed radiation-induced DNA fragmentation and rejoining.

  International journal of radiation biology 20080901

• Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma.

  Journal of gastrointestinal and liver diseases : JGLD 20080901

• Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard?

  Oncology (Williston Park, N.Y.) 20080901

• [Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma].

  Hinyokika kiyo. Acta urologica Japonica 20080901

• Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.

  African health sciences 20080901

• Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080820

• tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.

  British journal of cancer 20080819

• Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080815

• The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080815

• The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance.

  British journal of cancer 20080805

• Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer.

  Investigational new drugs 20080801

• Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080801

• A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.

  Investigational new drugs 20080801

• The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.

  Leukemia 20080801

• [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].

  Der Internist 20080801

• Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice.

  Drug metabolism and disposition: the biological fate of chemicals 20080801

• Extensive metabolism and hepatic accumulation of gemcitabine after multiple oral and intravenous administration in mice.

  Drug metabolism and disposition: the biological fate of chemicals 20080801

• Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium.

  Gynecologic oncology 20080801

• Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

  Biochemical pharmacology 20080801

• Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study.

  Anti-cancer drugs 20080801

• Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma.

  Oncology reports 20080801

• Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study.

  Annals of surgery 20080801

• The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro.

  International journal of radiation biology 20080801

• Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines.

  Planta medica 20080801

• Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080801

• Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer.

  Journal of chemotherapy (Florence, Italy) 20080801

• Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.

  Clinical journal of oncology nursing 20080801

• Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation.

  Nuclear medicine and biology 20080801

• FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.

  Current cancer drug targets 20080801

• Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine.

  Journal of gastroenterology and hepatology 20080801

• [A case of recurrent gall bladder cancer responding to chemotherapy with gemcitabine after endoscopic metallic biliary stent implantation].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080801

• [A case of left urothelial carcinoma with multiple bone metastasis, liver metastasis and right adrenal metastasis successfully treated with combination chemotherapy of gemcitabine and carboplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080801

• Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer.

  International journal of clinical oncology 20080801

• Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.

  Molecular cancer therapeutics 20080801

• New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine.

  Molecular cancer therapeutics 20080801

• Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.

  Leukemia & lymphoma 20080801

• Gemcitabine plus UFT combination chemotherapy as second- or third-line therapy in non-small cell lung cancer: a pilot study.

  The journal of medical investigation : JMI 20080801

• Acinar cell carcinoma--a rare tumour of the pancreas.

  South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie 20080801

• Clinical trials probe new therapies for some difficult-to-treat cancers.

  JAMA 20080723

• [Investigation into the controlled release behavior of gemcitabine-loaded nanovesicles].

  Zhonghua yi xue za zhi 20080722

• Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720

• Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720

• Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720

• Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720

• Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.

  Cancer 20080715

• Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.

  Cancer 20080715

• Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting.

  Langmuir : the ACS journal of surfaces and colloids 20080715

• New developments in the treatment of pancreatic cancer. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008.

  JOP : Journal of the pancreas 20080710

• Translational research in pancreatic cancer. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008.

  JOP : Journal of the pancreas 20080710

• Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008.

  JOP : Journal of the pancreas 20080710

• Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

  British journal of cancer 20080708

• Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.

  Cancer chemotherapy and pharmacology 20080701

• Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests.

  Clinical endocrinology 20080701

• Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20080701

• Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.

  Journal of cancer research and clinical oncology 20080701

• Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere.

  Lung cancer (Amsterdam, Netherlands) 20080701

• 188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.

  European journal of nuclear medicine and molecular imaging 20080701

• Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: local control and survival results.

  European radiology 20080701

• Inhibition of proliferation to omega-3 fatty acids in chemoresistant pancreatic cancer cells: mechanism of action may be more complex.

  Annals of surgical oncology 20080701

• Pancreatic cancer--is the wall crumbling?

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma.

  British journal of haematology 20080701

• Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma.

  Laboratory investigation; a journal of technical methods and pathology 20080701

• Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma.

  British journal of haematology 20080701

• The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry.

  Anti-cancer drugs 20080701

• A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting.

  Oncology reports 20080701

• Establishment of combined immuno-chemotherapy with systemically administered gemcitabine and intra-portal administration of interleukin-2 in murine models of liver metastases of pancreatic cancer.

  International journal of oncology 20080701

• Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701

• Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080701

• A pharmacodynamic model for the time course of tumor shrinkage by gemcitabine + carboplatin in non-small cell lung cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080701

• Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080701

• Gemcitabine pulmonary toxicity in ovarian cancer.

  The oncologist 20080701

• [Ethnic differences of genetic polymorphisms in cancer chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• [Randomized phase II study of carboplatin/paclitaxel followed by gemcitabine versus carboplatin/gemcitabine followed by docetaxel in patients with advanced nonsmall cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• [Chemotherapy with gemcitabine after non-curative resection of bile duct cancer--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• [Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial.

  Clinical lung cancer 20080701

• Salvage regimens for Hodgkin lymphoma.

  Clinical advances in hematology & oncology : H&O 20080701

• The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.

  Lung cancer (Amsterdam, Netherlands) 20080701

• Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma.

  Annals of the Academy of Medicine, Singapore 20080701

• [Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer: survival benefit in selected patients].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080701

• Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation.

  JAMA 20080625

• Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation.

  JAMA 20080625

• Targeting angiogenesis in pancreatic cancer.

  Lancet (London, England) 20080621

• Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study.

  Lancet (London, England) 20080621

• Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors.

  World journal of gastroenterology 20080621

• Nonmetastatic pancreatic cancer: many trials, little progress.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080620

• Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.

  British journal of cancer 20080617

• Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.

  Cancer 20080615

• Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology Group.

  Cancer 20080615

• Role of gemcitabine in metastatic breast cancer patients: a short review.

  Breast (Edinburgh, Scotland) 20080601

• A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20080601

• Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients.

  Annals of hematology 20080601

• Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine.

  Annals of hematology 20080601

• Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo.

  Gut 20080601

• A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas.

  Investigational new drugs 20080601

• A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080601

• Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine.

  The Journal of clinical endocrinology and metabolism 20080601

• Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells.

  Molecular pharmacology 20080601

• Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.

  American journal of surgery 20080601

• Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

  Gynecologic oncology 20080601

• A phase II study of oxaliplatin and gemcitabine in advanced inoperable stage IIIB/IV non-small cell lung cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601

• New directions in the management of advanced pancreatic cancer: a review.

  Anti-cancer drugs 20080601

• Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells.

  Nanomedicine : nanotechnology, biology, and medicine 20080601

• High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.

  Leukemia & lymphoma 20080601

• mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines.

  Respirology (Carlton, Vic.) 20080601

• Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck.

  Oncology reports 20080601

• Pancreatic cancer.

  Integrative cancer therapies 20080601

• Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601

• Update on T-cell lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080601

• Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080601

• Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080601

• Antibodies to vascular endothelial growth factor in non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080601

• Pulmonary strongyloidiasis mimicking cancer symptoms: a case of hyperinfection in a patient with metastatic lung cancer.

  American journal of clinical oncology 20080601

• Novel advances in pancreatic cancer treatment.

  Expert review of anticancer therapy 20080601

• Gemcitabine/docetaxel--welcome to a new standard.

  Gynecologic oncology 20080601

• Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

  Gynecologic oncology 20080601

• Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080601

• Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.

  Nucleosides, nucleotides & nucleic acids 20080601

• Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.

  Nucleosides, nucleotides & nucleic acids 20080601

• [Economic evaluation of gemcitabine-cisplatin chemotherapy for non small-cell lung cancer patient in an outpatient setting].

  Taehan Kanho Hakhoe chi 20080601

• [Phase II study of combination of gemcitabine and carboplatin in advanced non-small cell lung cancer (an interim report)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080601

• [Feasibility and anti-tumor activity of postoperative adjuvant chemotherapy with gemcitabine for resected pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080601

• [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080601

• Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.

  Clinical breast cancer 20080601

• Nutritional and pharmacologic support in patients with pancreatic cancer.

  Collegium antropologicum 20080601

• Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.

  Veterinary and comparative oncology 20080601

• Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats.

  European journal of pharmacology 20080531

• Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase.

  The Journal of biological chemistry 20080530

• [Chemotherapy and renal toxicity].

  Bulletin du cancer 20080528

• Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.

  British journal of cancer 20080520

• Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080520

• Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080520

• Gemcitabine and cisplatin treatment over a 3-week versus a 4-week dosing schedule: a randomized trial conducted in Chinese patients with nonsmall cell lung cancer.

  Chinese medical journal 20080520

• Efficacy of gemcitabine in patients with non-small cell lung cancer according to promoter polymorphisms of the ribonucleotide reductase M1 gene.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080515

• Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid.

  Journal of controlled release : official journal of the Controlled Release Society 20080508

• Comparison of two column characterisation systems based on pharmaceutical applications.

  Journal of chromatography. A 20080502

• A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20080501

• A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.

  Cancer chemotherapy and pharmacology 20080501

• Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma.

  Oral oncology 20080501

• Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).

  Lung cancer (Amsterdam, Netherlands) 20080501

• Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.

  Lung cancer (Amsterdam, Netherlands) 20080501

• Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20080501

• Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.

  The Journal of pharmacology and experimental therapeutics 20080501

• Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer.

  Gynecologic oncology 20080501

• Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer.

  Molecular therapy : the journal of the American Society of Gene Therapy 20080501

• Synthesis of gemcitabine triphosphate (dFdCTP) as a tris(triethylammonium) salt.

  Bioorganic & medicinal chemistry letters 20080501

• Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.

  Acta pharmacologica Sinica 20080501

• Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals.

  Canadian journal of physiology and pharmacology 20080501

• Protein kinase C: a target for therapy in pancreatic cancer.

  Pancreas 20080501

• Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer.

  Cancer investigation 20080501

• Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501

• Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501

• Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501

• Current role of gemcitabine in the treatment of Hodgkin lymphoma.

  Leukemia & lymphoma 20080501

• [A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080501

• [Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080501

• Metastatic pancreatic cancer 2008: is the glass less empty?

  The oncologist 20080501

• [Outpatient chemotherapy and oncology network : Onco Pays-de-la-Loire experiment].

  Bulletin du cancer 20080501

• Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine.

  Nucleosides, nucleotides & nucleic acids 20080501

• [Nonmuscle-invasive bladder cancer (NMIBC): when to perform cystectomy?].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080501

• [Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine for locally advanced inoperable pancreatic cancer].

  Harefuah 20080501

• The effect of HIF-1alpha siRNA on growth and chemosensitivity of MIA-paca cell line.

  Yonsei medical journal 20080430

• Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases.

  World journal of gastroenterology 20080428

• [Hemolytic uremic syndrome following gemcitabine treatment].

  Revue medicale suisse 20080423

• A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling.

  British journal of cancer 20080422

• A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.

  Cancer 20080415

• Compassionate approval process for experimental gene-based products.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells.

  British journal of cancer 20080408

• Gemcitabine in the management of metastatic breast cancer: a systematic review.

  Breast cancer research and treatment 20080401

• Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study.

  Cancer chemotherapy and pharmacology 20080401

• Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer.

  Cancer chemotherapy and pharmacology 20080401

• A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells.

  Investigational new drugs 20080401

• Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro.

  Cancer chemotherapy and pharmacology 20080401

• Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.

  Lung cancer (Amsterdam, Netherlands) 20080401

• Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080401

• 3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.

  International journal of radiation oncology, biology, physics 20080401

• Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancer.

  Drug metabolism and disposition: the biological fate of chemicals 20080401

• Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.

  Investigational new drugs 20080401

• Recombinant human endostatin-associated acute left heart failure.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080401

• Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

  Cancer 20080401

• Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs.

  Biomacromolecules 20080401

• Localized malignant mesenteric mesothelioma causing small bowel obstruction.

  Pathology international 20080401

• Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.

  Human mutation 20080401

• Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer.

  Pancreas 20080401

• Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.

  Pancreas 20080401

• A Phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization.

  Japanese journal of clinical oncology 20080401

• Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080401

• Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080401

• Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080401

• Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080401

• Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer.

  American journal of clinical oncology 20080401

• PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy.

  American journal of clinical oncology 20080401

• Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial.

  American journal of clinical oncology 20080401

• Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.

  Leukemia & lymphoma 20080401

• Gemcitabine in the treatment of metastatic pancreatic cancer.

  Expert review of anticancer therapy 20080401

• [Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080401

• [A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080401

• Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

  Seminars in oncology 20080401

• LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.

  Molecular cancer therapeutics 20080401

• Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.

  Journal of the National Comprehensive Cancer Network : JNCCN 20080401

• Systemic therapy for biliary tract cancers.

  The oncologist 20080401

• Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes.

  Archives of pharmacal research 20080401

• Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine.

  Anti-cancer drugs 20080401

• Chemoradiotherapy for unresectable pancreatic cancer.

  International journal of clinical oncology 20080401

• Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan.

  International journal of clinical oncology 20080401

• A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer.

  International journal of clinical oncology 20080401

• Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen.

  Journal of chemotherapy (Florence, Italy) 20080401

• Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer.

  Clinical therapeutics 20080401

• Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes.

  Journal of nanoscience and nanotechnology 20080401

• Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.

  Clinical breast cancer 20080401

• Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.

  Cancer research 20080315

• Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080315

• Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.

  World journal of gastroenterology 20080314

• Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.

  British journal of cancer 20080311

• Optimal second line treatment options for gemcitabine refractory advanced pancreatic cancer patients. Can we establish standard of care with available data?

  JOP : Journal of the pancreas 20080308

• Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.

  JOP : Journal of the pancreas 20080308

• [Elevation of CA 19.9 in urothelial bladder cancer].

  Medicina clinica 20080308

• Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

  JAMA 20080305

• Adjuvant therapy for surgically resected pancreatic adenocarcinoma.

  JAMA 20080305

• Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.

  Pediatric blood & cancer 20080301

• Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20080301

• A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.

  Cancer chemotherapy and pharmacology 20080301

• Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.

  The Journal of surgical research 20080301

• Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer.

  Cancer chemotherapy and pharmacology 20080301

• Neoadjuvant and adjuvant strategies for pancreatic cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080301

• Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases.

  European radiology 20080301

• Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate.

  British journal of clinical pharmacology 20080301

• Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study.

  Journal of neuro-oncology 20080301

• Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080301

• Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas.

  Cancer gene therapy 20080301

• CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy.

  Virchows Archiv : an international journal of pathology 20080301

• Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer.

  Japanese journal of clinical oncology 20080301

• Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01).

  Japanese journal of clinical oncology 20080301

• The importance of schedule in whole body thermochemotherapy.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20080301

• Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience.

  European journal of cancer care 20080301

• Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301

• Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301

• Gemcitabine resistance in pancreatic cancer: picking the key players.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080301

• HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080301

• [Unresectable pancreatic cancer in the Hokuriku area].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20080301

• Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model.

  Molecular cancer therapeutics 20080301

• [Combination of carboplatin and gemcitabine is a safe and feasible regimen in adjuvant therapy for stage II and IIIA NSCLC].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080301

• Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model.

  Pancreas 20080301

• Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy.

  The oncologist 20080301

• New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways.

  The oncologist 20080301

• [Radiochemotherapeutic options for bladder cancer].

  Aktuelle Urologie 20080301

• [Pancreatic cancer: ten years of systemic therapy].

  Bulletin du cancer 20080301

• Erlotinib-induced acute hepatitis in a patient with pancreatic cancer.

  Clinical advances in hematology & oncology : H&O 20080301

• Dose enhancement effect of anticaner drugs associated with increased temperature in vitro.

  Experimental oncology 20080301

• Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy.

  Clinical genitourinary cancer 20080301

• Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer.

  Anti-cancer drugs 20080301

• A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.

  Anti-cancer drugs 20080301

• Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220

• Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220

• Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220

• Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell lines.

  Cancer letters 20080218

• Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.

  Cancer 20080215

• Persistence of side population cells with high drug efflux capacity in pancreatic cancer.

  World journal of gastroenterology 20080214

• First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study.

  British journal of cancer 20080212

• Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.

  Cancer letters 20080208

• CXCL14 expression and potential function in pancreatic cancer.

  Cancer letters 20080208

• Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system.

  Cancer chemotherapy and pharmacology 20080201

• Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis.

  Cancer chemotherapy and pharmacology 20080201

• Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.

  Digestive diseases and sciences 20080201

• Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy.

  Lung cancer (Amsterdam, Netherlands) 20080201

• Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials.

  Critical reviews in oncology/hematology 20080201

• Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.

  Investigational new drugs 20080201

• Gemcitabine plus paclitaxel may be a promising chemotherapy regimen for metastatic granular cell tumour.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080201

• Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.

  Journal of mass spectrometry : JMS 20080201

• Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer.

  Molecular therapy : the journal of the American Society of Gene Therapy 20080201

• GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study.

  European journal of haematology 20080201

• Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080201

• Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study.

  Cancer investigation 20080201

• The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer.

  Future oncology (London, England) 20080201

• Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer.

  Future oncology (London, England) 20080201

• Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

  Cancer research 20080201

• Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.

  Small (Weinheim an der Bergstrasse, Germany) 20080201

• CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.

  The Lancet. Oncology 20080201

• Pulmonary complications of novel antineoplastic agents for solid tumors.

  Chest 20080201

• Trial methodology in soft tissue sarcomas; the 'one plus one is three or zero' phenomenon.

  Onkologie 20080201

• Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience.

  Onkologie 20080201

• [A pilot clinical trial of gemcitabine and capecitabine chemotherapy for the treatment of advanced renal cell carcinoma failing immunotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080201

• Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.

  The oncologist 20080201

• Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer.

  Journal of chemotherapy (Florence, Italy) 20080201

• [Radiation therapy in pancreatic cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080201

• [Chemotherapy for pancreatic cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080201

• Unilateral blindness as a presenting symptom of lung cancer treated with erlotinib.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20080201

• [Gemcitabine combined with capecitabine in the treatment for 41 patients with relapsed or metastatic biliary tract carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201

• Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer.

  Cancer letters 20080118

• Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy.

  British journal of cancer 20080115

• Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080115

• Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature.

  JOP : Journal of the pancreas 20080108

• Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.

  Cancer chemotherapy and pharmacology 20080101

• The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.

  Cancer chemotherapy and pharmacology 20080101

• Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.

  Lung cancer (Amsterdam, Netherlands) 20080101

• Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080101

• Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20080101

• Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080101

• Gemcitabine and cisplatin in locally advanced and metastatic bladder cancer; 3- or 4-week schedule?

  Acta oncologica (Stockholm, Sweden) 20080101

• Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Study Group.

  International journal of radiation oncology, biology, physics 20080101

• A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.

  Cancer chemotherapy and pharmacology 20080101

• Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.

  Cancer chemotherapy and pharmacology 20080101

• Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma.

  Gynecologic oncology 20080101

• A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.

  BJU international 20080101

• Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.

  Gynecologic oncology 20080101

• 19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy.

  Magnetic resonance in medicine 20080101

• Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: a phase II study.

  Chemotherapy 20080101

• Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.

  The Lancet. Oncology 20080101

• Carbon beam therapy in recurrent ovarian cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Primary advanced unresectable pancreatic cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20080101

• Re: The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.

  BJU international 20080101

• Survival and prognostic factors of unresectable pancreatic cancer.

  Journal of clinical gastroenterology 20080101

• Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.

  International journal of oncology 20080101

• Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080101

• The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080101

• Improving treatment of pancreatic cancer.

  The Lancet. Oncology 20080101

• [Interdisciplinary diagnosis of and therapy for cholangiocarcinoma].

  Zeitschrift fur Gastroenterologie 20080101

• Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer.

  Pancreas 20080101

• [Irinotecan plus gemcitabine(IRINOGEM)in the treatment of biliary malignancies].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080101

• [Short-term outcome of neoadjuvant gemcitabine-carboplatin therapy for muscle-invasive bladder cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080101

• [A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080101

• [A case of salvage chemotherapy with gemcitabine hydrochloride and nedaplatin for gemcitabine-refractory pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080101

• [Fatal liver failure associated with gemcitabine hydrochloride therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080101

• A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.

  Medical oncology (Northwood, London, England) 20080101

• A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.

  The journal of supportive oncology 20080101

• Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.

  The oncologist 20080101

• Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: a Phase II trial.

  Urologic oncology 20080101

• Effectiveness of gemcitabine as second-line chemotherapy in non-small cell lung cancer.

  Tuberkuloz ve toraks 20080101

• [National study of adjuvant treatments of resected cholangiocarcinoma].

  Gastroenterologie clinique et biologique 20080101

• Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer.

  Journal of clinical gastroenterology 20080101

• NS-398 enhances the efficacy of gemcitabine against lung adenocarcinoma through up-regulation of p21WAF1 and p27KIP1 protein.

  Neoplasma 20080101

• Intravesicle gemcitabine in management of BCG refractory superficial TCC of urinary bladder-our experience.

  Urologic oncology 20080101

• Palliative pancreatectomy with postoperative gemcitabine for patients with advanced pancreatic cancer.

  Journal of gastroenterology 20080101

• Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

  BMC cancer 20080101

• The utility of vitamin K3 (menadione) against pancreatic cancer.

  Anticancer research 20080101

• Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.

  Anticancer research 20080101

• Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

  Anticancer research 20080101

• Clinical interpretation of quality-of-life outcomes: an investigation of data from the randomized trial of gemcitabine plus paclitaxel compared with paclitaxel alone for advanced breast cancer.

  The breast journal 20080101

• Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer.

  In vivo (Athens, Greece) 20080101

• Highly elevated serum CA 125 in a lady with ascites and retroperitoneal mass--a diagnostic dilemma.

  The Journal of the Association of Physicians of India 20080101

• Novel approaches to deliver gemcitabine to cancers.

  Current pharmaceutical design 20080101

• Chemotherapy with gemcitabine in advanced biliary tract carcinoma.

  Reviews on recent clinical trials 20080101

• Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens.

  Medical oncology (Northwood, London, England) 20080101

• Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.

  Anticancer research 20080101

• Present treatment and future expectations in advanced pancreatic cancer.

  Anticancer research 20080101

• [Pulmonary metastases from a testicular cancer].

  Pneumologia (Bucharest, Romania) 20080101

• Schedule-dependent synergistic effect of pemetrexed combined with gemcitabine against malignant pleural mesothelioma and non-small cell lung cancer cell lines.

  Chemotherapy 20080101

• Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison.

  BMC cancer 20080101

• Interferon-alpha restitutes the chemosensitivity in pancreatic cancer.

  Anticancer research 20080101

• Phase II study of neo-adjuvant gemcitabine plus epirubicin in primarily unresectable locally advanced breast cancer.

  The breast journal 20080101

• Efficacy of gemcitabine for locally advanced pancreatic cancer: comparison with 5-fluorouracil-based chemoradiotherapy.

  Chemotherapy 20080101

• [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].

  Tumori 20080101

• Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature.

  In vivo (Athens, Greece) 20080101

• The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.

  The journal of supportive oncology 20080101

• Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer.

  Anticancer research 20080101

• Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma.

  Anticancer research 20080101

• Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcitabine for unresectable pancreatic cancer.

  Anticancer research 20080101

• CA 19-9 response as an early indicator of the effectiveness of gemcitabine in patients with advanced pancreatic cancer.

  Oncology 20080101

• A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.

  Radiation oncology (London, England) 20080101

• Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8.

  Tumori 20080101

• Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer.

  Tumori 20080101

• Postoperative adjuvant treatments for biliary tract cancer.

  Journal of hepato-biliary-pancreatic surgery 20080101

• -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro.

  Pharmacological research 20080101

• [Neoadjuvant intra-arterial oil chemoembolization and adjuvant selective intra-arterial chemoinfusion in the combined treatment of pancreatic cancer].

  Voprosy onkologii 20080101

• Quality-of-life assessment in phase III clinical trials of gemcitabine in non-small-cell lung cancer.

  Drugs & aging 20080101

• Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK).

  Drug metabolism and pharmacokinetics 20080101

• Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer.

  Journal of translational medicine 20080101

• Gemcitabine as palliative treatment in patients with unresectable pancreatic cancer previously treated with placement of a covered metal stent. A randomized controlled trial.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101

• Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model.

  Journal of experimental & clinical cancer research : CR 20080101

• Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine.

  Journal of hepato-biliary-pancreatic surgery 20080101

• Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.

  PloS one 20080101

• Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.

  Journal of gastroenterology 20080101

• Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancer.

  Anticancer research 20080101

• Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.

  Anticancer research 20080101

• Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.

  Anticancer research 20080101

• [Treatment of advanced pancreatic carcinoma].

  Onkologie 20080101

• The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

  BMC cancer 20080101

• Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer.

  Journal of cancer research and therapeutics 20080101

• Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

  BMC cancer 20080101

• Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

  BMC cancer 20080101

• Evaluation of therapeutic response to gemcitabine in pancreatic cancer.

  Hepato-gastroenterology 20080101

• Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.

  Cancer genomics & proteomics 20080101

• Psoriasis disappearance after the first phase of an oncologic treatment: a serendipity case report.

  La Clinica terapeutica 20080101

• Application of confidence intervals to bioanalytical method validation--drug stability in biological matrix testing.

  Acta poloniae pharmaceutica 20080101

• A randomized study of gemcitabine plus cisplatin and vinorelbine plus cisplatin in patients with advanced non-small-cell lung cancer.

  Chang Gung medical journal 20080101

• Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directions.

  Clinical lung cancer 20080101

• [Assessment of the value of PEF (cisplatin, epirubicin, 5 fluorouracil) in advanced extrahepatic biliary tract and pancreatic cancer].

  Przeglad lekarski 20080101

• Gemcitabine/5-flourouracil/leucovorin for the treatment of advanced pancreatic carcinoma.

  Hematology/oncology and stem cell therapy 20080101

• Questions about gemcitabine dose rate: answered or unanswered?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Finding clinical meaning in cancer data.

  Journal of the National Cancer Institute 20071219

• A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer.

  Cancer 20071215

• Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study.

  British journal of cancer 20071203

• A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium.

  Investigational new drugs 20071201

• Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia.

  Leukemia 20071201

• Chemotherapy improves low performance status lung cancer patients.

  The European respiratory journal 20071201

• Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models.

  Journal of colloid and interface science 20071201

• Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells.

  Annals of surgical oncology 20071201

• IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.

  Bone marrow transplantation 20071201

• Development and characterization of gemcitabine-resistant pancreatic tumor cells.

  Annals of surgical oncology 20071201

• Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib.

  International journal of oncology 20071201

• Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.

  International journal of oncology 20071201

• Gemcitabine in bladder cancer.

  Expert opinion on pharmacotherapy 20071201

• Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer.

  Expert opinion on pharmacotherapy 20071201

• Carbohydrate antigen 19-9-positive prostatic ductal adenocarcinoma effectively treated with cisplatin and gemcitabine.

  International journal of urology : official journal of the Japanese Urological Association 20071201

• Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071201

• [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• [A case undergoing repeated anaphylactic shock after systemic administration of vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071201

• Ureterovesical malignancy following renal transplantation: a case report.

  Transplantation proceedings 20071201

• TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth.

  Molecular cancer therapeutics 20071201

• [A rare primary tumor of the mediastinum: pleomorphic liposarcoma].

  Revue de pneumologie clinique 20071201

• [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].

  Revue de pneumologie clinique 20071201

• Combined systemic therapy and radiotherapy for bladder cancer.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20071201

• [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].

  Gastroenterologie clinique et biologique 20071201

• A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.

  Japanese journal of clinical oncology 20071201

• Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas.

  Oncology (Williston Park, N.Y.) 20071201

• Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer.

  Hepato-gastroenterology 20071201

• [Non-small cell lung neoplasms--weekly taxane combinations are possible].

  Pneumologie (Stuttgart, Germany) 20071201

• Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.

  Human & experimental toxicology 20071201

• Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.

  British journal of cancer 20071119

• [Chemotherapy and radiotherapy for inoperable pancreatic cancer. A survey of a Cochrane review].

  Ugeskrift for laeger 20071112

• Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?

  JOP : Journal of the pancreas 20071109

• A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors.

  Cancer chemotherapy and pharmacology 20071101

• Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim.

  Internal medicine journal 20071101

• Short versus continuous gemcitabine treatment of non-small cell lung cancer in an in vitro cell culture bioreactor system.

  Lung cancer (Amsterdam, Netherlands) 20071101

• Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules.

  International journal of pharmaceutics 20071101

• Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study.

  Lung cancer (Amsterdam, Netherlands) 20071101

• A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.

  Gynecologic oncology 20071101

• Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece.

  Lung cancer (Amsterdam, Netherlands) 20071101

• A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.

  Annals of surgical oncology 20071101

• Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071101

• Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network.

  Cancer 20071101

• Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis.

  Gynecologic oncology 20071101

• Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.

  Journal of medicinal chemistry 20071101

• Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study.

  Anti-cancer drugs 20071101

• Surgery combined with intra-arterial chemotherapy for stage iv advanced gastric cancer.

  ANZ journal of surgery 20071101

• A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer.

  Japanese journal of clinical oncology 20071101

• [Transarterial chemoperfusion with gemcitabine and mitomycin C in pancreatic carcinoma: results in locally recurrent tumors and advanced tumor stages].

  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20071101

• Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071101

• Role of platinum agents in the management of advanced pancreatic cancer.

  Expert opinion on pharmacotherapy 20071101

• Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma.

  International journal of urology : official journal of the Japanese Urological Association 20071101

• Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma.

  Leukemia & lymphoma 20071101

• Clinical potential of an antitumor drug sensitivity test and diffusion-weighted MRI in a patient with a recurrent solid pseudopapillary tumor of the pancreas.

  Journal of gastroenterology 20071101

• [Preparation of gemcitabine polybutylcyanoacrylate nanoparticles].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20071101

• Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women.

  Radiation medicine 20071101

• [A long-term survivor case with good quality of life due to biliary bypass and gemcitabine for advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071101

• Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.

  Journal of the National Comprehensive Cancer Network : JNCCN 20071101

• Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.

  The oncologist 20071101

• Inoperable pancreatic cancer: standard of care.

  Oncology (Williston Park, N.Y.) 20071101

• Bevacizumab: optimal dose, schedule, and duration of therapy.

  Clinical lung cancer 20071101

• [A case of gemcitabine-based chemo-radiation therapy for unresectable pancreatic cancer with liver metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071101

• [Assessment of efficacy of arterial infusion chemotherapy with gemcitabine for four cases of advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071101

• [Prediction of adverse drug reactions based on genomic information].

  Nihon rinsho. Japanese journal of clinical medicine 20071028

• Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen.

  Cancer letters 20071018

• The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer.

  Cancer letters 20071018

• Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015

• Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma.

  Cancer research 20071015

• Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010

• Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010

• Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.

  Cancer chemotherapy and pharmacology 20071001

• O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in SK-N-DZ neuroblastoma cells.

  Journal of cellular physiology 20071001

• Metastatic urothelial carcinoma of upper urinary tract.

  American journal of hematology 20071001

• Androgen receptor blockade in experimental combination therapy of pancreatic cancer.

  The Journal of surgical research 20071001

• Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20071001

• Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071001

• An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.

  Critical reviews in oncology/hematology 20071001

• Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer.

  Anti-cancer drugs 20071001

• Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation.

  Pharmacogenetics and genomics 20071001

• Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC).

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20071001

• Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models.

  Pancreas 20071001

• Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder.

  Pancreas 20071001

• The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20071001

• Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071001

• Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071001

• Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071001

• Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20071001

• Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20071001

• Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001

• Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.

  American journal of clinical oncology 20071001

• A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.

  American journal of clinical oncology 20071001

• COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.

  American journal of clinical oncology 20071001

• [Non-small-cell bronchial carcinoma--induction--combined with radiochemotherapy--a more certain alternative].

  Pneumologie (Stuttgart, Germany) 20071001

• Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma.

  International journal of clinical oncology 20071001

• Prognostic relevance of carbohydrate antigen 19-9 levels in patients with advanced biliary tract cancer.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20071001

• Gemcitabine combination in advanced NSCLC.

  The Lancet. Oncology 20071001

• Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience.

  Journal of chemotherapy (Florence, Italy) 20071001

• Study supports activity of gemcitabine in treatment of early-stage breast cancer.

  Oncology (Williston Park, N.Y.) 20071001

• Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach.

  World journal of gastroenterology 20070921

• Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer.

  Cancer 20070915

• Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis.

  World journal of gastroenterology 20070914

• Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.

  World journal of gastroenterology 20070907

• Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20070901

• Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model.

  Gut 20070901

• A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20070901

• Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: preliminary results of an in vitro study.

  Cell biology international 20070901

• Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique.

  Journal of colloid and interface science 20070901

• Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20070901

• The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.

  Molecular pharmacology 20070901

• Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy.

  Antioxidants & redox signaling 20070901

• Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner.

  The Journal of antimicrobial chemotherapy 20070901

• The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells.

  International journal of oncology 20070901

• Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis.

  Oncology reports 20070901

• siRNA directed against TrkA sensitizes human pancreatic cancer cells to apoptosis induced by gemcitabine through an inactivation of PI3K/Akt-dependent pathway.

  Oncology reports 20070901

• Gemcitabine-related 'pseudocellulitis': report of 2 cases and review of the literature.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070901

• Enhanced efficacy in anti-tumour activity by combined therapy of recombinant FGFR-1 related angiogenesis and low-dose cytotoxic agent.

  European journal of cancer (Oxford, England : 1990) 20070901

• Cutaneous metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case treated with gemcitabine.

  The Journal of dermatology 20070901

• Causes of thrombotic thrombocytopenic purpura.

  The Lancet. Oncology 20070901

• Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070901

• [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070901

• Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines.

  Cancer investigation 20070901

• Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma.

  Urology 20070901

• Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature.

  Urology 20070901

• Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.

  Clinical lung cancer 20070901

• Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: the emerging role of erlotinib.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070901

• Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.

  Clinical colorectal cancer 20070901

• Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group study.

  Clinical colorectal cancer 20070901

• Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720.

  Clinical lung cancer 20070901

• Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20070901

• Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.

  British journal of cancer 20070828

• Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.

  British journal of cancer 20070828

• 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.

  Journal of medicinal chemistry 20070823

• Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.

  British journal of cancer 20070820

• Column selection for pharmaceutical analyses based on a column classification using four test parameters.

  Journal of pharmaceutical and biomedical analysis 20070815

• Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.

  Cancer 20070815

• Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.

  British journal of cancer 20070806

• Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed.

  Thorax 20070801

• A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.

  Investigational new drugs 20070801

• Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.

  European urology 20070801

• Editorial comment on: Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.

  European urology 20070801

• A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge.

  Cancer chemotherapy and pharmacology 20070801

• Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells.

  Apoptosis : an international journal on programmed cell death 20070801

• A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20070801

• Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070801

• Chemotherapeutic stress selectively activates NF-kappa B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells.

  American journal of physiology. Cell physiology 20070801

• Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials.

  Cancer 20070801

• Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study.

  Pancreas 20070801

• A pure invasive micropapillary carcinoma of the pancreatic head: long disease-free survival after pancreatoduodenectomy and adjuvant chemotherapy with gemcitabine.

  Pancreas 20070801

• Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.

  Journal of separation science 20070801

• Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma.

  Cancer investigation 20070801

• American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 3.

  IDrugs : the investigational drugs journal 20070801

• Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070801

• Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070801

• A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

  Cancer research 20070801

• Locally advanced pancreatic cancer: a review.

  Seminars in oncology 20070801

• Future chemoradiation strategies in pancreatic cancer.

  Seminars in oncology 20070801

• Cytotoxic therapy for advanced pancreatic adenocarcinoma.

  Seminars in oncology 20070801

• [Consideration of preventive free-flowing IV infusion method for vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070801

• [Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• [Meta-analysis on gemcitabine of fixed-dose rate infusion plus oxaliplatin as first-line therapy for advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: a comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice.

  Cancer biology & therapy 20070801

• Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study.

  International journal of clinical oncology 20070801

• Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience.

  International journal of clinical oncology 20070801

• Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers.

  International journal of clinical oncology 20070801

• Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future.

  The oncologist 20070801

• A novel alkylating agent, glufosfamide, enhances the activity of gemcitabine in vitro and in vivo.

  Neoplasia (New York, N.Y.) 20070801

• [Chemotherapy in lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: a phase II study.

  Journal of chemotherapy (Florence, Italy) 20070801

• [Transhepatic arterial chemoembolization with gemcitabine and carboplatin for the treatment of stage III hepatocellular carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070801

• Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.

  Journal of medicinal chemistry 20070726

• Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?

  British journal of cancer 20070716

• S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

  Cancer research 20070715

• Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.

  JOP : Journal of the pancreas 20070709

• Gemcitabine-induced liver fibrosis in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20070709

• A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.

  British journal of cancer 20070702

• Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy.

  Cancer chemotherapy and pharmacology 20070701

• The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20070701

• Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.

  Cancer chemotherapy and pharmacology 20070701

• Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.

  European urology 20070701

• A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20070701

• Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results.

  International journal of radiation oncology, biology, physics 20070701

• Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.

  International journal of radiation oncology, biology, physics 20070701

• Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.

  Lung cancer (Amsterdam, Netherlands) 20070701

• Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.

  Annals of surgical oncology 20070701

• K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.

  Cancer science 20070701

• Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.

  Cancer 20070701

• Expression of orotate phosphoribosyl transferase in human pancreatic cancer: implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy.

  Oncology reports 20070701

• Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model.

  International journal of oncology 20070701

• Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.

  Biochimica et biophysica acta 20070701

• Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature.

  Onkologie 20070701

• Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701

• Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701

• Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070701

• Gemcitabine-associated thrombotic thrombocytopenic purpura.

  The Lancet. Oncology 20070701

• Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model.

  Journal of drug targeting 20070701

• The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.

  Cancer research 20070701

• [Treatment of pancreatic cancer--surgical point of view].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• [Treatments of pancreatic cancer from the standpoint of medical oncology].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine as second-line chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070701

• Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.

  Japanese journal of clinical oncology 20070701

• [Peak concentration of gemcitabine at fixed-dose-rate and its hematological toxicity profile].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20070701

• [Lung cancer treatment in elderly patients].

  Bulletin du cancer 20070701

• Locally advanced leiomyosarcoma of the urinary bladder: near-complete pathologic response to neoadjuvant gemcitabine and docetaxel.

  Anti-cancer drugs 20070701

• Neoadjuvant chemotherapy in locally advanced non-small cell lung cancer.

  The Gulf journal of oncology 20070701

• [Current situation and features of chemotherapy for breast neoplasms].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620

• Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620

• Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620

• Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.

  JAMA 20070620

• Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.

  JAMA 20070620

• An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone.

  Biochemical pharmacology 20070615

• A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070615

• Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer.

  World journal of gastroenterology 20070607

• Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.

  British journal of cancer 20070604

• A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.

  Cancer chemotherapy and pharmacology 20070601

• Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.

  Cancer chemotherapy and pharmacology 20070601

• Adjuvant therapy for pancreatic cancer: a time that has not yet come.

  Journal of surgical oncology 20070601

• Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel.

  Investigational new drugs 20070601

• Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens.

  The Journal of surgical research 20070601

• Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: multicenter phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20070601

• Chemotherapy induced reversible posterior leukoencephalopathy syndrome.

  Lung cancer (Amsterdam, Netherlands) 20070601

• Electrolyte abnormalities and progressive renal failure in a cancer patient.

  Kidney international 20070601

• Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20070601

• A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.

  Anti-cancer drugs 20070601

• Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.

  The Lancet. Oncology 20070601

• Concurrent chemoradiotherapy for advanced pancreatic cancer: 1,000 mg/m2 gemcitabine can be administered using limited-field radiotherapy.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070601

• Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Moving forward in advanced bladder cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070601

• Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.

  American journal of clinical oncology 20070601

• Her signaling in pancreatic cancer.

  Expert opinion on biological therapy 20070601

• Shortness of breath and hypoxemia after chemotherapy with carboplatin and gemcitabine.

  Chest 20070601

• [Biliary tract carcinoma in elderly patients in whom gemcitabine chemotherapy induced complete remission - a report of two cases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070601

• Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers.

  Molecular cancer therapeutics 20070601

• Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects.

  Cancer biology & therapy 20070601

• Collecting duct carcinoma producing granulocyte-colony-stimulating factor (G-CSF).

  International journal of urology : official journal of the Japanese Urological Association 20070601

• [Gemcitabine and radiotherapy for the future].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20070601

• An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.

  The oncologist 20070601

• In vitro simulation study of individualized chemotherapy in lung cancer.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20070601

• Pancreatic cancer: new studies, new treatments. 'Periodontal disease,', 'gemcitabine' and 'adjuvant therapy' are the new buzzwords.

  DukeMedicine healthnews 20070601

• [Lung adenocarcinoma feigning an interstitial lung disease in a 30-year-old man].

  Anales de medicina interna (Madrid, Spain : 1984) 20070601

• Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.

  Journal of the Egyptian National Cancer Institute 20070601

• Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma.

  World journal of gastroenterology 20070528

• Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070520

• Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity.

  Oncogene 20070517

• The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.

  Biochemical pharmacology 20070515

• Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?

  JOP : Journal of the pancreas 20070509

• Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.

  World journal of gastroenterology 20070507

• Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer.

  Journal of surgical oncology 20070501

• A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status.

  Lung cancer (Amsterdam, Netherlands) 20070501

• Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm.

  International journal of radiation oncology, biology, physics 20070501

• Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20070501

• A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20070501

• Novel therapeutic approaches in the treatment of advanced pancreatic carcinoma.

  Cancer treatment reviews 20070501

• Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070501

• Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial.

  Cancer 20070501

• Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells.

  Oncology reports 20070501

• Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.

  The Annals of pharmacotherapy 20070501

• Pancreatic cancer: an update.

  Current oncology reports 20070501

• Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.

  The Journal of urology 20070501

• Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells.

  Journal of gastroenterology and hepatology 20070501

• Role of induction chemotherapy in resectable N2 non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501

• Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man.

  Onkologie 20070501

• The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20070501

• 3,3',5-Triiodo-L-thyronine inhibits ductal pancreatic adenocarcinoma proliferation improving the cytotoxic effect of chemotherapy.

  The Journal of endocrinology 20070501

• EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501

• Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501

• Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification.

  Cancer research 20070501

• Treatment options for hepatobiliary and pancreatic cancer.

  Mayo Clinic proceedings 20070501

• [A resected case of effective treatment with gemcitabine for advanced pancreatic cancer with peritoneal metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070501

• Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070501

• Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas.

  Journal of gastroenterology 20070501

• Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer.

  Journal of Zhejiang University. Science. B 20070501

• A randomized phase II study of sorafenib/gemcitabine or sorafenib/erlotinib for advanced non-small-cell lung cancer in elderly patients or patients with a performance status of 2: treatment rationale and protocol dynamics.

  Clinical lung cancer 20070501

• Phase I study of irinotecan and gemcitabine in previously untreated patients with advanced non-small cell lung cancer.

  Japanese journal of clinical oncology 20070501

• Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420

• Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070415

• Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

  Cancer research 20070415

• [Palliative treatment of pancreatic cancer].

  Deutsche medizinische Wochenschrift (1946) 20070413

• [Molecular-based treatment concepts in advanced pancreatic cancer].

  Deutsche medizinische Wochenschrift (1946) 20070413

• [Diagnosis of and therapy for pancreatic neoplasms].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070410

• [Establishment of a multi drug-resistant human lung adenocarcinoma cell line and biological characteristics there of].

  Zhonghua yi xue za zhi 20070403

• Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

  Cancer chemotherapy and pharmacology 20070401

• Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder.

  European urology 20070401

• Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.

  Breast cancer research and treatment 20070401

• Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20070401

• Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.

  International journal of cancer 20070401

• Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070401

• Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.

  Annals of surgical oncology 20070401

• Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms.

  Cancer treatment reviews 20070401

• Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.

  Pharmacological research 20070401

• Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer.

  Cancer science 20070401

• Operative complications and early mortality after induction therapy for lung cancer.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20070401

• Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.

  Cancer 20070401

• Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.

  Cancer 20070401

• Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cells.

  Oncology reports 20070401

• Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.

  Anti-cancer drugs 20070401

• Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.

  Journal of neurology 20070401

• Gemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiation.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070401

• Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070401

• H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation.

  Molecular cancer therapeutics 20070401

• Radiation recall pneumonitis induced by gemcitabine.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070401

• Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070401

• Impact of gemcitabine on the survival of patients with stage IV pancreatic cancer.

  Pancreas 20070401

• Acute tubulointerstitial nephritis associated with long-term gemcitabine therapy.

  Pancreas 20070401

• A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.

  American journal of clinical oncology 20070401

• [Clinical comparison of GC regimen (gemcitabine and cisplatin) versus FEC regimen (fluorouracil, epirubicin, and cyclophosphamide) as neoadjuvant chemotherapy for breast cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070401

• [Non-cisplatin based chemotherapy in advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070401

• [Outpatient chemotherapy for lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070401

• Clinical phase I and pharmacology study of gemcitabine (2', 2'-difluorodeoxycytidine) administered in a two-weekly schedule.

  Journal of chemotherapy (Florence, Italy) 20070401

• Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice.

  Journal of biological rhythms 20070401

• Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer.

  International journal of clinical oncology 20070401

• Treatment of advanced pancreatic cancer.

  Seminars in oncology 20070401

• Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL).

  Hematology (Amsterdam, Netherlands) 20070401

• [A case of lung adenocarcinoma with Marie-Bamberger syndrome that improved by chemotherapy].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20070401

• [Strategy in the treatment of anthracycline-resistant breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070401

• [Clinical characteristics and chemotherapy of advanced-stage bronchioloalveolar carcinoma of the lung: report of 53 patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070401

• Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

  British journal of cancer 20070326

• Gemcitabine plus cisplatin in advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320

• Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial.

  Chinese medical journal 20070320

• Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.

  International journal of cancer 20070315

• Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.

  International journal of radiation oncology, biology, physics 20070315

• Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070315

• A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression.

  Cancer chemotherapy and pharmacology 20070301

• Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.

  Gynecologic oncology 20070301

• The determination of gemcitabine and 2'-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070301

• Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070301

• Gemcitabine in advanced biliary tract cancers.

  Critical reviews in oncology/hematology 20070301

• A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• Reversible posterior leukoencephalopathy syndrome after carboplatin therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells.

  Cancer gene therapy 20070301

• Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.

  Cancer science 20070301

• Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer.

  Anti-cancer drugs 20070301

• Treatment options for patients with pretreated metastatic breast cancer.

  The Lancet. Oncology 20070301

• Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.

  The Lancet. Oncology 20070301

• Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.

  Cancer research 20070301

• Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

  Molecular cancer therapeutics 20070301

• Integrating Chinese and conventional medicine in colorectal cancer treatment.

  Integrative cancer therapies 20070301

• 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20070301

• Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.

  Molecular cancer therapeutics 20070301

• bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.

  Journal of cellular and molecular medicine 20070301

• Pancreatic cancer: an update on a 'stealth' cancer. Treatment advances have been slow in coming. What makes this cancer so intractable?

  Harvard health letter 20070301

• A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301

• Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301

• A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301

• Four-modality therapy in malignant pleural mesothelioma: a phase II study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301

• Efficacy and safety of gemcitabine monotherapy in patients with transitional cell carcinoma after Cisplatin-containing therapy: a Japanese experience.

  Japanese journal of clinical oncology 20070301

• Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer.

  Clinical lung cancer 20070301

• Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel.

  Cancer 20070215

• Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070215

• Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells.

  British journal of cancer 20070212

• Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070210

• Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study.

  Investigational new drugs 20070201

• Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas.

  Cancer chemotherapy and pharmacology 20070201

• Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20070201

• Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20070201

• Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.

  American journal of hematology 20070201

• Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.

  Journal of hepatology 20070201

• Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized study.

  Lung cancer (Amsterdam, Netherlands) 20070201

• Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases.

  Lung cancer (Amsterdam, Netherlands) 20070201

• Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer.

  Anti-cancer drugs 20070201

• Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study.

  Anti-cancer drugs 20070201

• ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma.

  Clinical chemistry 20070201

• Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.

  Cancer 20070201

• Transcleral orbital invasion by a radiation and chemotherapy-resistant choroidal metastasis of a pulmonary adenocarcinoma.

  American journal of ophthalmology 20070201

• Data acquisition for the histoculture drug response assay in lung cancer.

  The Journal of thoracic and cardiovascular surgery 20070201

• Chemotherapy resistance and oncogene expression in non-small cell lung cancer.

  The Journal of thoracic and cardiovascular surgery 20070201

• Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070201

• Implementing Good Clinical Practice in two noncommercial phase II studies in children with cancer.

  Onkologie 20070201

• Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?

  Onkologie 20070201

• Prognostic factors in patients with gemcitabine-refractory pancreatic cancer.

  Japanese journal of clinical oncology 20070201

• Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.

  Haematologica 20070201

• [A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070201

• Prediction of drug combination chemosensitivity in human bladder cancer.

  Molecular cancer therapeutics 20070201

• Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas.

  Molecular cancer therapeutics 20070201

• Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer.

  Urology 20070201

• Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy.

  Urology 20070201

• Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070201

• Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer.

  Clinical nephrology 20070201

• Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070201

• Image-guided convection-enhanced delivery of gemcitabine to the brainstem.

  Journal of neurosurgery 20070201

• Gemcitabine plus bevacizumab no better than gemcitabine alone in clinical study of 600 patients with pancreatic cancer.

  Cancer biology & therapy 20070201

• Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

  JAMA 20070117

• Adjuvant therapy for pancreatic cancer: one small step forward.

  JAMA 20070117

• Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.

  British journal of cancer 20070115

• Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20070101

• A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.

  Cancer chemotherapy and pharmacology 20070101

• Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20070101

• Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101

• Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapy.

  International journal of urology : official journal of the Japanese Urological Association 20070101

• The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070101

• Evaluation of intrahepatic perfusion on fusion imaging using a combined CT/SPECT system: influence of anatomic variations on hemodynamic modification before installation of implantable port systems for hepatic arterial infusion chemotherapy.

  Cardiovascular and interventional radiology 20070101

• Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

  Haematologica 20070101

• Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo.

  Cell cycle (Georgetown, Tex.) 20070101

• Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.

  Current drug delivery 20070101

• Open, randomized, phase II study of single-agent gemcitabine and docetaxel as first- and second-line treatment in patients with advanced non-small-cell lung cancer.

  Clinical lung cancer 20070101

• Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients.

  The breast journal 20070101

• Synergistic antitumor activity of oxaliplatin in combination with gemcitabine in pancreatic tumor-bearing mice.

  Chemotherapy 20070101

• Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.

  Anticancer research 20070101

• Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101

• Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101

• Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma.

  Clinical & experimental metastasis 20070101

• Treatment of advanced hepatocellular carcinoma with gemcitabine plus oxaliplatin.

  Hepato-gastroenterology 20070101

• Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101

• Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.

  Anticancer research 20070101

• Intracavitary mass as the initial manifestation of primary pericardial mesothelioma: a case report.

  Angiology 20070101

• The cumulative incidence of gemcitabine-induced thrombotic microangiopathy.

  Acta oncologica (Stockholm, Sweden) 20070101

• A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium.

  BMC cancer 20070101

• A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.

  Respiratory research 20070101

• Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20070101

• The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer.

  Hepato-gastroenterology 20070101

• Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.

  BMC cancer 20070101

• Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.

  BMC cancer 20070101

• Chemotherapy for pancreatic cancer: from metastatic disease to adjuvant therapy.

  Cancer journal (Sudbury, Mass.) 20070101

• Understanding ribonucleotide reductase inactivation by gemcitabine.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20070101

• Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M.

  Anticancer research 20070101

• [Modern chemotherapy of invasive bladder cancer].

  Magyar onkologia 20070101

• Primary small cell bladder carcinoma.

  Tumori 20070101

• Medical treatment of uveal melanoma.

  Tumori 20070101

• [Skin lesions in a female patient with non-Hodgkin lymphoma].

  Enfermedades infecciosas y microbiologia clinica 20070101

• Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study.

  Anticancer research 20070101

• Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation.

  Anticancer research 20070101

• Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer.

  Anticancer research 20070101

• Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.

  Anticancer research 20070101

• A simple non-destructive test of cellular activity (NTCA) for in vitro assessment of cancer cell chemosensitivity/resistance.

  Anticancer research 20070101

• Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20070101

• Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20070101

• A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer.

  Hepato-gastroenterology 20070101

• Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma.

  Cardiovascular and interventional radiology 20070101

• [Gemcitabine and pemetrexed update].

  Bulletin du cancer 20070101

• [Gemcitabine: from preclinic to clinic passing by pharmacokinetics].

  Bulletin du cancer 20070101

• [Updates on gemcitabine on metastatic breast cancer].

  Bulletin du cancer 20070101

• [Gemcitabine and non small-cell lung cancer].

  Bulletin du cancer 20070101

• [Gemcitabine and digestive carcinomas].

  Bulletin du cancer 20070101

• [Gemcitabine and pemetrexed in genito-urinary tumors treatment].

  Bulletin du cancer 20070101

• [Docetaxel and gemcitabine combination in soft-tissue sarcomas treatment].

  Bulletin du cancer 20070101

• [Gemcitabine and radiotherapy in non-small cell lung cancer: dolce vita at last!].

  Bulletin du cancer 20070101

• [Gemcitabine and pemetrexed: novel associations and mechanisms of resistance].

  Bulletin du cancer 20070101

• Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.

  Medical oncology (Northwood, London, England) 20070101

• Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study.

  Cancer investigation 20070101

• Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer.

  Drugs & aging 20070101

• Trial of adjuvant gemcitabine for pancreatic cancer: the jury is still out.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20070101

• Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer.

  Medical oncology (Northwood, London, England) 20070101

• Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma.

  Medical oncology (Northwood, London, England) 20070101

• Feasibility and efficacy of chemotherapy with gemcitabine mono and with paclitaxel/mitoxantron in gynaecological cancers.

  European journal of gynaecological oncology 20070101

• Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.

  International braz j urol : official journal of the Brazilian Society of Urology 20070101

• The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer.

  Medicina (Kaunas, Lithuania) 20070101

• Bilateral renal infarction in a patient with lung carcinoma treated with cisplatin and gemcitabine.

  Renal failure 20070101

• Differential expression of autophagy in Hodgkin lymphoma cells treated with various anti-cancer drugs.

  Acta medica Indonesiana 20070101

• Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides.

  Urologic oncology 20070101

• Irinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer: a phase II study.

  Oncology 20070101

• Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

  Oncology 20070101

• Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.

  International braz j urol : official journal of the Brazilian Society of Urology 20070101

• Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.

  Anticancer research 20070101

• Long-term survivors after chemotherapy in advanced non-small cell lung cancer.

  Anticancer research 20070101

• A phase II study of gemcitabine at fixed infusion rate of 10 mg/m2/min with or without immunotherapy in advanced renal cancer.

  Anticancer research 20070101

• Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells.

  Hepato-gastroenterology 20070101

• A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients.

  Hepato-gastroenterology 20070101

• Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.

  Oncology 20070101

• Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.

  Oncology 20070101

• Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.

  Oncology 20070101

• Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment.

  Oncology 20070101

• Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: a single-institution experience.

  Oncology 20070101

• Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer.

  Oncology 20070101

• Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.

  Oncology 20070101

• Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine.

  Oncology 20070101

• [Neoadjuvant chemotherapy of invasive cancer of the urinary bladder].

  Urologiia (Moscow, Russia : 1999) 20070101

• Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.

  Journal of gastrointestinal cancer 20070101

• CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma.

  Journal of gastrointestinal cancer 20070101

• Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.

  Journal of the National Cancer Institute 20061220

• Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.

  Cancer 20061215

• Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy.

  World journal of gastroenterology 20061207

• Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.

  Cancer chemotherapy and pharmacology 20061201

• Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061201

• Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20061201

• A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061201

• ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061201

• Pifithrin-alpha enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes.

  The Journal of pharmacology and experimental therapeutics 20061201

• Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth.

  Molecular therapy : the journal of the American Society of Gene Therapy 20061201

• Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20061201

• A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients.

  Lung cancer (Amsterdam, Netherlands) 20061201

• Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.

  The Journal of surgical research 20061201

• First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study.

  BJOG : an international journal of obstetrics and gynaecology 20061201

• Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.

  Cancer 20061201

• Molecular features linked to the growth-inhibitory effects of gemcitabine on human pancreatic cancer cells.

  Oncology reports 20061201

• Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium.

  Oncology reports 20061201

• Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry.

  Journal of mass spectrometry : JMS 20061201

• Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature.

  Annals of diagnostic pathology 20061201

• A step in the right direction.

  Nature clinical practice. Oncology 20061201

• Phase I study of bryostatin 1 and gemcitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061201

• Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061201

• Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.

  Cancer research 20061201

• A phase II study of sequential neoadjuvant gemcitabine and paclitaxel, radiation therapy with cisplatin and 5-fluorouracil and surgery in locally advanced esophageal carcinoma.

  American journal of clinical oncology 20061201

• Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial.

  American journal of clinical oncology 20061201

• An unusual case of gemcitabine-induced radiation recall.

  American journal of clinical oncology 20061201

• Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061201

• Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061201

• Urachal carcinoma: surgical and chemotherapeutic options.

  Expert review of anticancer therapy 20061201

• [Two cases of advanced pancreas cancer treated with GTX: combined use of gemcitabine, docetaxel and capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• [A case of small cell carcinoma in the urinary bladder responding to gemcitabine/cisplatin combination therapy as neoadjuvant chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• [New therapeutics in the suppression of superficial bladder carcinoma].

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201

• [The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.1].

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201

• [The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.2].

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201

• Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone.

  World journal of gastroenterology 20061121

• Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study.

  British journal of cancer 20061120

• Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.

  Cancer 20061115

• Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes.

  International journal of radiation oncology, biology, physics 20061115

• [MMW drug award for gemcitabine. Cytostatic drug with growing indications].

  MMW Fortschritte der Medizin 20061109

• Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier.

  International journal of pharmaceutics 20061106

• Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.

  Gynecologic oncology 20061101

• Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.

  Gynecologic oncology 20061101

• Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines.

  Gynecologic oncology 20061101

• Surgery is an essential part of salvage treatment in refractory germ cell tumors.

  European urology 20061101

• Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor.

  European urology 20061101

• Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.

  International archives of occupational and environmental health 20061101

• Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.

  Gynecologic oncology 20061101

• Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model.

  Blood 20061101

• Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy.

  Journal of cancer research and clinical oncology 20061101

• Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy.

  The Prostate 20061101

• Gemcitabine-induced thrombotic microangiopathy: a systematic review.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20061101

• Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061101

• Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.

  International journal of radiation oncology, biology, physics 20061101

• State-of-the-art management of metastatic disease at initial presentation or recurrence.

  World journal of urology 20061101

• A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.

  Cancer science 20061101

• Pancreatic cancer: a review of recent advances.

  Expert opinion on investigational drugs 20061101

• Large topographic variability of upper abdominal lymphatics and the consequences for radiation treatment planning.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20061101

• Management dilemmas due to a paratracheal follicular dendritic cell tumor.

  The Annals of thoracic surgery 20061101

• Early detection of Richter's transformation: stable disease with dose-reduced gemcitabine and local radiation.

  Onkologie 20061101

• Metastatic non-small-cell lung carcinoma successfully treated with pre-operative chemotherapy and bilateral adrenalectomy.

  Japanese journal of clinical oncology 20061101

• Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine.

  Anti-cancer drugs 20061101

• Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy.

  Cancer research 20061101

• Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.

  Cancer research 20061101

• Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

  Cancer research 20061101

• Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.

  Pancreas 20061101

• Exatecan and gemcitabine: no better than gemcitabine only.

  The Lancet. Oncology 20061101

• [A case of gemcitabine-based chemo-radiation therapy for locally advanced unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• [A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• [Pancreatic cancer].

  Praxis 20061101

• Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101

• Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101

• Combination therapy with gemcitabine and 5-Fluorouracil: unblocking the pathways to survivin?

  Cancer biology & therapy 20061101

• [Low-dose gemcitabine concurrent with radiation therapy for locally advanced pancreatic carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• A case report--The marked response to gemcitabine combined with irinotecan and low-dose cisplatin chemotherapy for advanced gastric cancer with multiple liver metastases.

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• Gemcitabine/carboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancer.

  Clinical lung cancer 20061101

• [Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective].

  Revue des maladies respiratoires 20061101

• Basal cell carcinoma metastatic to cervical lymph nodes and lungs.

  Dermatology online journal 20061031

• Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061020

• RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061010

• Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061010

• Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.

  British journal of cancer 20061009

• Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.

  Cancer chemotherapy and pharmacology 20061001

• Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.

  Cancer chemotherapy and pharmacology 20061001

• Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20061001

• Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.

  Gynecologic oncology 20061001

• Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20061001

• Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma.

  Head & neck 20061001

• Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061001

• A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061001

• A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20061001

• Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2.

  Cancer biology & therapy 20061001

• Vitamins C and K3 sensitize human urothelial tumors to gemcitabine.

  The Journal of urology 20061001

• A phase II trial with gemcitabine and paclitaxel for the treatment of refractory and relapsed multiple myeloma patients.

  Oncology reports 20061001

• Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine.

  Journal of Zhejiang University. Science. B 20061001

• RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients.

  Anti-cancer drugs 20061001

• Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20061001

• Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data.

  American journal of clinical oncology 20061001

• [A case of adenocarcinoma of unknown primary site successfully treated with gemcitabine monotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061001

• [A case of stage IVA intrahepatic biliary tract cancer successfully treated with gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061001

• [Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061001

• Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.

  Breast (Edinburgh, Scotland) 20061001

• Haematological toxicity in patients treated with cisplatin and gemcitabine for bladder cancer: the Weston Park Hospital, Sheffield, experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20061001

• [Apoptosis of breast cancer cell line MCF-7 cells induced by gemcitabine and radiation].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20061001

• Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001

• Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001

• [Treatment of squamous cell carcinoma of the pancreas with gemcitabine].

  Gastroenterologie clinique et biologique 20061001

• Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.

  Cancer biotherapy & radiopharmaceuticals 20061001

• Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma.

  Canadian journal of physiology and pharmacology 20061001

• Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920

• A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.

  Cancer 20060915

• In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060915

• A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.

  British journal of cancer 20060904

• Phase I/II study of gemcitabine and epirubicine in stage IIIB-IV non small cell lung cancer.

  Frontiers in bioscience : a journal and virtual library 20060901

• Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine.

  Molecular pharmacology 20060901

• Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20060901

• Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.

  Lung cancer (Amsterdam, Netherlands) 20060901

• Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines.

  Oncology reports 20060901

• Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.

  Japanese journal of clinical oncology 20060901

• A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer.

  Japanese journal of clinical oncology 20060901

• Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.

  Cancer 20060901

• Intravesical gemcitabine: an update of clinical results.

  Current opinion in urology 20060901

• Modified approach of administering cytostatics to the lung: more efficient isolated lung perfusion.

  The Annals of thoracic surgery 20060901

• The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment.

  Cell cycle (Georgetown, Tex.) 20060901

• Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma.

  Scandinavian journal of gastroenterology 20060901

• Advanced non-small-cell lung cancer: 'triplets' better than 'doublets'?

  Nature clinical practice. Oncology 20060901

• [Malignant mesothelioma--diagnosis and treatment strategies].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• [Arterial infusion chemotherapy for patients with advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• [Tailored-dose chemotherapy using gemcitabine for advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• [Gemcitabine versus combined chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• [A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• [Gemcitabine is an effective single agent for the treatment of advanced biliary tract cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.

  International journal of urology : official journal of the Japanese Urological Association 20060901

• [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function].

  Aktuelle Urologie 20060901

• [Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20060901

• Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.

  Clinical genitourinary cancer 20060901

• Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer.

  Clinical lung cancer 20060901

• [Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy].

  Hinyokika kiyo. Acta urologica Japonica 20060901

• [A case of leiomyosarcoma of the scrotum: chemotherapy with anti-cancer agents was effective for the lung metastasis].

  Hinyokika kiyo. Acta urologica Japonica 20060901

• Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060901

• A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060901

• Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study.

  Journal of the Egyptian National Cancer Institute 20060901

• [Myositis as a 'radiation-recall phenomenon' following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma].

  Nederlands tijdschrift voor geneeskunde 20060826

• Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2.

  Biochemical and biophysical research communications 20060825

• Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060820

• Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors.

  Statistics in medicine 20060815

• [Requirements for the development of molecularly defined targeted therapy in oncology].

  Medizinische Klinik (Munich, Germany : 1983) 20060815

• Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060815

• Simultaneous determination of gemcitabine di- and triphosphate in human blood mononuclear and cancer cells by RP-HPLC and UV detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060807

• Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study.

  British journal of cancer 20060807

• In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

  British journal of cancer 20060807

• Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20060801

• A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.

  Cancer chemotherapy and pharmacology 20060801

• Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons.

  Cancer chemotherapy and pharmacology 20060801

• Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.

  Cancer chemotherapy and pharmacology 20060801

• Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma.

  Respiratory medicine 20060801

• Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.

  Gynecologic oncology 20060801

• Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.

  Gynecologic oncology 20060801

• Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.

  International journal of cancer 20060801

• Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.

  Pediatric blood & cancer 20060801

• Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: report of 2 cases and review of the literature.

  Gynecologic oncology 20060801

• Systemic chemotherapy in the management of malignant peritoneal mesothelioma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060801

• A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060801

• Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060801

• Common arm analysis: one approach to develop the basis for global standardization in clinical trials of non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060801

• Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060801

• Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060801

• Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.

  Cancer 20060801

• Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis.

  Cancer 20060801

• Growth inhibition and apoptosis induction in ovarian cancer cells.

  International journal of oncology 20060801

• Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

  Oncology reports 20060801

• Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: a randomised phase II study.

  European journal of cancer (Oxford, England : 1990) 20060801

• Combination of gemcitabine antagonizes antitumor activity of paclitaxel through prevention of mitotic arrest and apoptosis.

  Cancer biology & therapy 20060801

• Pancreatic cancer: from bench to 5-year survival.

  Pancreas 20060801

• Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.

  Pancreas 20060801

• Capecitabine in carcinoma of the pancreas.

  Expert opinion on pharmacotherapy 20060801

• An in vivo platform for translational drug development in pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060801

• Intrapericardial instillation of mitomycin C in recurrent cardiac tamponade due to malignant pericardial effusion.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060801

• Phase II study of gemcitabine in children with solid tumors of mesenchymal and embryonic origin.

  Anti-cancer drugs 20060801

• Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy.

  Molecular cancer therapeutics 20060801

• A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer.

  Nuclear medicine and biology 20060801

• Usefulness of predictive tests for cancer treatment.

  Bulletin du cancer 20060801

• [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• [Phase II trial of prolonged infusion of low-dose gemcitabine in advanced non-small cell lung cancer treatment].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• [Analysis of antineoplastic drugs used in Cancer Center, Sun Yat-sen University, during the period of 1996-2005].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• [Experience with gemcitabine-carboplatin chemotherapy in relapsed ovarian cancer].

  Orvosi hetilap 20060730

• Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.

  The Cochrane database of systematic reviews 20060719

• Serum tumor markers for pancreatic cancer: the dawn of new era?

  JOP : Journal of the pancreas 20060710

• Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.

  JOP : Journal of the pancreas 20060710

• Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.

  JOP : Journal of the pancreas 20060710

• CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.

  Cancer chemotherapy and pharmacology 20060701

• Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.

  Lung cancer (Amsterdam, Netherlands) 20060701

• Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20060701

• Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.

  Cancer 20060701

• Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice.

  International journal of oncology 20060701

• Clinical monitoring of innate cellular immunity of monocytes/macrophages by tumor necrosis factor alpha productivity in whole blood stimulated by lipopolysaccharide in patients with pancreatic cancer.

  Pancreas 20060701

• Correlation of hENT1 expression and function with gemcitabine cytotoxicity in mantle cell lymphoma lines and clinical samples.

  Haematologica 20060701

• Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.

  Haematologica 20060701

• [Interferon-alpha+cisplatin+5-FU therapy for gemcitabine-refractory unresectable and recurrent pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060701

• Erysipeloid skin toxicity induced by gemcitabine.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060701

• Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model.

  Surgery 20060701

• Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.

  Clinical lymphoma & myeloma 20060701

• Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma.

  International journal of urology : official journal of the Japanese Urological Association 20060701

• Hungarian laboratory scientist use gene therapy to improve gemcitabine chemotherapy in glioma tumours.

  European journal of cancer care 20060701

• The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity.

  Molecular cancer therapeutics 20060701

• Malignant acanthosis nigricans and tripe palms associated with pancreatic adenocarcinoma.

  Cutis 20060701

• High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.

  Anti-cancer drugs 20060701

• Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers.

  Anti-cancer drugs 20060701

• Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.

  Digestive diseases and sciences 20060701

• [A pilot study on the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20060701

• A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060701

• Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060701

• Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.

  Journal of the National Cancer Institute 20060621

• Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620

• Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.

  British journal of cancer 20060619

• Chemoradiotherapy in gallbladder cancer.

  Journal of surgical oncology 20060615

• Systemic therapy in the palliative management of advanced salivary gland cancers.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060610

• Streptokinase increases the sensitivity of colon cancer cells to chemotherapy by gemcitabine and cis-platine in vitro.

  Cancer letters 20060608

• Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data.

  British journal of cancer 20060605

• A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma.

  British journal of cancer 20060605

• Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

  British journal of cancer 20060605

• Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.

  Gynecologic oncology 20060601

• Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo.

  The Journal of pharmacology and experimental therapeutics 20060601

• Is thrombotic microangiopathy associated with antitumoral activity?

  Gynecologic oncology 20060601

• A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20060601

• A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060601

• A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20060601

• Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma.

  Cancer 20060601

• Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060601

• Phase II study of gemcitabine plus cisplatin in metastatic breast cancer.

  Anti-cancer drugs 20060601

• Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.

  Pharmacogenetics and genomics 20060601

• Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?

  Expert opinion on pharmacotherapy 20060601

• Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.

  Journal of gastroenterology and hepatology 20060601

• Current therapies and advances in the treatment of pancreatic cancer.

  Critical reviews in oncology/hematology 20060601

• Gemcitabine-cisplatin chemotherapy before lung resection: a case-matched analysis of early outcome.

  The Annals of thoracic surgery 20060601

• Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

  Gastroenterology 20060601

• Adjuvant treatment strategies for pancreatic cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060601

• [Chemotherapy for metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Gemcitabine plus cisplatin (GC): a salvage regimen for advanced breast cancer patients who have failed anthracycline and/or taxane therapy.

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• [Carboplatin plus gemcitabine therapy versus carboplatin plus weekly paclitaxel therapy for advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Model-based drug development: the road to quantitative pharmacology.

  Journal of pharmacokinetics and pharmacodynamics 20060601

• Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.

  Chest 20060601

• Intramedullary metastases due to non microcytic lung carcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601

• Overview of gemcitabine activity in advanced breast cancer.

  Seminars in oncology 20060601

• Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060601

• Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer.

  Japanese journal of clinical oncology 20060601

• Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9.

  Molecular cancer therapeutics 20060601

• Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1).

  Drug metabolism and pharmacokinetics 20060601

• [Combination chemotherapy with gemcitabine and S-1 for advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• A case of Guillain-Barré syndrome in a patient with non small cell lung cancer treated with chemotherapy.

  Journal of chemotherapy (Florence, Italy) 20060601

• Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060601

• Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: a randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study Group.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060601

• Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice.

  International journal of cancer 20060515

• Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine.

  The Journal of surgical research 20060515

• Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.

  Cancer 20060515

• Gemcitabine-induced rectus abdominus radiation recall.

  JOP : Journal of the pancreas 20060509

• Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer.

  British journal of cancer 20060508

• Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach.

  Journal of pharmaceutical and biomedical analysis 20060503

• Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study.

  Investigational new drugs 20060501

• An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma.

  Investigational new drugs 20060501

• Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer.

  Cancer chemotherapy and pharmacology 20060501

• High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20060501

• Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients.

  Cancer chemotherapy and pharmacology 20060501

• In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer.

  International journal of cancer 20060501

• Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.

  Cancer gene therapy 20060501

• Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3).

  Molecular pharmacology 20060501

• Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer.

  The European respiratory journal 20060501

• Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine).

  Molecular pharmacology 20060501

• Selective kinase inhibition with daily imatinib intensifies toxicity of chemotherapy in patients with solid tumours.

  European journal of cancer (Oxford, England : 1990) 20060501

• Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060501

• With a little help from small friends: Enhanced chemotherapeutic effects with imatinib.

  European journal of cancer (Oxford, England : 1990) 20060501

• Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).

  Lung cancer (Amsterdam, Netherlands) 20060501

• Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060501

• Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.

  Cancer 20060501

• Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

  Lung cancer (Amsterdam, Netherlands) 20060501

• High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060501

• Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a phase I-II study.

  Oncology reports 20060501

• Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer?

  Journal of surgical oncology 20060501

• Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20060501

• [Present and future home therapy in advanced stage of pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060501

• Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.

  Journal of gastroenterology and hepatology 20060501

• Cardiac metastasis from uterine leiomyosarcoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060501

• Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer.

  Clinical lung cancer 20060501

• Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Actual experience and future development of gemcitabine in superficial bladder cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Pharmacogenomics and gemcitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Gemcitabine: monochemotherapy of breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• In vitro studies on gemcitabine combinations with other antiblastics.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Gemcitabine and taxanes in metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Biological agents and gemcitabine in the treatment of breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Role of gemcitabine in ovarian cancer treatment.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Gemcitabine and anthracyclines in platinum-resistant ovarian cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• In vitro basis for schedule-dependent interaction between gemcitabine and topoisomerase-targeted drugs in the treatment of colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Topoisomerase I, II alpha and II beta mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary results.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Clinical studies of pemetrexed and gemcitabine combinations.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Development of gemcitabine in non-small cell lung cancer: the Italian contribution.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Simplified gemcitabine and platin regimen in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to be proposed as neoadjuvant therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• First line chemotherapy in advanced or metastatic NSCLC.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Cellular pharmacology of gemcitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Non-small-cell lung cancer: which platinum for gemcitabine?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Non-platinum combination of gemcitabine in NSCLC.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060501

• Gemcitabine and carboplatin chemotherapy safely administered to a patient with homocystinuria.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060501

• Introduction. Gemcitabine: ten years of clinical experience.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Gemcitabine: ten years of clinical experience. Proceedings of a workshop. September 19-21, 2005. Monastier di Treviso, Italy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420

• Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420

• Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.

  Proceedings of the National Academy of Sciences of the United States of America 20060418

• Targeting oncogenes to improve breast cancer chemotherapy.

  Cancer research 20060415

• Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo.

  Cancer research 20060415

• Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060415

• Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060415

• Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060410

• Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.

  Gut 20060401

• Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR).

  Respiratory medicine 20060401

• Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study.

  Gynecologic oncology 20060401

• Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060401

• Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience.

  Lung cancer (Amsterdam, Netherlands) 20060401

• Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20060401

• Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens.

  Breast cancer research and treatment 20060401

• Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous bolus dosing and its in vitro pharmacodynamics.

  Journal of veterinary pharmacology and therapeutics 20060401

• Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous infusion.

  Journal of veterinary pharmacology and therapeutics 20060401

• Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation.

  Oncology reports 20060401

• Triplet chemotherapy for malignant pericardial mesothelioma: a case report.

  Japanese journal of clinical oncology 20060401

• [Is there a nonsurgical therapeutic approach to cholangiocellular carcinomas?].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20060401

• What's new in pancreatic cancer treatment pipeline?

  Best practice & research. Clinical gastroenterology 20060401

• Chemotherapy for advanced pancreatic cancer.

  Best practice & research. Clinical gastroenterology 20060401

• The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer.

  Best practice & research. Clinical gastroenterology 20060401

• Erlotinib or capecitabine with gemcitabine in pancreatic cancer?

  Future oncology (London, England) 20060401

• Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma.

  Cancer research 20060401

• Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

  Cancer research 20060401

• Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial.

  American journal of clinical oncology 20060401

• Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma.

  American journal of clinical oncology 20060401

• A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer.

  American journal of clinical oncology 20060401

• Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20060401

• XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics.

  Pancreas 20060401

• [Non-surgical treatment for pancreatic cancer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060401

• Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer.

  The Canadian journal of urology 20060401

• Management of platinum-sensitive recurrent ovarian cancer.

  Seminars in oncology 20060401

• Optimizing gemcitabine regimens in ovarian cancer.

  Seminars in oncology 20060401

• The role of gemcitabine in first-line treatment of advanced ovarian carcinoma.

  Seminars in oncology 20060401

• Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer.

  Journal of chemotherapy (Florence, Italy) 20060401

• Something old, something new...

  Leukemia & lymphoma 20060401

• Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.

  British journal of cancer 20060327

• Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320

• A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.

  Cancer 20060315

• Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060315

• Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells.

  World journal of gastroenterology 20060314

• Monitoring of cell growth and assessment of cytotoxicity using electrochemical impedance spectroscopy.

  Biochimica et biophysica acta 20060301

• Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.

  Leukemia & lymphoma 20060301

• Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20060301

• Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.

  Lung cancer (Amsterdam, Netherlands) 20060301

• Interferon receptors and the caspase cascade regulate the antitumor effects of interferons on human pancreatic cancer cell lines.

  American journal of surgery 20060301

• Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.

  Expert review of anticancer therapy 20060301

• Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity.

  Anti-cancer drugs 20060301

• Toxicity and efficacy of isolated lung perfusion with gemcitabine in a rat model of pulmonary metastases.

  The Thoracic and cardiovascular surgeon 20060301

• Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor.

  Cancer science 20060301

• SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone.

  Molecular cancer therapeutics 20060301

• Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299).

  Molecular cancer therapeutics 20060301

• [Palliative chemotherapy of head and neck cancer: present status and future development].

  Laryngo- rhino- otologie 20060301

• Improvement of quality of life with Shenfu injection in non small cell lung cancer patients treated with gemcitabine plus cisplatin regimen.

  Chinese journal of integrative medicine 20060301

• Chemotherapy of advanced non-small cell lung cancer in elderly patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• [A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20060301

• Identification and treatment of aggressive thyroid cancers. Part 1: subtypes.

  Oncology (Williston Park, N.Y.) 20060301

• Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer.

  Journal of gastroenterology and hepatology 20060301

• Multicenter study on the use of gemcitabine to prevent recurrence of multiple-recurring superficial bladder tumors following intravesical antiblastic agents and/or BCG: evaluation of tolerance.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20060301

• High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.

  Journal of experimental & clinical cancer research : CR 20060301

• [Changes and clinical significance of serum soluble Apo-1/Fas in pancreatic cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301

• Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060301

• The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression.

  Cancer letters 20060227

• Antagonistic effects of sequential administration of BL1521, a histone deacetylase inhibitor, and gemcitabine to neuroblastoma cells.

  Cancer letters 20060227

• Relationship between cisplatin administration and the development of ototoxicity.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060220

• Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report.

  Pediatric blood & cancer 20060201

• Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

  International journal of radiation oncology, biology, physics 20060201

• Nucleoside ester prodrug substrate specificity of liver carboxylesterase.

  The Journal of pharmacology and experimental therapeutics 20060201

• Achieving cure for early stage pediatric Hodgkin disease with minimal morbidity: are we there yet?

  Pediatric blood & cancer 20060201

• Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

  Gynecologic oncology 20060201

• A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Phase II study of gemcitabine in children with relapsed leukemia.

  Pediatric blood & cancer 20060201

• Re: 'Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival'.

  Gynecologic oncology 20060201

• Prolonged gemcitabine infusion in advanced non-small-cell lung cancer with stable disease after gemcitabine 30-min infusion.

  Lung cancer (Amsterdam, Netherlands) 20060201

• Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells.

  Cancer 20060201

• Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.

  International journal of oncology 20060201

• Putting the chemo in chemoradiation for pancreatic cancer.

  Annals of surgical oncology 20060201

• Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.

  Japanese journal of clinical oncology 20060201

• A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.

  Annals of surgical oncology 20060201

• Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.

  The Journal of thoracic and cardiovascular surgery 20060201

• Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?

  Expert review of anticancer therapy 20060201

• Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

• A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060201

• A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancer.

  American journal of clinical oncology 20060201

• Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma.

  American journal of clinical oncology 20060201

• The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Role of gemcitabine in breast cancer management: an update.

  Seminars in oncology 20060201

• Gemcitabine-induced radiation necrosis of the pectoralis major muscle.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201

• Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201

• A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20060201

• [Recent progress in the treatment for urothelial cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• [Progress in therapy for testicular tumors].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• [Clinical features of long time survivors with unresectable pancreatic cancer treated by gemcitabine alone].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• [A case report of unresectable gallbladder cancer that responded remarkably to the combination of thalidomide, celecoxib, and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells.

  Molecular cancer therapeutics 20060201

• Analysis of mannitol in pharmaceutical formulations using hydrophilic interaction liquid chromatography with evaporative light-scattering detection.

  Journal of separation science 20060201

• [Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening].

  Gastroenterologie clinique et biologique 20060201

• Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer.

  Clinical breast cancer 20060201

• Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201

• Subcutaneous metastasis as the first manifestation of a solid-pseudopapillary tumor of the pancreas.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201

• [Development of a molecular target therapy on the basis of global gene analyses of gastrointestinal carcinoma].

  Fukuoka igaku zasshi = Hukuoka acta medica 20060201

• [Maintenance chemotherapy in advanced NSCLC].

  Revue de pneumologie clinique 20060201

• [From ASCO and WCLC 2005 to clinical practice: 'conventional' treatments].

  Revue de pneumologie clinique 20060201

• [Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma].

  Klinichna khirurhiia 20060201

• Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060201

• Gemcitabine doublets in advanced pancreatic cancer: should we move on?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120

• Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120

• SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer.

  British journal of cancer 20060116

• Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma.

  Cancer 20060115

• The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.

  Cancer 20060115

• Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma.

  Cancer research 20060115

• Folate-mediated targeting of polymeric conjugates of gemcitabine.

  International journal of pharmaceutics 20060113

• Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.

  JOP : Journal of the pancreas 20060111

• Squamous cell carcinoma of the pancreas: report of a case and review of the literature.

  JOP : Journal of the pancreas 20060111

• Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives.

  JOP : Journal of the pancreas 20060111

• Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma.

  Cancer chemotherapy and pharmacology 20060101

• A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: a Gynecologic Oncology Group study.

  Gynecologic oncology 20060101

• Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.

  Cancer chemotherapy and pharmacology 20060101

• Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy.

  Gynecologic oncology 20060101

• Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma.

  Bone marrow transplantation 20060101

• Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.

  Gynecologic oncology 20060101

• Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).

  Lung cancer (Amsterdam, Netherlands) 20060101

• In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.

  Anti-cancer drugs 20060101

• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors.

  Anti-cancer drugs 20060101

• Gemcitabine-related radiation recall in a patient with pancreatic cancer.

  Anti-cancer drugs 20060101

• Chemoradiotherapy in patients with pancreatic carcinoma: phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101

• Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.

  International journal of oncology 20060101

• Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue.

  Oncology reports 20060101

• Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma.

  Head & neck 20060101

• Differences in immune cells engaged in cell-mediated immunity after chemotherapy for far advanced pancreatic cancer.

  Pancreas 20060101

• Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data.

  Pancreas 20060101

• A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?

  Pancreas 20060101

• 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells.

  Cancer chemotherapy and pharmacology 20060101

• Multimodality approach in management of malignant pleural mesothelioma.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20060101

• Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060101

• Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060101

• p8 is a new target of gemcitabine in pancreatic cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060101

• Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).

  International journal of clinical practice 20060101

• [A 65-year-old man with liver metastases after lung cancer resection that responded to concomitant use of gemcitabine and carboplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060101

• [A case of drug-induced interstitial pneumonitis after gemcitabine treatment for advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060101

• Meta-analysis of inoperable pancreatic cancer: gemcitabine combined with cisplatin versus gemcitabine alone.

  Chinese journal of digestive diseases 20060101

• A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer.

  Japanese journal of clinical oncology 20060101

• [Geriatric urology -- tumour diseases].

  Aktuelle Urologie 20060101

• Preclinical in vivo activity of a combination gemcitabine/liposomal doxorubicin against cisplatin-resistant human ovarian cancer (A2780/CDDP).

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• [Management of pancreatic cancer: current therapy and continued development].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Combination chemotherapy in unresectable pancreatic carcinoma].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Adjuvant chemotherapy for pancreatic cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [IMRD therapy for patients with metastatic pancreas cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Therapeutics with replication--selective virus (RSV) for pancreatic cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Gene therapy of human pancreatic cancer cells by human interferon-beta gene].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Multimodal therapy for advanced pancreatic cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Arterial infusion chemotherapy and radiotherapy after vascular supply distribution for pancreatic carcinoma].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Chemoradiation therapy and immunotherapy for pancreatic cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Significance of thermo-chemotherapy for the patients with unresectable pancreas cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Prognostic significance of CA19-9 levels in patients with pancreatic cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Chemotherapy for biliary tract cancers: general remarks].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• Response of pseudomyxoma peritonei to gemcitabine.

  Acta oncologica (Stockholm, Sweden) 20060101

• Phase II trial of gemcitabine and cisplatin sequentially administered in Asian patients with unresectable or metastatic non-small cell lung cancer.

  Annals of the Academy of Medicine, Singapore 20060101

• Gemcitabine as a radiosensitizer in undifferentiated tumors.

  Anticancer research 20060101

• Evaluation of chemosensitivity of human bone marrow stromal cells--differences between common chemotherapeutic drugs.

  Anticancer research 20060101

• [A case of salvage combination chemotherapy of gemcitabine plus nedaplatin for squamous cell carcinoma of the ureter].

  Hinyokika kiyo. Acta urologica Japonica 20060101

• Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study.

  Urologia internationalis 20060101

• Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial.

  Journal of gastroenterology 20060101

• Evaluation of the efficacy of combined continuous arterial infusion and systemic chemotherapy for the treatment of advanced pancreatic carcinoma.

  Cardiovascular and interventional radiology 20060101

• Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

  BMC cancer 20060101

• Gemcitabine-carboplatin-paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Elevated CA125 level associated with Meigs' syndrome: case report and review of the literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.

  BMC cancer 20060101

• Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101

• Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience.

  BMC cancer 20060101

• A phase I study of oral uracil-tegafur prior to weekly intravenous gemcitabine in patients with advanced pancreatic cancer.

  Chemotherapy 20060101

• Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs.

  Anticancer research 20060101

• Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.

  Anticancer research 20060101

• Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer.

  Anticancer research 20060101

• Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer.

  Anticancer research 20060101

• Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20060101

• Primary carcinoid tumour of the pancreas.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060101

• Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas.

  In vivo (Athens, Greece) 20060101

• Cerebellar metastasis from pancreatic adenocarcinoma. A case report.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101

• Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.

  Oncology 20060101

• Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.

  Tumori 20060101

• Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report.

  BMC cancer 20060101

• Gemcitabine and acute myocardial infarction--a case report.

  Angiology 20060101

• [Concomitant treatment with gemcitabine and radiotherapy in patients with advanced stages of epidermoid carcinoma originating in the head and neck. A phase II sutdy].

  Gaceta medica de Mexico 20060101

• A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer.

  BMC cancer 20060101

• The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines.

  BMC cancer 20060101

• Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.

  Anticancer research 20060101

• Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study.

  Anticancer research 20060101

• Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients.

  Acta oncologica (Stockholm, Sweden) 20060101

• Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions.

  Drugs 20060101

• Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

  BMC cancer 20060101

• Gemcitabine plus mitoxantrone and prednisone in the palliative treatment of hormone-resistant prostate cancer (HRPC): A phase II study (GOAM 01.01 study).

  Anticancer research 20060101

• Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.

  BMC cancer 20060101

• Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trial.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101

• Vitamin D receptor agonists, cancer and the immune system: an intricate relationship.

  Current topics in medicinal chemistry 20060101

• Successful resection of advanced pancreatic tail cancer after neoadjuvant gemcitabine chemotherapy: report of a case.

  Surgery today 20060101

• Cisplatin, gemcitabine and paclitaxel triplet chemotherapy in 50 patients with advanced or metastatic urothelial cancer.

  The West Virginia medical journal 20060101

• Gemcitabine treatment of experimental C6 glioma: the effects on cell cycle and apoptotic rate.

  Anticancer research 20060101

• A phase II study of gemcitabine plus cisplatin in previously untreated advanced ovarian cancer.

  Anticancer research 20060101

• Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20060101

• New agents for intrathecal administration.

  Cancer investigation 20060101

• HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy.

  The oncologist 20060101

• Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.

  Neoplasma 20060101

• A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma.

  Medical oncology (Northwood, London, England) 20060101

• [The use of gemcitabine in the treatment of patients with mesothelioma].

  Voprosy onkologii 20060101

• Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.

  Oncology 20060101

• Cellular resistance against troxacitabine in human cell lines and pediatric patient acute myeloid leukemia blast cells.

  Nucleosides, nucleotides & nucleic acids 20060101

• Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits.

  Nucleosides, nucleotides & nucleic acids 20060101

• Enhanced activity of deoxycytidine kinase after pulsed low dose rate and single dose gamma irradiation.

  Nucleosides, nucleotides & nucleic acids 20060101

• Analysis of deoxycytidine accumulation in gemcitabine treated patients.

  Nucleosides, nucleotides & nucleic acids 20060101

• [Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer].

  Medicina (Kaunas, Lithuania) 20060101

• [Effect of combined treatment methods on quality of life in patients with pancreatic cancer].

  Medicina (Kaunas, Lithuania) 20060101

• Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer.

  Anticancer research 20060101

• Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer.

  Anticancer research 20060101

• Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.

  Anticancer research 20060101

• Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry.

  Molecular pharmaceutics 20060101

• A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.

  BMC cancer 20060101

• Phase II study of cisplatin combined with weekly gemcitabine in the treatment of patients with metastatic pancreatic carcinoma.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101

• Methylation patterns and chemosensitivity in NSCLC.

  Advances in experimental medicine and biology 20060101

• Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature.

  Oncology 20060101

• Single agent gemcitabine chemotherapy in dogs with spontaneously occurring lymphoma.

  Journal of veterinary internal medicine 20060101

• Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine.

  Anticancer research 20060101

• Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer.

  Tumori 20060101

• Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer.

  Medical oncology (Northwood, London, England) 20060101

• Second line chemotherapy with methotrexate and gemcitabine in patients with relapsing head and neck cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101

• Gemcitabine-cisplatin given on day 1 every 3 weeks in advanced non-small cell lung cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101

• Improved survival with single-agent paclitaxel consolidation/maintenance therapy in advanced ovarian carcinoma.

  Oncology 20060101

• Pick the winner designs in phase II cancer clinical trials.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060101

• A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060101

• A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors.

  Oncology research 20060101

• New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder.

  TheScientificWorldJournal 20060101

• A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.

  Oncology 20060101

• A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer.

  Oncology 20060101

• A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.

  Oncology 20060101

• The analgesic effect of gemcitabine in mice.

  Romanian journal of internal medicine = Revue roumaine de medecine interne 20060101

• Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Symptoms in cancer patients and an unusual tumor: Case 3. Follicular dendritic cell sarcoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

  Cancer 20051215

• Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051210

• Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells.

  FEBS letters 20051205

• Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.

  Cancer chemotherapy and pharmacology 20051201

• Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20051201

• Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination.

  Investigational new drugs 20051201

• A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.

  Investigational new drugs 20051201

• Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20051201

• In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabine.

  Molecular therapy : the journal of the American Society of Gene Therapy 20051201

• Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival.

  Molecular pharmacology 20051201

• Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.

  Cancer 20051201

• Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.

  Annals of surgical oncology 20051201

• No evidence of gemcitabine accumulation during weekly administration.

  European journal of clinical pharmacology 20051201

• Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors.

  Scandinavian journal of gastroenterology 20051201

• Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer.

  Japanese journal of clinical oncology 20051201

• Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.

  Leukemia 20051201

• A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin.

  European journal of haematology 20051201

• Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201

• Pegylated liposomal doxorubicin-based combination chemotherapy as salvage treatment in patients with advanced hepatocellular carcinoma.

  American journal of clinical oncology 20051201

• Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study.

  American journal of clinical oncology 20051201

• Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors.

  American journal of clinical oncology 20051201

• The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20051201

• [An outpatient with unresectable pancreatic cancer treated with gemcitabine showing prolonged NC (22 months)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• Brief communication: a new combination in the treatment of advanced pancreatic cancer.

  Seminars in oncology 20051201

• High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20051201

• A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD).

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20051201

• Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial.

  Clinical breast cancer 20051201

• Front-line therapy of advanced pancreatic cancer.

  Seminars in oncology 20051201

• Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer.

  Collegium antropologicum 20051201

• What news in urological cancer.

  La Tunisie medicale 20051201

• Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: impact of comorbidities on safety and efficacy outcome.

  Journal of chemotherapy (Florence, Italy) 20051201

• [The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051201

• Optimizing adjuvant chemotherapy in early-stage breast cancer.

  Oncology (Williston Park, N.Y.) 20051201

• Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.

  Lung cancer (Amsterdam, Netherlands) 20051201

• Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours.

  British journal of cancer 20051128

• MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells.

  World journal of gastroenterology 20051121

• Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120

• [Pancreatic carcinoma (ductal adenocarcinoma)].

  Praxis 20051116

• Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20051115

• Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations.

  Cancer research 20051115

• Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.

  Cancer research 20051115

• Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer.

  British journal of cancer 20051114

• [Review of effectiveness of chemotherapy with gemcitabine in ovarian cancer].

  Orvosi hetilap 20051113

• What's happening in PHARMAC--where do all the submissions go? On the trail of gemcitabine.

  The New Zealand medical journal 20051111

• PHARMAC's response on gemcitabine and transparency.

  The New Zealand medical journal 20051111

• Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20051101

• S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

  Cancer chemotherapy and pharmacology 20051101

• Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.

  Annals of hematology 20051101

• Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.

  Cancer 20051101

• Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer.

  International journal of oncology 20051101

• Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis.

  Oncology reports 20051101

• Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a Phase II Hoosier Oncology Group Study.

  The Journal of urology 20051101

• Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.

  Anti-cancer drugs 20051101

• Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer.

  Anti-cancer drugs 20051101

• Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.

  BJU international 20051101

• Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53.

  Radiation research 20051101

• Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease.

  Onkologie 20051101

• Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051101

• Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.

  Pancreas 20051101

• Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer.

  Respirology (Carlton, Vic.) 20051101

• 5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20051101

• Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity.

  Molecular cancer therapeutics 20051101

• [Molecular targeted therapy--non-small-cell lung cancer and gefitinib].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051101

• [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051101

• Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.

  Urology 20051101

• Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer.

  Chest 20051101

• Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules.

  Clinical lung cancer 20051101

• Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer.

  Clinical lung cancer 20051101

• Gemcitabine and radiotherapy in the treatment of uterine cervical cancer patients at Phramongkutklao Hospital.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20051101

• Gallbladder cancer, a different disease that needs individual trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020

• In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.

  Cancer research 20051015

• In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051015

• Rob Ashley of AmpliMed discusses the discovery and development of Imexon. Interview by Steve Carney.

  Drug discovery today 20051015

• UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial.

  British journal of cancer 20051003

• CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials.

  British journal of cancer 20051003

• Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.

  British journal of cancer 20051003

• Cisplatin and gemcitabine in malignant mesothelioma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• Synergistic interaction of hyperthermia and Gemcitabine in lung cancer.

  Cancer biology & therapy 20051001

• Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy.

  International journal of oncology 20051001

• Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria.

  Anti-cancer drugs 20051001

• Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities.

  Anti-cancer drugs 20051001

• Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.

  Anti-cancer drugs 20051001

• Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

  Anti-cancer drugs 20051001

• A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.

  Melanoma research 20051001

• Systemic therapy for pancreatic cancer.

  Seminars in radiation oncology 20051001

• Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001

• Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001

• Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma.

  American journal of clinical oncology 20051001

• Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer.

  American journal of clinical oncology 20051001

• Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051001

• Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.

  Cancer research 20051001

• Aerosol delivery of chemotherapy in an orthotopic model of lung cancer.

  The European respiratory journal 20051001

• Erlotinib in the treatment of non-small cell lung cancer.

  Expert review of anticancer therapy 20051001

• [A case report of chemotherapy with thalidomide, celecoxib and gemcitabine in the treatment of patients with brain metastases from lung cancer].

  No shinkei geka. Neurological surgery 20051001

• Adjuvant systemic chemotherapy with gemcitabine for stage IV pancreatic cancer: a preliminary report of initial experience.

  Chemotherapy 20051001

• [Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• [Combined systemic and intraarterial chemotherapy with gemcitabine and concomitant external-beam radiotherapy in patients with liver metastasis from pancreatic cancer--report of two cases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study.

  Urology 20051001

• [Successful removal of T4 lung cancer with left atrial invasion after induction chemotherapy].

  Kyobu geka. The Japanese journal of thoracic surgery 20051001

• Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

  Neoplasia (New York, N.Y.) 20051001

• Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Cancer mouse models and other techniques for improved prediction of efficacy.

  IDrugs : the investigational drugs journal 20051001

• [Drug resistance and activity changes of thioredoxin reductase in pancreatic cancer cells strain SW1990 induced by gemcitabine].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20051001

• North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer.

  Clinical breast cancer 20051001

• Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20051001

• Using translational research to tailor the use of chemotherapy in the treatment of NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20051001

• A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20051001

• The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20051001

• Incorporating novel agents with gemcitabine-based treatment of NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20051001

• [A study of recurrent pancreatic cancer with metastatic liver tumors after pancreatectomy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• [Intraperitoneal and intrapleural gemcitabine in patients with advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• [Gemcitabine concurrent with radiation for locally advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• [A case of advanced pancreatic cancer treated with chemoradiation].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells.

  Cancer letters 20050928

• Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050920

• Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree.

  Cancer 20050915

• Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050915

• Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas.

  Cancer immunology, immunotherapy : CII 20050901

• Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.

  International journal of cancer 20050901

• Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Muller S, Schütt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Moritz T. Ann. Hematol. 2005 Feb; 84(2):110-4.

  Annals of hematology 20050901

• Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trials.

  Lung cancer (Amsterdam, Netherlands) 20050901

• cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050901

• Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.

  European urology 20050901

• The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.

  Lung cancer (Amsterdam, Netherlands) 20050901

• Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

  Cancer 20050901

• Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.

  Journal of cancer research and clinical oncology 20050901

• Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.

  Journal of cancer research and clinical oncology 20050901

• Phase I study of vinorelbine plus gemcitabine as third-line chemotherapy for refractory non-small cell lung cancer.

  Oncology reports 20050901

• Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer.

  The Journal of urology 20050901

• In vitro partition of docetaxel and gemcitabine in human volunteer blood: the influence of concentration and gender.

  Anti-cancer drugs 20050901

• Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.

  Leukemia & lymphoma 20050901

• Treatment cost of pancreatic cancer in Japan: analysis of the difference after the introduction of gemcitabine.

  Japanese journal of clinical oncology 20050901

• A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer.

  Respirology (Carlton, Vic.) 20050901

• Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Is the tolerance to MIP chemotherapy different between English and other European populations?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.

  American journal of hematology 20050901

• Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder.

  Urology 20050901

• Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy.

  Cancer research 20050901

• Gemcitabine in the treatment of advanced head and neck cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20050901

• Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.

  Human gene therapy 20050901

• Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer.

  Clinical lung cancer 20050901

• [Phase II study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050901

• [Two cases of advanced gallbadder cancer with para-aortic lymph node metastasis responding to intra-aortic infusion of gemcitabine and low-dose CDDP/5-FU].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050901

• [Experience of gemcitabine therapy after non-curative resection for biliary tract cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050901

• Treatment of metastatic pancreatic cancer.

  Journal of the National Comprehensive Cancer Network : JNCCN 20050901

• [First-line non-small-cell lung cancer: role of gemcitabine].

  Revue de pneumologie clinique 20050901

• [Experience of gemcitabine plus cisplatin chemotherapy in 52 patients with head and neck cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050901

• A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

  Yonsei medical journal 20050831

• Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820

• Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050815

• Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.

  The Journal of biological chemistry 20050812

• Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.

  British journal of cancer 20050808

• Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer.

  Gene therapy 20050801

• Mismatch repair proficiency is not required for radioenhancement by gemcitabine.

  International journal of radiation oncology, biology, physics 20050801

• ['Second line' polychemotherapy in metastatic urothelial cancer of the renal pelvis. Persisting partial remission by 18 treatment cycles of gemcitabine/paclitaxel after 24 treatment cycles gemcitabine/cisplatin 'stable disease'].

  Der Urologe. Ausg. A 20050801

• Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.

  Gynecologic oncology 20050801

• Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.

  Neuroradiology 20050801

• Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.

  European journal of haematology 20050801

• Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma.

  Japanese journal of clinical oncology 20050801

• The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer.

  Journal of evaluation in clinical practice 20050801

• Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.

  Oncology reports 20050801

• Gemcitabine and mitoxantrone in metastatic breast cancer: a phase-I-study.

  Investigational new drugs 20050801

• Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.

  Investigational new drugs 20050801

• Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050801

• Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: a multicentre phase II study.

  Lung cancer (Amsterdam, Netherlands) 20050801

• Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung.

  Anti-cancer drugs 20050801

• Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study.

  International journal of radiation oncology, biology, physics 20050801

• Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.

  The Annals of thoracic surgery 20050801

• Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine.

  Cancer research 20050801

• Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050801

• Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.

  American journal of clinical oncology 20050801

• Cisplatin and gemcitabine for small cell carcinoma of the gall bladder.

  American journal of clinical oncology 20050801

• [A randomized trial of docetaxol plus cisplatin versus gemzar plus cisplatin in treating advanced non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20050801

• [Application of adenosine triphosphate tumor chemosensitive assay system to individual chemotherapy for hepatocellular carcinoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20050801

• Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

  Molecular cancer therapeutics 20050801

• GRiN: a trial and tribulation in respiratory radiotherapy research.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20050801

• A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20050801

• Importance of rational pre-clinical development: gemcitabine comes of age.

  Cancer biology & therapy 20050801

• [Survey of gemcitabine treatment for advanced pancreatic cancer in 20 hospitals of Nagano Prefecture].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050801

• [An orbital metastasis as the presentation of lung adenocarcinoma].

  Archivos de la Sociedad Espanola de Oftalmologia 20050801

• Recent updates on the role of chemotherapy in pancreatic cancer.

  Seminars in oncology 20050801

• Gemcitabine and carboplatin in second-line ovarian cancer.

  Seminars in oncology 20050801

• Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.

  Seminars in oncology 20050801

• Gemcitabine plus paclitaxel in breast cancer.

  Seminars in oncology 20050801

• A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.

  Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20050801

• Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.

  Surgery 20050801

• [Treatment of Bacillus Calmette-Guerin refractory superficial bladder cancer: further intravesical therapy].

  Hinyokika kiyo. Acta urologica Japonica 20050801

• Pancreatic cancer combo treatment promising.

  Health news (Waltham, Mass.) 20050801

• Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.

  Cancer biology & therapy 20050801

• Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells.

  British journal of cancer 20050725

• Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).

  British journal of cancer 20050725

• Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.

  British journal of cancer 20050725

• Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720

• Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.

  Journal of immunology (Baltimore, Md. : 1950) 20050715

• Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft.

  Cancer research 20050715

• Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.

  British journal of cancer 20050711

• Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.

  JOP : Journal of the pancreas 20050708

• A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms.

  Cancer chemotherapy and pharmacology 20050701

• Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.

  Molecular pharmacology 20050701

• A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer.

  Gynecologic oncology 20050701

• Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.

  Oncology reports 20050701

• Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin.

  The Journal of urology 20050701

• Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20050701

• Neoadjuvant chemotherapy in malignant pleural mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20050701

• Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.

  Lung cancer (Amsterdam, Netherlands) 20050701

• Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: pharmacoeconomic considerations.

  European journal of cancer (Oxford, England : 1990) 20050701

• Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.

  International journal of dermatology 20050701

• Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.

  The Journal of thoracic and cardiovascular surgery 20050701

• Chemotherapy for non-small cell lung cancer in elderly patients.

  Chest 20050701

• Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050701

• Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.

  Neoplasia (New York, N.Y.) 20050701

• [Cut-off level of docetaxel, paclitaxel and gemcitabine in histoculture drug response assay for non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050701

• [Effect of full-length cyclin B1 antisense cDNA on chemosensitivity of lewis lung carcinoma cells to gemicitabine in vitro and in vivo].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20050701

• Perspectives on salvage therapy for non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20050701

• Chemotherapy dosing in the setting of liver dysfunction.

  Oncology (Williston Park, N.Y.) 20050701

• Case records of the Massachusetts General Hospital. Case 20-2005. A 58-year-old man with locally advanced pancreatic cancer.

  The New England journal of medicine 20050630

• Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis.

  Oncogene 20050623

• Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

  British journal of cancer 20050620

• Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.

  Blood 20050615

• In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy.

  Cancer research 20050615

• Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050615

• Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.

  British journal of cancer 20050606

• A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20050601

• Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression.

  Langenbeck's archives of surgery 20050601

• A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20050601

• First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050601

• Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine.

  Anti-cancer drugs 20050601

• Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.

  Cancer 20050601

• Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer.

  Investigational new drugs 20050601

• Cisplatin and gemcitabine induction chemotherapy followed by concurrent chemoradiotherapy or surgery for locally advanced non-small cell lung cancer.

  Internal medicine journal 20050601

• Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy.

  Lung cancer (Amsterdam, Netherlands) 20050601

• Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.

  Melanoma research 20050601

• Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

  American journal of clinical oncology 20050601

• A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.

  American journal of clinical oncology 20050601

• Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial.

  The Lancet. Oncology 20050601

• Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050601

• Pharmacokinetics of gemcitabine combined with trastuzumab in patients with advanced breast cancer.

  Onkologie 20050601

• Combination chemotherapy for advanced pancreatic cancer--has its time finally come?

  The Lancet. Oncology 20050601

• [Chemotherapy for advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• [New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• [Chemotherapy of pancreatic carcinoma].

  Praxis 20050601

• A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.

  Clinical lymphoma 20050601

• Gemcitabine in metastatic breast cancer.

  Expert review of anticancer therapy 20050601

• Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  Clinical breast cancer 20050601

• Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520

• Synthesis and biological evaluation of gemcitabine-lipid conjugate (NEO6002).

  Bioorganic & medicinal chemistry letters 20050516

• Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.

  JOP : Journal of the pancreas 20050510

• Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin.

  British journal of cancer 20050509

• Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine.

  Journal of cancer research and clinical oncology 20050501

• Treosulfan and gemcitabine.

  Journal of cancer research and clinical oncology 20050501

• Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501

• A mechanistic study of the permeation kinetics through biomembrane models: gemcitabine-phospholipid bilayer interaction.

  Journal of colloid and interface science 20050501

• Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer.

  Journal of Zhejiang University. Science. B 20050501

• Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer.

  European journal of cancer care 20050501

• Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.

  Gynecologic oncology 20050501

• RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050501

• Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050501

• Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050501

• Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line.

  Cancer science 20050501

• [A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050501

• Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers.

  European journal of cancer (Oxford, England : 1990) 20050501

• [Recent important insights into treatment of pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050501

• Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours.

  Cancer treatment reviews 20050501

• In focus: advanced pancreatic cancer.

  Clinical advances in hematology & oncology : H&O 20050501

• Chemotherapy for metastatic NSCLC: current status and future direction.

  Nature clinical practice. Oncology 20050501

• Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.

  British journal of cancer 20050425

• Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050415

• [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].

  Zhonghua yi xue za zhi 20050413

• In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes.

  Mutation research 20050404

• Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

  Pediatric blood & cancer 20050401

• New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: potential use for suppression of local recurrence of pancreatic cancer.

  Journal of biomedical materials research. Part B, Applied biomaterials 20050401

• Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401

• Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050401

• Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.

  The Journal of urology 20050401

• Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050401

• Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the 'polmone toscano group' (POLTO).

  Lung cancer (Amsterdam, Netherlands) 20050401

• A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients with metastatic pancreas cancer.

  Pancreas 20050401

• 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.

  Pancreas 20050401

• Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.

  Gynecologic oncology 20050401

• Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401

• A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.

  American journal of clinical oncology 20050401

• A nonplatinum combination in metastatic transitional cell carcinoma.

  American journal of clinical oncology 20050401

• A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma.

  American journal of clinical oncology 20050401

• A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study.

  American journal of clinical oncology 20050401

• Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.

  American journal of clinical oncology 20050401

• Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050401

• [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].

  Ai zheng = Aizheng = Chinese journal of cancer 20050401

• Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer.

  Breast cancer research and treatment 20050401

• A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer.

  Japanese journal of clinical oncology 20050401

• Clinical experience with single-agent gemcitabine chemotherapy in patients with non-small-cell lung cancer in whom previous chemotherapy has failed.

  Journal of the Chinese Medical Association : JCMA 20050401

• A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.

  Clinical breast cancer 20050401

• LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.

  Neoplasia (New York, N.Y.) 20050401

• Docetaxel in the management of advanced pancreatic cancer.

  Seminars in oncology 20050401

• Experience with docetaxel in the treatment of gastric cancer.

  Seminars in oncology 20050401

• Docetaxel in the treatment of esophageal cancer.

  Seminars in oncology 20050401

• Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.

  Clinical advances in hematology & oncology : H&O 20050401

• Which should be added to cisplatin for advanced non-small-cell lung cancer--vinorelbine or gemcitabine?

  Nature clinical practice. Oncology 20050401

• Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.

  British journal of cancer 20050328

• Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

  International journal of radiation oncology, biology, physics 20050315

• Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study.

  International journal of radiation oncology, biology, physics 20050315

• Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

  British journal of cancer 20050314

• Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

  Cancer 20050301

• Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma.

  Cancer 20050301

• Chemotherapy options and new advances in malignant pleural mesothelioma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050301

• Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.

  International journal of radiation oncology, biology, physics 20050301

• First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule.

  Lung cancer (Amsterdam, Netherlands) 20050301

• A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050301

• Sonography and CT of vasculitis during gemcitabine therapy.

  AJR. American journal of roentgenology 20050301

• Automated nanospray using chip-based emitters for the quantitative analysis of pharmaceutical compounds.

  Journal of the American Society for Mass Spectrometry 20050301

• Preoperative gemcitabine for unresectable, solid pseudopapillary tumour of the pancreas.

  The Lancet. Oncology 20050301

• Prolonged infusion of gemcitabine in advanced solid tumors: a phase-I-study.

  Investigational new drugs 20050301

• Short communication: the efficacy of fixed dose rate infusion of gemcitabine combined with IFN-alpha2a in patients with advanced refractory renal cell carcinoma.

  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20050301

• Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells.

  Breast cancer research and treatment 20050301

• [Low-dose gemcitabine promotes radiation-induced apoptosis of human hepatoma cell line SMMC-7721].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050301

• [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].

  La Revue de medecine interne 20050301

• [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].

  Bulletin du cancer 20050301

• Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery.

  Clinical lung cancer 20050301

• [Active combination immunochemotherapy with interferon-alpha, interleukin-2 and gemcitabine for four patients with metastatic renal cell carcinoma].

  Hinyokika kiyo. Acta urologica Japonica 20050301

• Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study.

  British journal of cancer 20050227

• Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.

  British journal of cancer 20050227

• Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.

  World journal of gastroenterology 20050227

• Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050220

• A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.

  Cancer 20050215

• Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts.

  Cancer research 20050215

• A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma.

  British journal of cancer 20050214

• Long-term disease-free survival effected by gemcitabine in a heavily pretreated patient with recurrent ovarian carcinoma.

  Archives of gynecology and obstetrics 20050201

• Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.

  Cancer chemotherapy and pharmacology 20050201

• Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.

  Annals of hematology 20050201

• Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.

  Cancer gene therapy 20050201

• Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes.

  Cancer gene therapy 20050201

• Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20050201

• Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination.

  Cancer 20050201

• A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

  Cancer 20050201

• Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study.

  Lung cancer (Amsterdam, Netherlands) 20050201

• Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.

  Lung cancer (Amsterdam, Netherlands) 20050201

• Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.

  Oncology reports 20050201

• Induction of apoptosis in non-small lung carcinoma cell line (H1299) by combination of anti-asthma drugs with gemcitabine and cisplatin.

  International journal of oncology 20050201

• Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine.

  International journal of molecular medicine 20050201

• Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.

  Gynecologic oncology 20050201

• A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.

  Gynecologic oncology 20050201

• A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8).

  Gynecologic oncology 20050201

• Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.

  International journal of radiation oncology, biology, physics 20050201

• Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050201

• The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050201

• Gefitinib and cisplatin-based chemotherapy in non-small-cell lung cancer: simply a bad combination?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201

• Unusual liver abscess.

  Internal medicine journal 20050201

• Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study.

  Japanese journal of clinical oncology 20050201

• [Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report].

  Pneumologie (Stuttgart, Germany) 20050201

• Successful treatment of chemo-refractory pulmonary metastases of renal pelvic cancer by second-line chemotherapy including gemcitabine followed by salvage surgery.

  International journal of urology : official journal of the Japanese Urological Association 20050201

• [The effect of gemcitabine on proliferation and telomerase activity of Tca8113 cell lines].

  Shanghai kou qiang yi xue = Shanghai journal of stomatology 20050201

• [A case of recurrence and systemic metastasis of oral cancer successfully treated with combination chemotherapy of cisplatin and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050201

• [Local recurrence of pancreatic cancer successfully treated with gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050201

• [A case of unresectable advanced pancreatic tail cancer successfully treated with gemcitabine hydrochloride].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050201

• [Two-year survivor in response to gemcitabine-based chemotherapy for advanced pancreatic cancer with multiple lung metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050201

• [Acute myocardial infarction induced by lung cancer chemotherapy after radiation of left lung].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050201

• [Digital ischaemia and gemcitabine. Two new cases].

  Journal des maladies vasculaires 20050201

• Role of gemcitabine in cancer therapy.

  Future oncology (London, England) 20050201

• Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.

  World journal of gastroenterology 20050121

• Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120

• Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway.

  Oncogene 20050106

• Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.

  Cancer 20050101

• Gemcitabine does not prevent acute rejection of the transplanted liver in rats.

  Transplant international : official journal of the European Society for Organ Transplantation 20050101

• Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

  Gynecologic oncology 20050101

• Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer.

  Gynecologic oncology 20050101

• Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.

  Lung cancer (Amsterdam, Netherlands) 20050101

• Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050101

• Impact of gemcitabine on the treatment of metastatic pancreatic cancer.

  Journal of gastroenterology and hepatology 20050101

• Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial.

  Anti-cancer drugs 20050101

• In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer.

  Anti-cancer drugs 20050101

• Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

  European journal of cancer (Oxford, England : 1990) 20050101

• Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?

  Leukemia & lymphoma 20050101

• Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• Symptom-free T4 lung cancer with bilateral pulmonary artery infiltration.

  The Lancet. Oncology 20050101

• Combined modality therapy of gemcitabine and radiation.

  The oncologist 20050101

• Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.

  Breast cancer research and treatment 20050101

• Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.

  Urology 20050101

• Gemcitabine, ovarian cancer, and the elderly.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• [Second-line treatment for advanced non-small-cell lung cancers].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• [The second-line chemotherapy for urological cancers].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• [Cisplatin schedule in combination with gemcitabine in unresectable non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• [A patient with recurrent gallbladder cancer responding to chemotherapy with CDDP/CPT-11 and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.

  Clinical lung cancer 20050101

• Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies.

  Journal of veterinary internal medicine 20050101

• [Experimental study on effect of chemotherapy combined ginsengnoside Rg3 in treating pulmonary carcinoma].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20050101

• Chemoresistance in non-small cell lung cancer.

  Current medicinal chemistry. Anti-cancer agents 20050101

• Primary alveolar soft part sarcoma (ASPS) of the breast: report of a deceptive case with xanthomatous features confirmed by TFE3 immunohistochemistry and electron microscopy.

  International journal of surgical pathology 20050101

• Nucleosomes in pancreatic cancer patients during radiochemotherapy.

  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20050101

• Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study.

  Cancer investigation 20050101

• Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer.

  Lung 20050101

• Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.

  Molecular pharmaceutics 20050101

• Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study.

  Cancer investigation 20050101

• Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status.

  Anticancer research 20050101

• Efficacy of gemcitabine--cisplatin treatment in stage IIIA ('bulky'N2), IIIB and IV non-small cell lung cancer.

  Anticancer research 20050101

• Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel.

  Anticancer research 20050101

• Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Review of gemcitabine-based combinations for platinum-resistant ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma.

  Tumori 20050101

• Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer.

  Anticancer research 20050101

• Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.

  Neoplasma 20050101

• [Gemcitabine plus cisplatin therapy in breast cancer refractory to anthracyclines, docetaxel and capecitabine].

  Voprosy onkologii 20050101

• Impact of different treatment methods on survival in advanced pancreatic cancer.

  Medicina (Kaunas, Lithuania) 20050101

• Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.

  BMC cancer 20050101

• The role of chemotherapy in cholangiocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Safety of pulmonary administration of gemcitabine in rats.

  Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20050101

• Gemcitabine radiosensitization for rectal cancer: step forward or dance step?

  Cancer journal (Sudbury, Mass.) 20050101

• Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial.

  Cancer journal (Sudbury, Mass.) 20050101

• Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20050101

• Major response and clinical benefit following third-line treatment for Bellini duct carcinoma.

  Wiener klinische Wochenschrift 20050101

• Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.

  BMC cancer 20050101

• Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20050101

• Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors.

  Oncology 20050101

• Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma.

  Oncology 20050101

• Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.

  Oncology 20050101

• Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.

  Oncology 20050101

• Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.

  Oncology 20050101

• Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.

  Oncology 20050101

• Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.

  Oncology 20050101

• The effect of gemcitabine in the treatment of rejection in experimental small intestine transplantation.

  Folia biologica 20050101

• Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.

  Anticancer research 20050101

• Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study.

  Anticancer research 20050101

• Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer.

  Anticancer research 20050101

• Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.

  Anticancer research 20050101

• Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.

  Oncology 20050101

• Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy.

  Anticancer research 20050101

• Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells.

  Anticancer research 20050101

• Hyperoxia-induced improvement of the in vitro response to gemcitabine in transitional cell carcinoma.

  Anticancer research 20050101

• Bi-weekly administration of docetaxel and gemcitabine as first-line therapy for non-small cell lung cancer: a phase II study.

  Anticancer research 20050101

• Bevacizumab as treatment for chemotherapy-resistant pancreatic cancer.

  Anticancer research 20050101

• Mesothelioma: treatment and survival of a patient population and review of the literature.

  Anticancer research 20050101

• Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.

  BMC cancer 20050101

• Predictive value of heparanase expression in the palliative therapy of pancreatic cancer.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20050101

• A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma.

  Oncology 20050101

• Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra-arterial delivery in unresectable pancreatic cancer patients.

  Clinical pharmacokinetics 20050101

• The evolution of cancer research and drug discovery at Lilly Research Laboratories.

  Advances in enzyme regulation 20050101

• Anticancer activity of a lectin-rich mistletoe extract injected intratumorally into human pancreatic cancer xenografts.

  Anticancer research 20050101

• Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.

  BMC cancer 20050101

• Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.

  Cancer investigation 20050101

• 518A2 melanoma cells are protected by G3139 and other antineoplastic agents against the cytotoxic effects of DTIC.

  Oligonucleotides 20050101

• Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].

  BMC cancer 20050101

• Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.

  Medical oncology (Northwood, London, England) 20050101

• Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer.

  Medical oncology (Northwood, London, England) 20050101

• Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer.

  PharmacoEconomics 20050101

• Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.

  Oncology 20050101

• Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer.

  Anticancer research 20050101

• Same-day pegfilgrastim and chemotherapy.

  Cancer investigation 20050101

• Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine.

  Cancer investigation 20050101

• Paclitaxel decreases the accumulation of gemcitabine and its metabolites in human leukemia cells and primary cell cultures.

  Anticancer research 20050101

• The role of taxanes in the management of bladder cancer.

  The oncologist 20050101

• First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.

  BMC cancer 20050101

• Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.

  Oncology 20050101

• A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer.

  Oncology 20050101

• Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy.

  Urologia internationalis 20050101

• Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A.

  Journal of proteome research 20050101

• Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Treatment of recurrent disease: randomized trials of monotherapy versus combination chemotherapy.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Gemcitabine-taxane experience in the treatment of metastatic breast cancer.

  Cancer treatment reviews 20050101

• Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?

  Cancer treatment reviews 20050101

• What is the best schedule for administration of gemcitabine-taxane?

  Cancer treatment reviews 20050101

• Gemcitabine in patients with ovarian cancer.

  Cancer treatment reviews 20050101

• [Metastatic breast cancer: new chemotherapy regimens with taxanes].

  La Clinica terapeutica 20050101

• A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20050101

• Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.

  Biochemical pharmacology 20041215

• Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041215

• Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041215

• Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.

  Journal of controlled release : official journal of the Controlled Release Society 20041210

• A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

  Cancer chemotherapy and pharmacology 20041201

• Results of a Phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20041201

• Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20041201

• Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.

  Acta pharmacologica Sinica 20041201

• Current chemotherapeutic treatment of malignant pleural mesothelioma.

  Expert opinion on pharmacotherapy 20041201

• A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.

  American journal of clinical oncology 20041201

• Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.

  Gynecologic oncology 20041201

• Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20041201

• Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20041201

• Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041201

• Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

  International journal of radiation oncology, biology, physics 20041201

• A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20041201

• Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20041201

• [Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)].

  Pneumologie (Stuttgart, Germany) 20041201

• [Efficacy of selective continuous transarterial infusion chemotherapy on advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20041201

• [Short-term efficacy of combined chemotherapy of gemcitabine and cisplatin on advanced hormone refractory prostate cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20041201

• Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.

  Chemotherapy 20041201

• Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20041201

• A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.

  The Canadian journal of urology 20041201

• FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.

  Japanese journal of clinical oncology 20041201

• [New horizon of the treatment of pancreatic cancer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041201

• Gemcitabine and paclitaxel in metastatic breast cancer: a review.

  Oncology (Williston Park, N.Y.) 20041201

• Gemcitabine and docetaxel in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20041201

• Gemcitabine and platinum-based chemotherapy in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20041201

• Adjuvant chemotherapy for early-stage breast cancer: the tAnGo trial.

  Oncology (Williston Park, N.Y.) 20041201

• Neoadjuvant therapy with gemcitabine in breast cancer.

  Oncology (Williston Park, N.Y.) 20041201

• Gemcitabine in combination with trastuzumab and/or platinum salts in breast cancer cells with HER2 overexpression.

  Oncology (Williston Park, N.Y.) 20041201

• Integrating gemcitabine into breast cancer therapy.

  Oncology (Williston Park, N.Y.) 20041201

• Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.

  Oncology (Williston Park, N.Y.) 20041201

• Development of docetaxel in advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20041201

• Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology.

  Journal of chemotherapy (Florence, Italy) 20041201

• Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers.

  Seminars in oncology 20041201

• Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation.

  Cancer 20041115

• Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma.

  British journal of cancer 20041115

• Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.

  Cancer research 20041115

• Recurrent ovarian cancer: how important is it to treat to disease progression?

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041115

• Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma.

  Investigational new drugs 20041101

• Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells.

  International journal of cancer 20041101

• Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation.

  International journal of molecular medicine 20041101

• [Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder].

  La Revue de medecine interne 20041101

• Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101

• Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.

  Bone marrow transplantation 20041101

• Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.

  European journal of cancer (Oxford, England : 1990) 20041101

• Evaluation of gemcitabine in relapsed or refractory multiple myeloma.

  Haematologica 20041101

• [Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?].

  Revue de pneumologie clinique 20041101

• Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.

  Molecular cancer therapeutics 20041101

• Activity of bortezomib in advanced non-small-cell lung cancer.

  Clinical lung cancer 20041101

• [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].

  Ai zheng = Aizheng = Chinese journal of cancer 20041101

• [Initial results of intra-arterial chemotherapy for poorly differentiated bladder transitional cell carcinoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20041101

• Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small cell lung cancer: a prospective observational study.

  Chinese medical journal 20041101

• [Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041101

• Pemetrexed in pancreatic cancer.

  Oncology (Williston Park, N.Y.) 20041101

• Pemetrexed in transitional cell carcinoma of the urothelium.

  Oncology (Williston Park, N.Y.) 20041101

• The promise of pharmacogenomics: gemcitabine and pemetrexed.

  Oncology (Williston Park, N.Y.) 20041101

• [Chemoradiation for pancreatic adenocarcinoma].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20041101

• [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20041101

• Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer.

  International journal of cancer 20041020

• Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway.

  European journal of pharmacology 20041019

• BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer.

  Human molecular genetics 20041015

• The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041015

• A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer.

  Cancer chemotherapy and pharmacology 20041001

• Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line.

  Cancer chemotherapy and pharmacology 20041001

• Neoadjuvant induction chemotherapy followed by chemoradiation: a phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies.

  Surgical oncology clinics of North America 20041001

• The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.

  Surgical oncology clinics of North America 20041001

• Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).

  Lung cancer (Amsterdam, Netherlands) 20041001

• Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial.

  Lung cancer (Amsterdam, Netherlands) 20041001

• Gemcitabine and haemolytic-uraemic syndrome.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041001

• Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.

  The Journal of urology 20041001

• Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma.

  Cancer 20041001

• Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20041001

• Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behçet's disease-like mouse model.

  Experimental dermatology 20041001

• Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.

  The Annals of thoracic surgery 20041001

• Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testis.

  Urology 20041001

• Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.

  Urology 20041001

• [Histoculture drug response assay for solitary fibrous tumor--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• [Multimodality therapy for diffuse malignant pleural mesothelioma].

  Kyobu geka. The Japanese journal of thoracic surgery 20041001

• [A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• [Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• [The QOL of the patient with advanced pancreatic carcinoma was changed for the better with combination therapy consisting of arterial chemotherapy and injection of interferon].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• [A case of unresectable pancreatic cancer showing tumor dormancy treated with gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.

  Nucleosides, nucleotides & nucleic acids 20041001

• Fluorescence studies of substrate binding to human recombinant deoxycytidine kinase.

  Nucleosides, nucleotides & nucleic acids 20041001

• Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.

  Nucleosides, nucleotides & nucleic acids 20041001

• Increased cytotoxicity of 2',2'-difluoro-2'-deoxycytidine in human leukemic cell-lines after a preincubation with cyclopentenyl cytosine.

  Nucleosides, nucleotides & nucleic acids 20041001

• Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.

  Nucleosides, nucleotides & nucleic acids 20041001

• Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.

  World journal of surgery 20041001

• Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.

  American journal of clinical oncology 20041001

• Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity.

  Cancer letters 20040930

• Investigation of the pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in human plasma by liquid chromatography.

  Analytical biochemistry 20040915

• Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040915

• Microregional effects of gemcitabine in HCT-116 xenografts.

  Cancer research 20040915

• A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040915

• Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides.

  British journal of cancer 20040913

• Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.

  European journal of pharmacology 20040913

• Cytotoxic chemotherapy for metastatic renal cell carcinoma.

  Der Urologe. Ausg. A 20040901

• HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support.

  Bone marrow transplantation 20040901

• Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20040901

• Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC).

  European urology 20040901

• New approaches for pancreatic cancer in Japan.

  Cancer chemotherapy and pharmacology 20040901

• Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040901

• A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

  Cancer 20040901

• Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040901

• A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.

  European journal of cancer (Oxford, England : 1990) 20040901

• Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer.

  Gynecologic oncology 20040901

• Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.

  Urology 20040901

• Analysis of treatment for small cell cancer of the bladder and report of three cases.

  Urology 20040901

• [Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040901

• [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040901

• [Synergistic effects of paclitaxel and gemcitabine on androgen-independent prostate cancer].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20040901

• Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.

  Clinical lymphoma 20040901

• Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases.

  Japanese journal of clinical oncology 20040901

• Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer.

  Cancer science 20040901

• Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial.

  Clinical lung cancer 20040901

• Chemoradiation with gemcitabine for cervical cancer in patients with renal failure.

  Anti-cancer drugs 20040901

• Non-toxic and short treatment with gemcitabine inhibits in vitro migration of HT-1080 cells.

  Anti-cancer drugs 20040901

• [The synergistic effects of paclitaxel and gemcitabine on prostate cancer cell line PC-3].

  Zhonghua nan ke xue = National journal of andrology 20040901

• [Evaluation of advanced non-small-cell lung cancer (ANSCLC) chemotherapy in routine practice].

  Revue des maladies respiratoires 20040901

• Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study.

  Bulletin du cancer 20040901

• A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.

  British journal of cancer 20040831

• Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.

  British journal of cancer 20040816

• A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer.

  British journal of cancer 20040816

• Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2'-2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000.

  Biochemical pharmacology 20040815

• The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas.

  Cancer research 20040815

• Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040815

• Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040815

• Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.

  British journal of cancer 20040802

• Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.

  British journal of cancer 20040802

• Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.

  Carcinogenesis 20040801

• Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC).

  Investigational new drugs 20040801

• In vitro assessment of nucleoside analogs in multiple myeloma.

  Cancer chemotherapy and pharmacology 20040801

• Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji.

  Journal of medical virology 20040801

• A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040801

• Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.

  The Journal of urology 20040801

• Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site.

  Cancer 20040801

• Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.

  International journal of radiation oncology, biology, physics 20040801

• A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040801

• Gemcitabine-associated scleroderma-like changes of the lower extremities.

  Journal of the American Academy of Dermatology 20040801

• Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040801

• Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.

  American journal of clinical oncology 20040801

• Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040801

• Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature.

  Gynecologic oncology 20040801

• Triplet combination of gemcitabine, carboplatin, and paclitaxel in previously treated, relapsed ovarian and peritoneal carcinoma: an experience in Taiwan.

  Gynecologic oncology 20040801

• Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040801

• Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040801

• Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer.

  Surgery 20040801

• [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].

  Ai zheng = Aizheng = Chinese journal of cancer 20040801

• Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice.

  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20040801

• [Role of postoperative adjuvant chemotherapy with gemcitabine for pancreatic cancer: feasibility and anti-tumor effect].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040801

• Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.

  British journal of cancer 20040801

• Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences.

  Pharmacy world & science : PWS 20040801

• Current and future strategies for treating metastatic pancreatic cancer.

  Clinical advances in hematology & oncology : H&O 20040801

• Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine.

  Journal of computational chemistry 20040730

• Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040715

• Effect of LY293111 in combination with gemcitabine in colonic cancer.

  Cancer letters 20040708

• Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.

  Journal of cancer research and clinical oncology 20040701

• Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.

  Lung cancer (Amsterdam, Netherlands) 20040701

• Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil.

  Oncology reports 20040701

• Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience.

  Anti-cancer drugs 20040701

• Non-allergic nature of docetaxel-induced acute hypersensitivity reactions.

  Anti-cancer drugs 20040701

• Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.

  The Annals of thoracic surgery 20040701

• The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.

  The Annals of thoracic surgery 20040701

• Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040701

• Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040701

• Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium.

  International journal of urology : official journal of the Japanese Urological Association 20040701

• Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.

  Urology 20040701

• Cisplatin and gemcitabine in patients with metastatic cervical cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20040701

• New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed.

  Oncology (Williston Park, N.Y.) 20040701

• Carboplatin/gemcitabine combination in advanced NSCLC.

  Oncology (Williston Park, N.Y.) 20040701

• Gemcitabine-containing regimens vs others in first-line treatment of NSCLC.

  Oncology (Williston Park, N.Y.) 20040701

• Chemoradiation in NSCLC: focus on the role of gemcitabine.

  Oncology (Williston Park, N.Y.) 20040701

• [Intraoperative 125I brachytherapy combined with chemotherapy for pancreatic cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040701

• Gemcitabine, pemetrexed, and novel agents in the treatment of thoracic cancer. Selected presentations from the 10th World Congress on Lung Cancer. Vancouver, Canada.

  Oncology (Williston Park, N.Y.) 20040701

• Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Gemcitabine-associated thrombotic microangiopathy.

  Cancer 20040615

• Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040615

• Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine.

  Cancer chemotherapy and pharmacology 20040601

• Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells.

  The Journal of urology 20040601

• Experimental study on the toxicity and the local and systemic tolerability of gemcitabine after topical treatment of the rabbit bladder.

  Oncology reports 20040601

• High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.

  Lung cancer (Amsterdam, Netherlands) 20040601

• Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

  International journal of radiation oncology, biology, physics 20040601

• Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.

  Cancer treatment reviews 20040601

• Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer.

  British journal of cancer 20040601

• Complete remission of metastatic pancreatic cancer with cardiac involvement after gemcitabine, oxaliplatin and 46-h infusion of 5-fluorouracil/leucovorin.

  Journal of gastroenterology and hepatology 20040601

• Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II trial.

  Cancer 20040601

• Gemcitabine (Gemzar) in non-small cell lung cancer.

  Expert review of anticancer therapy 20040601

• [Bronchiolitis obliterans organizing pneumonia induced by chemotherapy].

  Archivos de bronconeumologia 20040601

• Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.

  Anti-cancer drugs 20040601

• Gemcitabine in patients with solid tumors and renal impairment: a pharmacokinetic phase I study.

  American journal of clinical oncology 20040601

• An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines.

  Cancer research 20040601

• A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.

  Cancer research 20040601

• [Development and characterization of a gemcitabine-resistant variant of human lung adenocarcinoma cell line A549].

  Ai zheng = Aizheng = Chinese journal of cancer 20040601

• siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.

  Journal of the American College of Surgeons 20040601

• Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials.

  Gynecologic oncology 20040601

• Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer.

  International journal of clinical oncology 20040601

• Advanced pancreatic carcinoma showing a complete response to arterial infusion chemotherapy.

  International journal of clinical oncology 20040601

• [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040601

• [A case of advanced pancreatic cancer with remarkable response to thalidomide, celecoxib and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040601

• Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma.

  Clinical lymphoma 20040601

• Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.

  Clinical breast cancer 20040601

• Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.

  Clinical breast cancer 20040601

• Irinotecan in advanced lung cancer: focus on North American trials.

  Oncology (Williston Park, N.Y.) 20040601

• [Chemotherapy of the elderly patients with advanced non-small cell lung cancer].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20040601

• Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

  Chemotherapy 20040601

• Gemcitabine and oxaliplatinum: an effective regimen in a patient with progressive refractory mantle cell lymphoma.

  Leukemia & lymphoma 20040601

• Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. How important is quality of life?

  The European journal of health economics : HEPAC : health economics in prevention and care 20040601

• Second-line chemotherapy and beyond for non-small-cell lung cancer.

  Clinical advances in hematology & oncology : H&O 20040601

• Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.

  Journal of the National Cancer Institute 20040519

• Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II study.

  Cancer 20040515

• Multidisciplinary management of lung cancer.

  The New England journal of medicine 20040506

• Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.

  British journal of cancer 20040504

• A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.

  British journal of cancer 20040504

• Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.

  European journal of haematology 20040501

• Novel therapies for pancreatic adenocarcinoma.

  Current oncology reports 20040501

• Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence.

  Oncology reports 20040501

• Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040501

• Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.

  Gynecologic oncology 20040501

• Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040501

• Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040501

• Gemcitabine-related radiation recall preferentially involves internal tissue and organs.

  Cancer 20040501

• Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040501

• Comparison of zero- and second-order derivative spectrophotometric and HPLC methods for the determination of gemcitabine in human plasma.

  Farmaco (Societa chimica italiana : 1989) 20040501

• A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine.

  Cancer chemotherapy and pharmacology 20040501

• Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040501

• Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040501

• 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.

  The journal of gene medicine 20040501

• Emerging drugs in pancreatic cancer.

  Expert opinion on emerging drugs 20040501

• [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].

  Zhonghua fu chan ke za zhi 20040501

• [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].

  Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 20040501

• Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.

  Clinical lung cancer 20040501

• Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

  Japanese journal of clinical oncology 20040501

• Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.

  International journal of cancer 20040420

• A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

  British journal of cancer 20040419

• Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone.

  Biochemical pharmacology 20040415

• Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415

• Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040405

• Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer.

  British journal of cancer 20040405

• Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer.

  Investigational new drugs 20040401

• Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery.

  BJOG : an international journal of obstetrics and gynaecology 20040401

• Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease.

  Lung cancer (Amsterdam, Netherlands) 20040401

• Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040401

• Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer.

  Gynecologic oncology 20040401

• Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer.

  Journal of the American College of Surgeons 20040401

• Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040401

• Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040401

• Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report.

  International journal of clinical oncology 20040401

• Novel combinations using pemetrexed in malignant mesothelioma.

  Clinical lung cancer 20040401

• High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.

  Japanese journal of clinical oncology 20040401

• Gemcitabine in the treatment of soft tissue sarcomas.

  Onkologie 20040401

• [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].

  Hinyokika kiyo. Acta urologica Japonica 20040401

• Novel therapies for pancreatic adenocarcinoma.

  Current gastroenterology reports 20040401

• Promising combination therapies with gemcitabine.

  Seminars in oncology 20040401

• Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.

  Seminars in oncology 20040401

• Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial.

  Seminars in oncology 20040401

• In vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer: general concepts and future perspectives.

  Seminars in oncology 20040401

• Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study.

  Seminars in oncology 20040401

• Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer.

  Seminars in oncology 20040401

• Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies.

  Journal of chemotherapy (Florence, Italy) 20040401

• Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa.

  Journal of experimental therapeutics & oncology 20040401

• Pancreatic cancer.

  Lancet (London, England) 20040327

• Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells.

  Biochemical and biophysical research communications 20040326

• Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.

  International journal of cancer 20040320

• Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site.

  Cancer 20040315

• Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040315

• A novel cell line and xenograft model of ampulla of Vater adenocarcinoma.

  Virchows Archiv : an international journal of pathology 20040301

• Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer.

  Pharmacological research 20040301

• Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model.

  Gut 20040301

• Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma.

  International journal of radiation oncology, biology, physics 20040301

• In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104.

  International journal of radiation oncology, biology, physics 20040301

• Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040301

• Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Management of primary resistance to gemcitabine and cisplatin (G-C) chemotherapy in metastatic bladder cancer with HER2 over-expression.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.

  BJU international 20040301

• Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040301

• Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.

  Anti-cancer drugs 20040301

• Combination with liposome-entrapped, ends-modified raf antisense oligonucleotide (LErafAON) improves the anti-tumor efficacies of cisplatin, epirubicin, mitoxantrone, docetaxel and gemcitabine.

  Anti-cancer drugs 20040301

• Right pneumonectomy for adenocarcinoma stage IIIA-N2 in a heart transplant patient after induction chemotherapy.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040301

• Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

  Molecular cancer therapeutics 20040301

• The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.

  Molecular cancer therapeutics 20040301

• [A case of inoperable advanced gallbladder cancer that has maintained stable disease status for a long period with gemcitabine and cisplatin therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040301

• Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation.

  Journal of radiation research 20040301

• Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.

  Pediatric hematology and oncology 20040301

• A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040301

• Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms.

  Lung cancer (Amsterdam, Netherlands) 20040301

• [Docetaxel and non-small cell lung cancer].

  Bulletin du cancer 20040301

• Systemic treatment of pancreatic cancer.

  European journal of gastroenterology & hepatology 20040301

• RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.

  Oncogene 20040226

• Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.

  Journal of medicinal chemistry 20040226

• [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line].

  Zhonghua yi xue za zhi 20040217

• Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040215

• Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040215

• Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour.

  Oral oncology 20040201

• Rationale for the use of gemcitabine in breast cancer (Review).

  International journal of oncology 20040201

• Intravesical gemcitabine: a phase 1 and pharmacokinetic study.

  European urology 20040201

• Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040201

• Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.

  Journal of cancer research and clinical oncology 20040201

• New agents in acute myeloid leukemia and other myeloid disorders.

  Cancer 20040201

• Gemcitabine-induced severe pulmonary toxicity.

  Fundamental & clinical pharmacology 20040201

• Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.

  International journal of radiation oncology, biology, physics 20040201

• Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma.

  American journal of clinical oncology 20040201

• Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study.

  Gynecologic oncology 20040201

• Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer.

  Gynecologic oncology 20040201

• State-of-the-art chemotherapy for advanced non-small cell lung cancer.

  Seminars in oncology 20040201

• [Outcomes of treatment with gemcitabine for unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040201

• Recurrent ovarian cancer.

  Onkologie 20040201

• Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum.

  Onkologie 20040201

• [Chemotherapy in pancreatic cancer].

  Orvosi hetilap 20040201

• Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma.

  Canadian journal of physiology and pharmacology 20040201

• [The role of meta-analysis in assessing the treatment of advanced non-small cell lung cancer].

  Revue de pneumologie clinique 20040201

• An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines.

  British journal of cancer 20040126

• Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040115

• [Conservative therapy for pancreatic cancer].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040110

• Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids.

  Journal of cancer research and clinical oncology 20040101

• Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites.

  Oncology reports 20040101

• First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer.

  International journal of oncology 20040101

• Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma.

  Cancer 20040101

• Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908.

  Lung cancer (Amsterdam, Netherlands) 20040101

• Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe.

  Lung cancer (Amsterdam, Netherlands) 20040101

• Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101

• Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.

  Investigational new drugs 20040101

• Palliative treatment for advanced or metastatic osteosarcoma.

  The Israel Medical Association journal : IMAJ 20040101

• [Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040101

• Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.

  Gynecologic oncology 20040101

• Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.

  Gynecologic oncology 20040101

• An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines.

  Gynecologic oncology 20040101

• Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study.

  Lung 20040101

• New perspectives with antimetabolites in the management of breast cancer.

  Clinical breast cancer 20040101

• Single-agent gemcitabine in the treatment of advanced breast cancer.

  Clinical breast cancer 20040101

• Gemcitabine and taxanes as a new standard of care in breast cancer.

  Clinical breast cancer 20040101

• Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.

  Clinical breast cancer 20040101

• Gemcitabine and trastuzumab combinations for patients with metastatic breast cancer overexpressing HER2/neu.

  Clinical breast cancer 20040101

• Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer.

  Clinical breast cancer 20040101

• [A case of primary squamous cell carcinoma of the lung with a metastatic thyroid tumor improved following chemotherapy].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20040101

• Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo.

  Anticancer research 20040101

• [Effectiveness of gemcitabine in combination with cisplatin in a randomized study of untreated patients with advanced non-small-cell lung carcinoma].

  Medicinski arhiv 20040101

• Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer.

  Oncology 20040101

• Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.

  Oncology 20040101

• Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040101

• [Pharmacogenetics in tumors of the lung].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [Medical therapy of elderly patients with advanced non-small cell lung carcinoma: significance and possibilities].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [Rational and results of a scheduled sequential combination in advanced non-small cell lung carcinoma].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• Neoadjuvant strategies for non-small cell lung cancer.

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [Combined treatment of esophageal cancer: a review].

  Medicina (Kaunas, Lithuania) 20040101

• Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab.

  Dermatology (Basel, Switzerland) 20040101

• A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences.

  The breast journal 20040101

• The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer.

  Hepato-gastroenterology 20040101

• Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial.

  Tumori 20040101

• Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20040101

• Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

  BMC pharmacology 20040101

• Down-regulation of the human tumor antigen mucin by gemcitabine on the pancreatic cancer cell line capan-2.

  Anticancer research 20040101

• Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis.

  Anticancer research 20040101

• Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.

  Oncology 20040101

• Setting the record straight: activity of gemcitabine monotherapy for breast cancer.

  Oncology 20040101

• A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.

  Oncology 20040101

• Gemcitabine and cisplatin in refractory malignant lymphoma.

  Oncology 20040101

• Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway.

  The pharmacogenomics journal 20040101

• Treatment of metastatic pancreatic cancer with a combination of gemcitabine and 5-fluorouracil: a single center phase II study.

  Tumori 20040101

• Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.

  Hepato-gastroenterology 20040101

• Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.

  The International journal of biological markers 20040101

• Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment.

  Anticancer research 20040101

• Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study.

  Anticancer research 20040101

• Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma.

  European journal of gynaecological oncology 20040101

• Phase I trial of bi-weekly paclitaxel and gemcitabine as second-line therapy for patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

  Medical oncology (Northwood, London, England) 20040101

• Gemcitabine in multi-resistant non-Hodgkin lymphomas.

  Tumori 20040101

• Palliative treatment of advanced pancreatic carcinoma in community-based oncology group practices.

  The journal of supportive oncology 20040101

• A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine.

  Anticancer research 20040101

• Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells.

  BMC cancer 20040101

• Severe neurotoxicity caused by gemcitabine treatment.

  Acta oncologica (Stockholm, Sweden) 20040101

• Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.

  Medical oncology (Northwood, London, England) 20040101

• [Application of principles of evidence-based medicine in cancer of the urinary bladder].

  Urologiia (Moscow, Russia : 1999) 20040101

• Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment.

  Oncology 20040101

• A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer.

  Urologic oncology 20040101

• A vanishing carina: a rare cause of cough.

  Respiration; international review of thoracic diseases 20040101

• Unexpected toxicity following use of gemcitabine as a radiosensitizer in head and neck carcinomas: a veterinary radiation therapy oncology group pilot study.

  Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 20040101

• Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.

  Cancer investigation 20040101

• Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study.

  Anticancer research 20040101

• [Chemotherapy for advanced non-small-cell lung cancer. From the exclusive use of 'P' to a quantitative probabilistic interpretation of meta-analytic data].

  Tumori 20040101

• An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis.

  Anticancer research 20040101

• Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

  Anticancer research 20040101

• [Pancreatic carcinoma: progress in therapy].

  Krankenpflege Journal 20040101

• Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer.

  Medicina (Kaunas, Lithuania) 20040101

• Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model.

  Clinical & experimental metastasis 20040101

• Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study.

  Oncology 20040101

• The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.

  BMC cancer 20040101

• Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.

  The oncologist 20040101

• Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma.

  Cancer investigation 20040101

• Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).

  Cancer investigation 20040101

• Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.

  Cancer investigation 20040101

• Chemotherapeutic response with single agent gemcitabine in metastatic Bellini duct tumor.

  Cancer investigation 20040101

• Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53.

  Advances in enzyme regulation 20040101

• Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro.

  Neoplasma 20040101

• Gemcitabine and cisplatin following surgical treatment of urinary bladder carcinosarcoma.

  Tumori 20040101

• [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma].

  Tumori 20040101

• [A new therapy standard in metastatic breast cancer--gemzar/paclitaxel. Longer survival by optimized combination therapy].

  Krankenpflege Journal 20040101

• Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II study.

  Oncology 20040101

• Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane.

  Oncology 20040101

• Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress.

  The Journal of biological chemistry 20031226

• Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.

  Cancer 20031215

• Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.

  British journal of cancer 20031215

• Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study.

  British journal of cancer 20031215

• Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.

  British journal of cancer 20031215

• Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity.

  The Journal of biological chemistry 20031212

• Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot study.

  Leukemia research 20031201

• A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin.

  Cancer chemotherapy and pharmacology 20031201

• Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.

  International journal of radiation oncology, biology, physics 20031201

• Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

  European urology 20031201

• Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20031201

• Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20031201

• Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.

  American journal of clinical oncology 20031201

• Dramatic improvement of psoriasis with gemcitabine monotherapy.

  The British journal of dermatology 20031201

• [A case of undifferentiated bladder carcinoma with axilla lymph node metastasis successfully treated with gemcitabine and cisplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031201

• Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.

  Integrative cancer therapies 20031201

• Radiation sensitizers and targeted therapies.

  Oncology (Williston Park, N.Y.) 20031201

• Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.

  Oncology (Williston Park, N.Y.) 20031201

• Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.

  Clinical advances in hematology & oncology : H&O 20031201

• Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.

  Journal of experimental & clinical cancer research : CR 20031201

• RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.

  Biochemical and biophysical research communications 20031121

• Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma.

  British journal of cancer 20031117

• Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro.

  International journal of radiation oncology, biology, physics 20031115

• Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study.

  World journal of gastroenterology 20031115

• Trans-tissue, sustained release of gemcitabine from photocured gelatin gel inhibits the growth of heterotopic human pancreatic tumor in nude mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031115

• Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs.

  European urology 20031101

• Rapid in vitro chemosensitivity analysis of human colon tumor cell lines.

  Toxicology and applied pharmacology 20031101

• Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031101

• Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101

• A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.

  Cancer 20031101

• Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.

  Anti-cancer drugs 20031101

• A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.

  Gynecologic oncology 20031101

• Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy.

  Gynecologic oncology 20031101

• Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20031101

• Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.

  Journal of neurosurgery 20031101

• [Chemotherapy of bladder cancer. Systemic therapy with reduced toxicity].

  Der Urologe. Ausg. A 20031101

• [Home chemotherapy for lung cancer: a five year retrospective study].

  Revue des maladies respiratoires 20031101

• [Chemotherapy for pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031101

• [Non-platinum induction chemotherapy for stage III non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031101

• Highlights from the 10th World Conference on Lung Cancer. Vancouver, British Columbia, Canada, August 10-14, 2003.

  Clinical lung cancer 20031101

• Phase II study of an alternate carboplatin and gemcitabine dosing schedule in advanced non-small-cell lung cancer.

  Clinical lung cancer 20031101

• [Phase II clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101

• [Combined gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101

• Impact of Gemcitabine and Cisplatin with radiotherapy in locally advanced or metastatic transitional cell carcinoma of urinary bladder.

  JPMA. The Journal of the Pakistan Medical Association 20031101

• Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

  International journal of cancer 20031020

• Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine.

  British journal of cancer 20031020

• Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study.

  Cancer 20031015

• Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat.

  Transplantation 20031015

• A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031015

• Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031015

• Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.

  Cancer research 20031015

• Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.

  British journal of cancer 20031006

• First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.

  British journal of cancer 20031006

• The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine.

  Cancer chemotherapy and pharmacology 20031001

• Selective targeting of homologous DNA recombination repair by gemcitabine.

  International journal of radiation oncology, biology, physics 20031001

• Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases.

  The Journal of urology 20031001

• Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.

  The Journal of urology 20031001

• Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of brefeldin-a on the resistant cell line.

  Pancreas 20031001

• An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography.

  Therapeutic drug monitoring 20031001

• Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20031001

• A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.

  Leukemia 20031001

• Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line.

  Journal of cancer research and clinical oncology 20031001

• Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.

  Gynecologic oncology 20031001

• Pharmacokinetics after pulmonary artery perfusion with gemcitabine.

  The Annals of thoracic surgery 20031001

• Extensive palliative surgery for advanced mesothelioma of the tunica vaginalis.

  Urology 20031001

• Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine.

  Cancer research 20031001

• Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.

  Molecular cancer therapeutics 20031001

• Gemcitabine: current role and future options in the treatment of ovarian cancer.

  Critical reviews in oncology/hematology 20031001

• Doxorubicin, paclitaxel and gemcitabine: a Phase I study of a new sequential treatment in stage III B - IV breast cancer.

  Journal of chemotherapy (Florence, Italy) 20031001

• Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.

  Journal of chemotherapy (Florence, Italy) 20031001

• Advanced pancreatic cancer: is there a role for combination therapy?

  Expert review of anticancer therapy 20031001

• Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report.

  Journal of chemotherapy (Florence, Italy) 20031001

• Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?

  Onkologie 20031001

• An autopsy case of acute pulmonary toxicity associated with gemcitabine.

  Internal medicine (Tokyo, Japan) 20031001

• [Chemoradiation therapy for stage IV pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031001

• [Novel chemoradiotherapy for locally advanced pancreatic cancer using arterial infusion chemotherapy following the alteration of peripancreatic blood flow].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031001

• [Gemcitabine infusion via splenic artery for advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031001

• Influence of genetic markers on survival in non-small cell lung cancer.

  Drugs of today (Barcelona, Spain : 1998) 20031001

• Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells.

  Biochimica et biophysica acta 20030923

• It's what's inside that counts.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915

• Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915

• Supportive care in patients with advanced non-small-cell lung cancer.

  British journal of cancer 20030915

• Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915

• Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside.

  Journal of medicinal chemistry 20030911

• Effect of metal-based anticancer drugs on wild type and metallothionein null cell lines.

  Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20030901

• Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20030901

• Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1.

  Cancer chemotherapy and pharmacology 20030901

• Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.

  Cancer chemotherapy and pharmacology 20030901

• Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study.

  International journal of radiation oncology, biology, physics 20030901

• Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.

  Lung cancer (Amsterdam, Netherlands) 20030901

• Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment.

  Lung cancer (Amsterdam, Netherlands) 20030901

• Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901

• Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901

• Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901

• A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030901

• Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer.

  Gynecologic oncology 20030901

• Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine.

  Anti-cancer drugs 20030901

• Unusual response to gemcitabine in a case of peritoneal malignant fibrous histiocytoma.

  Anti-cancer drugs 20030901

• Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine.

  Anti-cancer drugs 20030901

• Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030901

• Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030901

• Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030901

• Localized pleural malignant mesothelioma.

  Pathology international 20030901

• [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030901

• Fatal cholestatic liver failure associated with gemcitabine therapy.

  Digestive diseases and sciences 20030901

• Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I study.

  Oncology (Williston Park, N.Y.) 20030901

• Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.

  Oncology (Williston Park, N.Y.) 20030901

• [Two cases of radiation myositis probably induced by recall phenomenon].

  Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 20030901

• Dose-finding with two agents in Phase I oncology trials.

  Biometrics 20030901

• Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment.

  International journal of cancer 20030820

• Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815

• Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.

  Cancer chemotherapy and pharmacology 20030801

• Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20030801

• Genetic testing for chemotherapy in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030801

• Low-dose gemcitabine plus cisplatin in previously treated, relapsed non-Hodgkin's lymphoma.

  American journal of hematology 20030801

• Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.

  Cancer 20030801

• A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030801

• Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801

• The systemic treatment of advanced and metastatic bladder cancer.

  The Lancet. Oncology 20030801

• Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer.

  American journal of clinical oncology 20030801

• Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II study.

  American journal of clinical oncology 20030801

• Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.

  Cancer research 20030801

• [Chemoradiation in pancreatic carcinoma].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20030801

• Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.

  Seminars in oncology 20030801

• Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approach.

  Seminars in oncology 20030801

• Targeted therapy in combination with gemcitabine in non-small cell lung cancer.

  Seminars in oncology 20030801

• Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5.

  Gynecologic oncology 20030801

• Gemcitabine in cervical cancer.

  Gynecologic oncology 20030801

• Gemcitabine combination chemotherapy of ovarian cancer.

  Gynecologic oncology 20030801

• Gemcitabine as a single-agent treatment for ovarian cancer.

  Gynecologic oncology 20030801

• [Remission rate of mediastinal lymph nodes after multimodal therapy of lung cancer--is it a prognostic factor?].

  Zentralblatt fur Chirurgie 20030801

• [A case of advanced pancreatic cancer treated with gemcitabine hydrochloride].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030801

• The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.

  Seminars in oncology 20030801

• Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study.

  Onkologie 20030801

• New perspectives in the management of pancreas cancer.

  Seminars in oncology 20030801

• [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].

  Der Urologe. Ausg. A 20030801

• Combination chemotherapy with topotecan for non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030801

• Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines.

  European journal of pharmacology 20030725

• A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.

  British journal of cancer 20030721

• Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.

  International journal of radiation oncology, biology, physics 20030715

• Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.

  Cancer 20030715

• Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705

• Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.

  Cancer chemotherapy and pharmacology 20030701

• A phase II/III study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer.

  European journal of cancer (Oxford, England : 1990) 20030701

• Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030701

• Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20030701

• Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.

  Lung cancer (Amsterdam, Netherlands) 20030701

• Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.

  Cancer 20030701

• In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development.

  Leukemia 20030701

• Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients.

  European journal of cancer (Oxford, England : 1990) 20030701

• A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030701

• A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030701

• Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030701

• The global role of irinotecan in the treatment of lung cancer: 2003 update.

  Oncology (Williston Park, N.Y.) 20030701

• [Multi-center trial of gemcitabine for 49 patients with advanced pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030701

• Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer.

  The Journal of surgical research 20030701

• A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.

  The Journal of surgical research 20030701

• Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial.

  Clinical lung cancer 20030701

• Special patients, special treatments.

  Clinical lung cancer 20030701

• Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.

  Clinical lung cancer 20030701

• Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease.

  Clinical advances in hematology & oncology : H&O 20030701

• Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers.

  Critical reviews in oncology/hematology 20030627

• The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.

  Mutation research 20030619

• Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines.

  British journal of cancer 20030616

• A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases.

  Cancer 20030615

• Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

  Oncogene 20030605

• Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group.

  Cancer 20030601

• Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.

  Cancer 20030601

• Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030601

• In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line.

  Lung cancer (Amsterdam, Netherlands) 20030601

• Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.

  Anti-cancer drugs 20030601

• Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.

  The Journal of rheumatology 20030601

• The recent past and future of adjuvant therapy for pancreatic cancer.

  Annals of surgical oncology 20030601

• Fatal hepatic failure due to gemcitabine and vinorelbine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030601

• Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.

  American journal of clinical oncology 20030601

• Gemcitabine, Paclitaxel, and piritrexim: a phase I study.

  American journal of clinical oncology 20030601

• Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin.

  Gynecologic oncology 20030601

• A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas.

  Chemotherapy 20030601

• Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602).

  American journal of obstetrics and gynecology 20030601

• Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer.

  Journal of neuro-oncology 20030601

• A new therapeutical approach: topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum.

  The journal of obstetrics and gynaecology research 20030601

• [Combination therapy with vinorelbine and gemcitabine in unresectable non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030601

• [Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030601

• Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report.

  Journal of chemotherapy (Florence, Italy) 20030601

• A phase I study of gemcitabine and docetaxel for advanced stage solid tumors.

  Cancer investigation 20030601

• Pancreatic cancer.

  Clinical evidence 20030601

• Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

  Oncogene 20030522

• Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.

  Journal of immunology (Baltimore, Md. : 1950) 20030515

• High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model.

  Cancer research 20030515

• Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody.

  The Journal of surgical research 20030515

• Developmental chemotherapy and management of recurrent ovarian cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515

• Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.

  International journal of cancer 20030510

• Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo.

  Mutation research 20030509

• Chemotherapeutic advances in pancreatic cancer.

  Current oncology reports 20030501

• Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030501

• Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20030501

• Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.

  Lung cancer (Amsterdam, Netherlands) 20030501

• A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.

  Lung cancer (Amsterdam, Netherlands) 20030501

• Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.

  Cancer 20030501

• Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): a dose-optimizing phase II trial.

  Cancer 20030501

• Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.

  Annals of surgical oncology 20030501

• Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030501

• [Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence].

  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20030501

• [Malignant pleural mesothelioma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030501

• [Pancreatic cancer--diagnostics and therapy].

  Zentralblatt fur Chirurgie 20030501

• [Adjuvant treatment of pancreatic cancer].

  Zentralblatt fur Chirurgie 20030501

• New chemotherapy agents in veterinary medicine.

  The Veterinary clinics of North America. Small animal practice 20030501

• Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma.

  British journal of cancer 20030422

• Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.

  International journal of cancer 20030420

• Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group.

  Cancer 20030415

• Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415

• Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia.

  Leukemia research 20030401

• Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines.

  Molecular pharmacology 20030401

• Activity of raltitrexed and gemcitabine in advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030401

• Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030401

• Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030401

• The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro.

  European journal of cancer (Oxford, England : 1990) 20030401

• A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20030401

• Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study.

  Lung cancer (Amsterdam, Netherlands) 20030401

• Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.

  Lung cancer (Amsterdam, Netherlands) 20030401

• Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study.

  Expert opinion on pharmacotherapy 20030401

• Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.

  Anti-cancer drugs 20030401

• [Comparison of cisplatin combined with gemcitabine versus cisplatin combined with vinorelbine regimen for treatment of patients with advanced non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20030401

• Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer.

  American journal of clinical oncology 20030401

• Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.

  American journal of clinical oncology 20030401

• Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.

  International journal of clinical oncology 20030401

• Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20030401

• Monotherapy options in the management of metastatic breast cancer.

  Seminars in oncology 20030401

• Gemcitabine and anthracyclines in breast cancer.

  Seminars in oncology 20030401

• Gemcitabine combined with docetaxel in metastatic breast cancer.

  Seminars in oncology 20030401

• Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer.

  Seminars in oncology 20030401

• Gemcitabine and trastuzumab in metastatic breast cancer.

  Seminars in oncology 20030401

• [Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• [Successful treatment with chemotherapy of vinorelbine and gemcitabine for an elderly patient with advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• [Gemcitabine improved QOL and survival in a case of diffuse malignant pleural mesothelioma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

  Cancer investigation 20030401

• Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.

  Cancer investigation 20030401

• Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial.

  Clinical breast cancer 20030401

• [Asbestos--gemcitabin. Combined risk for pulmonary toxicity?].

  Revue des maladies respiratoires 20030401

• [Acute pulmonary toxicity due to gemcitabine: a role for asbestos exposure?].

  Revue des maladies respiratoires 20030401

• Palliative chemotherapy in patients with salivary gland neoplasms and preliminary reports of 2 recent phase II studies with trastuzumab and gemcitabine.

  Clinical advances in hematology & oncology : H&O 20030401

• Chemotherapy for elderly patients with advanced non-small-cell lung cancer.

  Journal of the National Cancer Institute 20030305

• Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

  Journal of the National Cancer Institute 20030305

• Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030301

• A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.

  Cancer 20030301

• Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030301

• The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.

  Breast cancer research and treatment 20030301

• An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.

  Critical reviews in oncology/hematology 20030301

• [Adjuvant and additive therapy for cancer of the pancreas].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20030301

• Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.

  British journal of haematology 20030301

• Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

  Gynecologic oncology 20030301

• Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies.

  Cancer chemotherapy and pharmacology 20030301

• Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment.

  Cancer chemotherapy and pharmacology 20030301

• [Pancreatic carcinoma--overcome technically but not oncologically].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20030301

• [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].

  Revue medicale de Liege 20030301

• Effects of intraperitoneal administration of gemcitabine and paclitaxel on hepatic regeneration in rats.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20030301

• Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030225

• Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.

  British journal of cancer 20030224

• Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• Timing is everything, or could be.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).

  British journal of cancer 20030210

• Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

  Annals of oncology : official journal of the European Society for Medical Oncology 20030201

• Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030201

• A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030201

• Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer.

  Anti-cancer drugs 20030201

• A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030201

• Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030201

• In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030201

• Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma.

  American journal of clinical oncology 20030201

• Radiation enhancement by gemcitabine-mediated cell cycle modulations.

  American journal of clinical oncology 20030201

• Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.

  Lung cancer (Amsterdam, Netherlands) 20030201

• A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030201

• Extensive cutaneous metastasis of transitional cell carcinoma of the bladder.

  International journal of urology : official journal of the Japanese Urological Association 20030201

• [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030201

• Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030201

• Gemcitabine in transitional cell carcinoma of the urothelium.

  Expert review of anticancer therapy 20030201

• Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells.

  Urology 20030201

• Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies.

  Medical science monitor : international medical journal of experimental and clinical research 20030201

• Overview of gemcitabine triplets in metastatic bladder cancer.

  Critical reviews in oncology/hematology 20030201

• [A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030201

• [A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030201

• Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival.

  The Journal of surgical research 20030201

• CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X.

  Leukemia & lymphoma 20030201

• [Mucinous adenocarcinoma of the urachus].

  Actas urologicas espanolas 20030201

• DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin.

  Biochemical pharmacology 20030115

• Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment.

  Cancer letters 20030110

• Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study.

  Oncology 20030101

• Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.

  Oncology 20030101

• Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines.

  International journal of oncology 20030101

• Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies.

  Cancer 20030101

• Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030101

• Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20030101

• Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20030101

• Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum- and multidrug-resistant ovarian and peritoneal carcinoma.

  Gynecologic oncology 20030101

• Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.

  Gynecologic oncology 20030101

• Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030101

• Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model.

  Cancer research 20030101

• The mechanism of action of radiosensitization of conventional chemotherapeutic agents.

  Seminars in radiation oncology 20030101

• A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030101

• Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas.

  Anti-cancer drugs 20030101

• [Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030101

• Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20030101

• Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study.

  Oncology 20030101

• [Gemcitabine in advanced bladder cancer].

  Der Urologe. Ausg. A 20030101

• Antineoplastic therapy in colorectal cancer through proteasome inhibition.

  The American surgeon 20030101

• 27th ESMO Congress, Nice, 18-22 October 2002. Iressa disappoints in NSCLC.

  European journal of cancer (Oxford, England : 1990) 20030101

• [Gemcitabine treatment of pancreatic cancer peritonitis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20030101

• Phase I study of oral CI-994 in combination with gemcitabine in treatment of patients with advanced cancer.

  Cancer journal (Sudbury, Mass.) 20030101

• [Preclinical studies of concomitant chemoradiation].

  Medicina (Kaunas, Lithuania) 20030101

• Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

  Cancer investigation 20030101

• Developments in the systemic therapy of pancreatic cancer.

  Cancer investigation 20030101

• Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.

  Cancer investigation 20030101

• Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU).

  Immunobiology 20030101

• Synergistic cytotoxic effect of TRAIL and gemcitabine in pancreatic cancer cells.

  Anticancer research 20030101

• Role of gemcitabine in the treatment of advanced and metastatic breast cancer.

  Oncology 20030101

• Efficacy of gemcitabine in heavily pretreated advanced ovarian cancer patients.

  European journal of gynaecological oncology 20030101

• [Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer].

  Voprosy onkologii 20030101

• Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.

  Stem cells (Dayton, Ohio) 20030101

• Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study.

  Oncology 20030101

• Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.

  Oncology 20030101

• Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

  Anticancer research 20030101

• Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials.

  International journal of radiation oncology, biology, physics 20030101

• Chemotherapy for advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20030101

• Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents.

  International journal of radiation oncology, biology, physics 20030101

• Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.

  International journal of radiation oncology, biology, physics 20030101

• Gemcitabine plus cisplatin in adjuvant regimen for bladder cancer. Toxicity evaluation.

  Urologia internationalis 20030101

• [Case report: Acro-necrosis of the upper limbs caused by gemcitabine therapy].

  La Clinica terapeutica 20030101

• Breast cancer--response rates to chemotherapeutic agents studied in vitro.

  Anticancer research 20030101

• Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site.

  Anticancer research 20030101

• Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.

  Anticancer research 20030101

• Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products.

  Journal of clinical laboratory analysis 20030101

• [Effectiveness of Gemzar-Cisplatin therapy in stage IIIA-N2, IIIB and IV non-small cell lung cancer].

  Magyar onkologia 20030101

• [Gemcitabine-cisplatin combination in the first line treatment of non-small cell lung cancer. Our experience and analysis of safety].

  Magyar onkologia 20030101

• [Experience with the treatment of advanced pancreatic cancer in Hungary].

  Magyar onkologia 20030101

• [Role of gemcitabine/cisplatin in the treatment of advanced and metastatic bladder cancer].

  Magyar onkologia 20030101

• Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20030101

• Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma.

  Journal of the American Animal Hospital Association 20030101

• Synergistic activity of gamma-linolenic acid and cytotoxic drugs against pancreatic adenocarcinoma cell lines.

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20030101

• Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): a highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas.

  Cancer investigation 20030101

• Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer.

  Cancer investigation 20030101

• A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.

  Cancer investigation 20030101

• Large cell neuroendocrine carcinoma of the urinary bladder with lymphoepithelioma-like features.

  Pathology, research and practice 20030101

• Structural basis for topoisomerase I inhibition by nucleoside analogs.

  Nucleosides, nucleotides & nucleic acids 20030101

• [The update on pancreatic cancer chemotherapy].

  Medicina (Kaunas, Lithuania) 20030101

• Antiblastic drug combinations with ifosfamide: an update.

  Oncology 20030101

• Ifosfamide in non-small cell lung cancer.

  Oncology 20030101

• A phase I study of gemcitabine combined with vinblastine in patients with solid tumors.

  Tumori 20030101

• A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer.

  International journal of clinical pharmacology research 20030101

• Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma.

  Cancer investigation 20030101

• Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabine.

  Oncology 20030101

• Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study.

  Oncology 20030101

• Forced expression of cytidine deaminase confers sensitivity to capecitabine.

  Oncology 20030101

• Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study.

  Anticancer research 20030101

• [Arterial oil chemoembolization: a new method of treatment for pancreatic cancer].

  Voprosy onkologii 20030101

• [New: gemzar plus taxan in metastatic breast carcinoma. Optimal combination].

  Krankenpflege Journal 20030101

• Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patients.

  Oncology 20030101

• Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer.

  Medical oncology (Northwood, London, England) 20030101

• Gemcitabine and reactivation of hepatitis B.

  Medical oncology (Northwood, London, England) 20030101

• Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination.

  Cancer investigation 20030101

• Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines.

  Anticancer research 20030101

• Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.

  International journal of gastrointestinal cancer 20030101

• Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.

  International journal of gastrointestinal cancer 20030101

• Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.

  Cancer 20021215

• Unusual radiation response of gemcitabine-treated HeLa cells: reduced and enhanced survival.

  Cancer letters 20021210

• Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study.

  British journal of cancer 20021202

• Metastatic pancreatic cancer.

  Current treatment options in oncology 20021201

• Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas.

  Expert opinion on investigational drugs 20021201

• Chemotherapy for advanced non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20021201

• Combined platinum containing treatment in NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Two- versus three-drug combinations in the chemotherapy of advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021201

• The role of chemotherapy (CT) and supportive care (SC) in advanced non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20021201

• Challenging the platinum combinations in the chemotherapy of NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20021201

• [Weekly administration of gemcitabine in outpatient clinic for non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• [Gemcitabine in elderly patients with unresectable pancreas cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.

  Cancer biotherapy & radiopharmaceuticals 20021201

• Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.

  Seminars in oncology 20021201

• Emerging insights into the biology and therapy of malignant mesothelioma.

  Seminars in oncology 20021201

• Pemetrexed in the treatment of non-small cell lung cancer.

  Seminars in oncology 20021201

• Pemetrexed in pancreatic cancer.

  Seminars in oncology 20021201

• Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality.

  Seminars in oncology 20021201

• Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.

  Seminars in oncology 20021201

• Future directions in the treatment of pancreatic cancer.

  Seminars in oncology 20021201

• Review of gemcitabine in biliary tract carcinoma.

  Seminars in oncology 20021201

• Chemotherapy in biliary tract carcinomas: results in India.

  Seminars in oncology 20021201

• Chemotherapy for biliary tract cancer in Japan.

  Seminars in oncology 20021201

• A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings.

  Seminars in oncology 20021201

• Gemcitabine therapy in patients with advanced pancreatic cancer.

  The Korean journal of internal medicine 20021201

• Isocratic ion-exchange chromatographic assay for the nucleotide gemcitabine triphosphate in human white blood cells.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125

• Chemoradiation protocols offer only incremental gains for pancreatic cancer patients.

  Journal of the National Cancer Institute 20021120

• Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.

  Cancer 20021115

• Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation.

  International journal of radiation oncology, biology, physics 20021115

• Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.

  International journal of cancer 20021110

• Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer.

  International journal of radiation oncology, biology, physics 20021101

• Early changes in [18F]FLT uptake after chemotherapy: an experimental study.

  European journal of nuclear medicine and molecular imaging 20021101

• Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.

  Journal of surgical oncology 20021101

• Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021101

• A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021101

• Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021101

• Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021101

• Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021101

• Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20021101

• Gemzar platinum combinations: phase III trials in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Healthcare outcomes: gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Gemcitabine/carboplatin in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?

  Lung cancer (Amsterdam, Netherlands) 20021101

• Non-platinum gemcitabine combinations in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial.

  Cancer chemotherapy and pharmacology 20021101

• Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.

  Investigational new drugs 20021101

• Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.

  Investigational new drugs 20021101

• Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer.

  Investigational new drugs 20021101

• [Phase I study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non-small-cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021101

• [A case of vulval extramammary Paget's disease associated with pancreatic cancer that was successfully treated with chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021101

• [A case of pancreatic tail cancer with peritoneal carcinosis treated with gemcitabine hydrochloride].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021101

• Caspase activation is required for gemcitabine activity in multiple myeloma cell lines.

  Molecular cancer therapeutics 20021101

• [Intra-arterial chemotherapy with gemcitabine (GEM) for unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021101

• [New data presented at ASCO 2002 concerning non-small cell bronchial cancers].

  Revue de pneumologie clinique 20021101

• [New data presented at ASCO 2002 concerning small cell bronchial cancer].

  Revue de pneumologie clinique 20021101

• [New therapeutic options for mesothelioma].

  Revue de pneumologie clinique 20021101

• [Therapeutic strategies in advanced non-small cell bronchial cancers: platin-based combinations].

  Revue de pneumologie clinique 20021101

• [Gemcitabine in the treatment of relapsed or refractory non-Hodgkin's lymphoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20021101

• A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.

  Cancer 20021015

• A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma.

  Cancer 20021015

• Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015

• Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.

  Cancer 20021001

• Gemcitabine-associated hemolytic-uremic syndrome.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20021001

• An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy.

  Cancer research 20021001

• A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021001

• Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale.

  Lung cancer (Amsterdam, Netherlands) 20021001

• Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• [Effect of preoperative concurrent chemo-radiotherapy for thymic carcinoma].

  Kyobu geka. The Japanese journal of thoracic surgery 20021001

• Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.

  American journal of clinical oncology 20021001

• Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2).

  American journal of clinical oncology 20021001

• Gemcitabine and interferon-alpha 2b in solid tumors: a phase I study in patients with advanced or metastatic non-small cell lung, ovarian, pancreatic or renal cancer.

  Anti-cancer drugs 20021001

• Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody.

  Seminars in oncology 20021001

• [Palliative second-line treatment with oxaliplatin, gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in patients with metastatic pancreatic adenocarcinoma].

  Zeitschrift fur Gastroenterologie 20021001

• [Severe interstitial pneumonitis related to Gemcitabine].

  Revue des maladies respiratoires 20021001

• Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.

  Leukemia & lymphoma 20021001

• Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients.

  British journal of cancer 20020923

• A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma.

  Cancer 20020915

• Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.

  Cancer 20020915

• Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915

• Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial.

  International journal of radiation oncology, biology, physics 20020901

• Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.

  International journal of radiation oncology, biology, physics 20020901

• Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer.

  The Journal of urology 20020901

• Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020901

• Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study.

  Leukemia 20020901

• Treatment of advanced non-small-cell lung cancer with two-drug combinations.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901

• Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901

• Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas.

  The American journal of pathology 20020901

• Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.

  Journal of neuro-oncology 20020901

• Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

  Journal of cancer research and clinical oncology 20020901

• [Gemcitabine-based chemotherapy for non-small cell lung cancer (NSCLC)--a review of 30 randomized trials].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020901

• Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20020901

• Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer.

  Anti-cancer drugs 20020901

• Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer.

  Anti-cancer drugs 20020901

• Gemcitabine and its combinations in the treatment of malignant lymphoma.

  Clinical lymphoma 20020901

• Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells.

  Cancer letters 20020828

• The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).

  British journal of cancer 20020827

• A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.

  British journal of cancer 20020827

• Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study.

  British journal of cancer 20020827

• Gemcitabine and platinum combinations in pancreatic cancer.

  Cancer 20020815

• Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer.

  Cancer 20020815

• Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations.

  Cancer 20020815

• The pemetrexed/gemcitabine combination in pancreatic cancer.

  Cancer 20020815

• On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.

  Cancer 20020815

• New applications of gemcitabine and future directions in the management of pancreatic cancer.

  Cancer 20020815

• Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.

  Cancer 20020815

• Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.

  Cancer letters 20020808

• Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20020801

• Gemcitabine and vascular toxicity.

  Lung cancer (Amsterdam, Netherlands) 20020801

• Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

  European journal of cancer (Oxford, England : 1990) 20020801

• Gemcitabine and the interaction with anticoagulants.

  The Lancet. Oncology 20020801

• Intravesical therapy for superficial cancer: need for more options.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801

• Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801

• Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801

• Chemotherapy of non-small cell lung cancer in elderly patients.

  Current medicinal chemistry 20020801

• Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020801

• Gemcitabine in models of acute and accelerated rejection.

  Transplantation proceedings 20020801

• Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020801

• Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020801

• New drugs and new approaches for the treatment of metastatic urothelial cancer.

  World journal of urology 20020801

• A report on serious pulmonary toxicity associated with gemcitabine-based therapy.

  Investigational new drugs 20020801

• Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer.

  Investigational new drugs 20020801

• Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas.

  Investigational new drugs 20020801

• A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma.

  Investigational new drugs 20020801

• Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs.

  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20020801

• [Clinical pharmacology of nucleoside analogues].

  Bulletin du cancer 20020801

• [New neoadjuvant approaches using gemcitabine in non-small-cell lung cancer].

  Bulletin du cancer 20020801

• [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].

  Bulletin du cancer 20020801

• [Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].

  Bulletin du cancer 20020801

• [Gemcitabine and pancreatic cancer].

  Bulletin du cancer 20020801

• [Gemcitabine-based combinations in inoperable pancreatic cancers].

  Bulletin du cancer 20020801

• [Gemcitabine and urogenital tumors].

  Bulletin du cancer 20020801

• [Gemcitabine and breast cancer].

  Bulletin du cancer 20020801

• [Gemicitabine in the treatment of epithelial ovarian cancer].

  Bulletin du cancer 20020801

• [Role of gemcitabine in the treatment of other malignant tumors].

  Bulletin du cancer 20020801

• [The role of gemcitabine in hematology].

  Bulletin du cancer 20020801

• [Combined gemcitabine and radiotherapy].

  Bulletin du cancer 20020801

• [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].

  Bulletin du cancer 20020801

• Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma.

  Molecular cancer therapeutics 20020801

• Systemic therapy for advanced pancreatic cancer.

  Expert review of anticancer therapy 20020801

• Bayesian two-stage designs for phase II clinical trials.

  Statistics in medicine 20020730

• Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer.

  British journal of cancer 20020715

• A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.

  British journal of cancer 20020715

• 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.

  Biochemical pharmacology 20020715

• The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.

  Cancer 20020715

• Current therapy for malignant mesothelioma.

  Current oncology reports 20020701

• Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.

  Lung cancer (Amsterdam, Netherlands) 20020701

• Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701

• Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701

• Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701

• Pilot study of gemcitabine (10 mg/m(2) per min) and cisplatin.

  Cancer chemotherapy and pharmacology 20020701

• Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020701

• Pharmacokinetics of intrathecal gemcitabine in nonhuman primates.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020701

• Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer.

  Current opinion in oncology 20020701

• [Refractory non-small-cell lung cancer responding to combination chemotherapy with gemcitabine and cisplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020701

• Selective cytotoxicity of gemcitabine in bladder cancer cell lines.

  Anti-cancer drugs 20020701

• The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors.

  Anti-cancer drugs 20020701

• Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020701

• [Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report].

  Hinyokika kiyo. Acta urologica Japonica 20020701

• Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer.

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20020701

• Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615

• A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.

  Cancer 20020615

• Phase II trial of gemcitabine in advanced sarcomas.

  Cancer 20020615

• A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.

  British journal of cancer 20020605

• Gemcitabine-induced radiation recall.

  International journal of radiation oncology, biology, physics 20020601

• Gemcitabine in non-small cell lung cancer.

  Expert opinion on pharmacotherapy 20020601

• Novel treatments and therapies in development for pancreatic cancer.

  Expert opinion on investigational drugs 20020601

• Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.

  European journal of cancer (Oxford, England : 1990) 20020601

• Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.

  Medical science monitor : international medical journal of experimental and clinical research 20020601

• New treatment approaches for lung cancer and impact on survival.

  Seminars in oncology 20020601

• Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).

  Seminars in oncology 20020601

• Present and future treatment of pancreatic cancer.

  Seminars in oncology 20020601

• The present and future of combination chemotherapy in bladder cancer.

  Seminars in oncology 20020601

• Gemcitabine and pemetrexed (Alimta) in thoracic cancers: present and future perspectives. Introduction and current controversies.

  Seminars in oncology 20020601

• Early results of a randomized phase III trial of platinum-containing doublets versus a nonplatinum doublet in the treatment of advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer 08975.

  Seminars in oncology 20020601

• Gemcitabine versus gemcitabine/carboplatin in advanced non-small cell lung cancer: preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group.

  Seminars in oncology 20020601

• Gemcitabine induction chemotherapy in non-small cell lung cancer.

  Seminars in oncology 20020601

• Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents.

  Cancer chemotherapy and pharmacology 20020601

• Docetaxel in the management of advanced or metastatic urothelial tract cancer.

  Oncology (Williston Park, N.Y.) 20020601

• A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer.

  Journal of chemotherapy (Florence, Italy) 20020601

• A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020601

• Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020601

• Gemcitabine and targeted therapy in metastatic breast cancer.

  Seminars in oncology 20020601

• Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020601

• Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey.

  Journal of experimental & clinical cancer research : CR 20020601

• Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma.

  Leukemia & lymphoma 20020601

• Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer.

  Seminars in oncology 20020601

• [Ureteroplasty using the appendix: apropos of a case].

  Archivos espanoles de urologia 20020601

• Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.

  Biochemical and biophysical research communications 20020524

• A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.

  British journal of cancer 20020520

• A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma.

  Cancer 20020515

• Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma. Carboplatin and gemcitabine followed by paclitaxel.

  Cancer 20020515

• [Renal toxicity with a gemcitabine-cisplatin combination in lung cancer].

  Presse medicale (Paris, France : 1983) 20020511

• [New drugs in bronchial cancer].

  Presse medicale (Paris, France : 1983) 20020511

• Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.

  Lung cancer (Amsterdam, Netherlands) 20020501

• Vasculitis due to gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20020501

• Is long term gemcitabine useful in small cell lung cancer?

  Lung cancer (Amsterdam, Netherlands) 20020501

• Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: requirements for a regional chemotherapy.

  The Journal of pharmacology and experimental therapeutics 20020501

• Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.

  Cancer chemotherapy and pharmacology 20020501

• Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020501

• Barriers to winning the battle with head-and-neck cancer.

  International journal of radiation oncology, biology, physics 20020501

• Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.

  International journal of radiation oncology, biology, physics 20020501

• Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.

  International journal of radiation oncology, biology, physics 20020501

• Effect of gemcitabine on acute and late radiation toxicity of skin and underlying soft tissues to single-dose irradiation in a nude mice model.

  International journal of radiation oncology, biology, physics 20020501

• Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines.

  Japanese journal of cancer research : Gann 20020501

• Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).

  Cancer chemotherapy and pharmacology 20020501

• Overview: gemcitabine as single-agent therapy for advanced breast cancer.

  Clinical breast cancer 20020501

• Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.

  Clinical breast cancer 20020501

• Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results.

  Clinical breast cancer 20020501

• Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanes.

  Clinical breast cancer 20020501

• Gemcitabine plus cisplatin for the treatment of metastatic breast cancer.

  Clinical breast cancer 20020501

• Gemcitabine/anthracycline combinations in metastatic breast cancer.

  Clinical breast cancer 20020501

• Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.

  Clinical breast cancer 20020501

• Neoadjuvant gemcitabine therapy for breast cancer.

  Clinical breast cancer 20020501

• Gemcitabine in breast cancer: future directions.

  Clinical breast cancer 20020501

• Chemotherapy with gemcitabine in patients with gall-bladder carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020501

• [Docetaxel].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• [Gemcitabine].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• [Carboplatin].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• [Chemotherapy for elderly patients with lung cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• Irinotecan and gemcitabine in patients with solid tumors: phase I trial.

  Oncology (Williston Park, N.Y.) 20020501

• Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer.

  Oncology (Williston Park, N.Y.) 20020501

• Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20020501

• Chemoradiation with novel agents for rectal cancer.

  Clinical colorectal cancer 20020501

• [Gemcitabine-induced thrombotic microangiopathy].

  Presse medicale (Paris, France : 1983) 20020427

• Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.

  Cancer research 20020415

• Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20020401

• Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20020401

• Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.

  Cancer research 20020401

• An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

  European journal of cancer (Oxford, England : 1990) 20020401

• Enhancement of DNA ligase I level by gemcitabine in human cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020401

• Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

  International journal of radiation oncology, biology, physics 20020401

• [Antitumor activity of combination treatment combining gemcitabine with topotecin against human lung cancer xenografted in nude mice].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020401

• [Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination].

  Bulletin du cancer 20020401

• Recurrent ovarian cancer as chronic disease.

  Oncology (Williston Park, N.Y.) 20020401

• [Acute respiratory failure due to Gemcitabine-induced pulmonary toxicity].

  Revue des maladies respiratoires 20020401

• Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• Epithelial ovarian cancer.

  Current treatment options in oncology 20020401

• Gemcitabine and radiotherapy in the treatment of brain metastases from transitional cell carcinoma of the bladder: a case report.

  Journal of neuro-oncology 20020401

• Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

  Molecular cancer therapeutics 20020401

• [Regional intra-arterial infusion chemotherapy for pancreatic cancer: an experimental study].

  Zhonghua yi xue za zhi 20020325

• A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer.

  British journal of cancer 20020318

• Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315

• Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315

• Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315

• Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315

• Selective sensitization of transformed cells to flavopiridol-induced apoptosis following recruitment to S-phase.

  Cancer research 20020315

• A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20020301

• Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020301

• Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.

  European journal of cancer (Oxford, England : 1990) 20020301

• Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020301

• NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial.

  Langenbeck's archives of surgery 20020301

• [Radiotherapy and chemotherapy for unresectable pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020301

• [An elderly patient with advanced non-small-cell lung cancer that responded remarkably to combination chemotherapy of vinorelbine and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020301

• Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.

  European journal of cancer (Oxford, England : 1990) 20020301

• [How I treat ... An advanced pancreatic cancer].

  Revue medicale de Liege 20020301

• Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.

  Cancer 20020215

• Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

  International journal of cancer 20020201

• Prolonged infusion of gemcitabine: clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Severe pulmonary toxicity in a patient treated with gemcitabine.

  American journal of clinical oncology 20020201

• Gemcitabine-induced pulmonary toxicity: case report and review of the literature.

  American journal of clinical oncology 20020201

• Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation.

  The Journal of thoracic and cardiovascular surgery 20020201

• The role of gemcitabine in the treatment of malignant mesothelioma.

  Seminars in oncology 20020201

• The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020201

• Second-line treatment of ovarian cancer with single-agent gemcitabine.

  Seminars in oncology 20020201

• The role of gemcitabine-based doublets in the management of ovarian carcinoma.

  Seminars in oncology 20020201

• Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma.

  Seminars in oncology 20020201

• Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182).

  Seminars in oncology 20020201

• Pancreatic cancer: what the oncologist can offer for palliation.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020201

• Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.

  British journal of cancer 20020201

• [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].

  La Revue de medecine interne 20020201

• Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020201

• Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life.

  Onkologie 20020201

• Current and future perspectives in advanced bladder cancer: is there a new standard?

  Seminars in oncology 20020201

• Gemcitabine doublets in advanced urothelial cancer.

  Seminars in oncology 20020201

• Novel gemcitabine-containing triplets in the management of urothelial cancer.

  Seminars in oncology 20020201

• Gemcitabine-based combination treatment of pancreatic cancer.

  Seminars in oncology 20020201

• Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.

  Seminars in oncology 20020201

• Future directions for gemcitabine in the treatment of genitourinary cancer.

  Seminars in oncology 20020201

• Determinants of response and resistance to cytotoxics.

  Seminars in oncology 20020201

• Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.

  Anti-cancer drugs 20020201

• Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment.

  Anti-cancer drugs 20020201

• [Developed new agents for lung cancer].

  Nihon Geka Gakkai zasshi 20020201

• [Combined radiotherapy and gemcitabine. Evaluation of clinical data based on experimental knowledge].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020201

• Phase I/II study of 3-week cycle cisplatin-gemcitabine in advanced non-small cell lung cancer.

  Japanese journal of clinical oncology 20020201

• [Interstitial lung disease in a patient given gemcitabine].

  Revue de pneumologie clinique 20020201

• Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells.

  Leukemia & lymphoma 20020201

• The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study.

  Investigational new drugs 20020201

• Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer.

  Investigational new drugs 20020201

• Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel.

  International journal of urology : official journal of the Japanese Urological Association 20020201

• A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.

  Hematology/oncology clinics of North America 20020201

• Management of locally advanced adenocarcinoma of the pancreas.

  Hematology/oncology clinics of North America 20020201

• Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20020201

• NMR structure of a gemcitabine-substituted model Okazaki fragment.

  Biochemistry 20020122

• Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.

  British journal of cancer 20020121

• Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer.

  International journal of cancer 20020120

• Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115

• Gemcitabine-related pulmonary toxicity.

  Swiss medical weekly 20020112

• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  The New England journal of medicine 20020110

• A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life.

  Lung cancer (Amsterdam, Netherlands) 20020101

• Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis.

  Journal of surgical oncology 20020101

• Gemcitabine (Gemzar) and radiotherapy--is it feasible?

  Frontiers of radiation therapy and oncology 20020101

• Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020101

• Biological basis for chemo-radiotherapy interactions.

  European journal of cancer (Oxford, England : 1990) 20020101

• Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model.

  European journal of nuclear medicine and molecular imaging 20020101

• Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.

  Thorax 20020101

• Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.

  Oncology 20020101

• A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients.

  Oncology 20020101

• Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.

  Oncology 20020101

• A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

  Cancer 20020101

• Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature.

  Cancer 20020101

• [Successful outpatient treatment with chemotherapy of weekly gemcitabine and vinorelbine for a patient with recurrent lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020101

• Prediction of cell kill kinetics of anticancer agents using the collagen gel droplet embedded-culture drug sensitivity test.

  Oncology reports 20020101

• Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes.

  Clinical breast cancer 20020101

• Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study.

  Cancer investigation 20020101

• Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.

  Oncology 20020101

• [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20020101

• [Therapy of gallbladder carcinoma. Experience of a central hospital].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20020101

• Type III radical hysterectomy induction chemotherapy for patients with locally advanced cervical carcinoma.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20020101

• Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer.

  PharmacoEconomics 20020101

• What's new in pancreatic cancer treatment?

  Journal of hepato-biliary-pancreatic surgery 20020101

• First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.

  Cancer investigation 20020101

• Gemcitabine for patients with relapsed nasopharyngeal carcinoma.

  Internal medicine journal 20020101

• Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.

  The breast journal 20020101

• Evolving considerations in the design and interpretation of phase I trials investigating gemcitabine based chemoradiotherapy regimens.

  Cancer journal (Sudbury, Mass.) 20020101

• Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.

  Cancer journal (Sudbury, Mass.) 20020101

• Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: a phase I study.

  Tumori 20020101

• Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment.

  Acta dermato-venereologica 20020101

• A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study.

  Oncology 20020101

• Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.

  Oncology 20020101

• [Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin].

  Pneumonologia i alergologia polska 20020101

• The antineoplastic treatment in the elderly.

  La Clinica terapeutica 20020101

• Time and sequence dependence of hydroxyurea in combination with gemcitabine in human KB cells.

  Anticancer research 20020101

• A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.

  Anticancer research 20020101

• Clinical benefit of gemcitabine-cisplatin in advanced non-small cell lung cancer elderly patients.

  Anticancer research 20020101

• Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report.

  Anticancer research 20020101

• Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.

  Anticancer research 20020101

• A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer.

  Anticancer research 20020101

• Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma.

  Acta dermato-venereologica 20020101

• Granulomatous mycosis fungoides responsive to gemcitabine.

  European journal of dermatology : EJD 20020101

• Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.

  Drugs & aging 20020101

• [Gemcitabine in the treatment of advanced non-small cell lung cancer: report of one case].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20020101

• [An association of paraneoplastic syndromes in a patient].

  Annales de dermatologie et de venereologie 20020101

• Cyclophosphamide, doxorubicin, and gemcitabine combination chemotherapy for treatment of metastatic and locally advanced breast cancer.

  Cancer investigation 20020101

• Early detection and successful treatment of drug-induced pneumonitis with corticosteroids.

  Cancer investigation 20020101

• Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.

  Urologic oncology 20020101

• The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.

  Cancer treatment and research 20020101

• A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer.

  The oncologist 20020101

• Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II.

  Anticancer research 20020101

• Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study.

  Anticancer research 20020101

• Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.

  Anticancer research 20020101

• A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.

  Anticancer research 20020101

• Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine.

  International journal of gastrointestinal cancer 20020101

• Phase II study of gemcitabine, UFT and leucovorin in patients with advanced pancreatic cancer.

  Acta oncologica (Stockholm, Sweden) 20020101

• Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage.

  Cancer research 20011215

• Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

  Cancer 20011215

• [New developments in chemotherapy for metastasized bladder cancer].

  Nederlands tijdschrift voor geneeskunde 20011215

• Drug resistance in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.

  European journal of cancer (Oxford, England : 1990) 20011201

• Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20011201

• Treatment of advanced ovarian cancer.

  European journal of cancer (Oxford, England : 1990) 20011201

• A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Activity of the combination of high-dose epirubicin with gemcitabine in advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Radiosensitization with chemotherapeutic agents.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Gemcitabine and pemetrexed disodium combinations in vitro and in vivo.

  Lung cancer (Amsterdam, Netherlands) 20011201

• ALIMTA (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

  Cancer 20011201

• Gemcitabine activity in cervical cancer cell lines.

  Cancer chemotherapy and pharmacology 20011201

• Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer.

  American journal of clinical oncology 20011201

• Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study.

  American journal of clinical oncology 20011201

• Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.

  Breast cancer research and treatment 20011201

• Pancreatic cancer: the evolving role of systemic therapy.

  Expert opinion on pharmacotherapy 20011201

• Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.

  International journal of clinical oncology 20011201

• A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.

  International journal of clinical oncology 20011201

• Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.

  International journal of radiation oncology, biology, physics 20011115

• Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115

• Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .

  Cancer 20011115

• Gemcitabine in hematologic malignancies.

  Current opinion in oncology 20011101

• A feasibility study of carboplatin with fixed dose of gemcitabine in 'unfit' patients with advanced bladder cancer.

  European journal of cancer (Oxford, England : 1990) 20011101

• Gemcitabine and small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011101

• Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man.

  Urology 20011101

• Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).

  British journal of cancer 20011101

• Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

  Cancer 20011101

• A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.

  Bone marrow transplantation 20011101

• Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• Gemcitabine-induced systemic capillary leak syndrome.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• [Does treatment for malignant pleural mesothelioma exist?].

  Revue de pneumologie clinique 20011101

• [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].

  Revue de pneumologie clinique 20011101

• [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].

  Revue de pneumologie clinique 20011101

• Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011015

• Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.

  International journal of cancer 20011015

• Chemotherapy for non-small-cell lung cancer.

  Lancet (London, England) 20011013

• Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria.

  Biochemical and biophysical research communications 20011012

• Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.

  Lung cancer (Amsterdam, Netherlands) 20011001

• Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction.

  Cancer research 20011001

• Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.

  Cancer research 20011001

• Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells.

  Pancreas 20011001

• Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors.

  Anti-cancer drugs 20011001

• Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011001

• Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011001

• Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011001

• Recent advances in the use of radiosensitizing nucleosides.

  Seminars in radiation oncology 20011001

• [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011001

• Gemcitabine-associated CD8+ CD30+ pseudolymphoma.

  The British journal of dermatology 20011001

• A phase II study of gemcitabine in gallbladder carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Use of gemcitabine (GEM) in advanced myelodysplastic syndromes.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.

  Cancer biotherapy & radiopharmaceuticals 20011001

• Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.

  Cancer 20010915

• New chemotherapy combinations for advanced bladder cancer.

  Current opinion in urology 20010901

• Second-line treatment of advanced transitional cell carcinoma of the urothelial tract.

  Current opinion in urology 20010901

• Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.

  The Journal of pharmacology and experimental therapeutics 20010901

• Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome.

  The Journal of surgical research 20010901

• Sustained complete remission in a patient with platinum-resistant ovarian yolk sac tumor.

  Gynecologic oncology 20010901

• [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].

  Revue des maladies respiratoires 20010901

• Indications for chemotherapy in stage IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20010901

• Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer.

  Anti-cancer drugs 20010901

• Gemcitabine-associated diffuse alveolar hemorrhage.

  Intensive care medicine 20010901

• Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010901

• Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010901

• [Prognosis of pancreatic adenocarcinoma].

  Gastroenterologie clinique et biologique 20010901

• Resistance to topoisomerase poisons due to loss of DNA mismatch repair.

  International journal of cancer 20010815

• Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma: a phase II multicenter trial.

  Cancer 20010815

• Cell cycle effects of gemcitabine.

  International journal of cancer 20010801

• Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer.

  The Journal of urology 20010801

• Bladder tumor markers, intravesical therapy and systemic chemotherapy.

  The Journal of urology 20010801

• Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010801

• Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010801

• Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.

  International journal of radiation oncology, biology, physics 20010801

• Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010801

• Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010801

• Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010801

• Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010801

• CaSm/gemcitabine chemo-gene therapy leads to prolonged survival in a murine model of pancreatic cancer.

  Surgery 20010801

• Nuclear factor-kappa B is upregulated in colorectal cancer.

  Surgery 20010801

• New cytotoxic agents and schedules for advanced breast cancer.

  Seminars in oncology 20010801

• Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.

  Cancer 20010801

• Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.

  Cancer chemotherapy and pharmacology 20010801

• Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

  Cancer chemotherapy and pharmacology 20010801

• Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model.

  Cancer chemotherapy and pharmacology 20010801

• Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.

  Cancer chemotherapy and pharmacology 20010801

• Adjuvant chemotherapy for muscle-invasive bladder cancer.

  Seminars in urologic oncology 20010801

• [Preclinical studies of oxaliplatin in combination chemotherapy].

  Bulletin du cancer 20010801

• Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010801

• Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010801

• [Gemcitabine in the treatment of 4 patients with cholangiocarcinoma].

  Revista medica de Chile 20010801

• A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors.

  Cancer 20010715

• Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine.

  Biochemical pharmacology 20010701

• Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay.

  International journal of oncology 20010701

• Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer.

  European journal of cancer (Oxford, England : 1990) 20010701

• Chemotherapy and quality of life in advanced NSCLC.

  British journal of cancer 20010701

• Evaluating new treatments for advanced cancer.

  British journal of cancer 20010701

• Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel.

  Cancer 20010701

• Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin.

  Cancer 20010701

• Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.

  Pancreas 20010701

• Rationale for non-platinum chemotherapy in advanced NSCLC.

  Oncology (Williston Park, N.Y.) 20010701

• Gemcitabine active in patients with metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20010701

• Pancreatic cancer in the older patient.

  Oncology (Williston Park, N.Y.) 20010701

• Recent advances in the chemotherapy of non-small cell lung cancer.

  Japanese journal of clinical oncology 20010701

• Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010701

• [Therapeutic strategies in neoadjuvant therapy of non-small cell lung cancer: benefits of gemcitabine].

  Anti-cancer drugs 20010701

• [Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials].

  Anti-cancer drugs 20010701

• Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.

  Breast cancer research and treatment 20010701

• Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010615

• Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.

  Biochemical pharmacology 20010601

• Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia.

  Leukemia research 20010601

• Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.

  Gynecologic oncology 20010601

• Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.

  British journal of haematology 20010601

• Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer.

  American journal of clinical oncology 20010601

• Gemcitabine in advanced pancreatic cancer: a phase II trial.

  American journal of clinical oncology 20010601

• Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

  Leukemia 20010601

• Neoadjuvant strategies for pancreatic cancer.

  Oncology (Williston Park, N.Y.) 20010601

• Recent developments in chemotherapy for bladder cancer.

  Oncology (Williston Park, N.Y.) 20010601

• Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.

  Seminars in oncology 20010601

• Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.

  Seminars in oncology 20010601

• Neoadjuvant chemotherapy with docetaxel in non--small cell lung cancer.

  Seminars in oncology 20010601

• Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.

  The Surgical clinics of North America 20010601

• Therapy for regionally unresectable pancreatic cancer.

  The Surgical clinics of North America 20010601

• Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010601

• Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study.

  Journal of experimental & clinical cancer research : CR 20010601

• Gemcitabine-containing regimens in bladder cancer: A new standard of care.

  Seminars in oncology 20010601

• Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer.

  Seminars in oncology 20010601

• A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: toxicity of a three- versus a four-week schedule.

  Seminars in oncology 20010601

• Gemcitabine/carboplatin versus cisplatin/etoposide for patients with poor-prognosis small cell lung cancer: a phase III randomized trial with quality-of-life evaluation.

  Seminars in oncology 20010601

• Gemcitabine/carboplatin in advanced urothelial cancer.

  Seminars in oncology 20010601

• Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.

  Seminars in oncology 20010601

• Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies.

  Seminars in oncology 20010601

• Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer.

  Seminars in oncology 20010601

• Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.

  Seminars in oncology 20010601

• A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: a preliminary report.

  Seminars in oncology 20010601

• Gemcitabine in ovarian cancer.

  Seminars in oncology 20010601

• Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.

  Breast cancer research and treatment 20010601

• Nucleoside analogues in the treatment of haematological malignancies.

  Expert opinion on pharmacotherapy 20010601

• Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.

  Lancet (London, England) 20010512

• [Decline in the need for blood transfusions in cancer patients due to the use of epoietin alfa during cisplatin based chemotherapy].

  Nederlands tijdschrift voor geneeskunde 20010505

• Akt, MAPK (Erk1/2), and p38 act in concert to promote apoptosis in response to ErbB receptor family inhibition.

  The Journal of biological chemistry 20010504

• Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20010501

• Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

  Lung cancer (Amsterdam, Netherlands) 20010501

• Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.

  European journal of cancer (Oxford, England : 1990) 20010501

• Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study.

  British journal of cancer 20010501

• Intestinal permeability in patients with chemotherapy-induced stomatitis.

  Journal of cancer research and clinical oncology 20010501

• The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)-cytosine: effects of its triphosphate on mammalian DNA polymerases.

  Japanese journal of cancer research : Gann 20010501

• [Non-small cell lung cancer with liver metastasis responsive to gemcitabine--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010501

• Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates.

  Cancer chemotherapy and pharmacology 20010501

• New combinations with epirubicin in advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20010501

• [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].

  Presse medicale (Paris, France : 1983) 20010501

• Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM).

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.

  International journal of cancer 20010420

• 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.

  Molecular pharmacology 20010401

• Alterations in taste sensation: a case presentation of a patient with end-stage pancreatic cancer.

  Cancer nursing 20010401

• Treatment of refractory T-cell malignancies using gemcitabine.

  British journal of haematology 20010401

• A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer.

  Journal of chemotherapy (Florence, Italy) 20010401

• Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma.

  American journal of clinical oncology 20010401

• Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.

  Anti-cancer drugs 20010401

• Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule.

  Anti-cancer drugs 20010401

• Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine.

  European journal of nuclear medicine 20010401

• [Gemcitabine and cisplatin as induction therapy for patients with histologically proven stage IIIA-N2 non-small-cell bronchial cancer: a phase-II study of the EORTC Cooperative Group (EORTC 08955)].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010401

• Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer.

  Seminars in oncology 20010401

• Gemcitabine in advanced bladder cancer.

  Seminars in oncology 20010401

• The current role of gemcitabine in ovarian cancer.

  Seminars in oncology 20010401

• Treatment of metastatic urothelial cancer in the post-MVAC era.

  World journal of urology 20010401

• A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010401

• Single-agent gemcitabine in patients with resistant small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010401

• Intraoperative saline and gemcitabine irrigation improves tumour control in human squamous cell carcinoma-contaminated surgical wounds.

  The Journal of otolaryngology 20010401

• Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance.

  The Journal of biological chemistry 20010330

• Cotton-wool spots associated with pancreatic carcinoma.

  European journal of medical research 20010326

• Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells.

  European journal of pharmacology 20010323

• Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010315

• Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.

  International journal of radiation oncology, biology, physics 20010301

• Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.

  Annals of surgical oncology 20010301

• [A case of primary malignant hemangiopericytoma of the lung with marked response to combination chemotherapy with cisplatin, ifosfamide and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010301

• Latent hematopoietic stem cell toxicity associated with protracted drug administration.

  Experimental hematology 20010301

• Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial.

  European journal of cancer (Oxford, England : 1990) 20010301

• Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.

  Anti-cancer drugs 20010301

• Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Gemcitabine in combination with new platinum compounds: an update.

  Oncology (Williston Park, N.Y.) 20010301

• Gemcitabine and nonplatinum combinations in non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Gemcitabine for the treatment of non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Optimizing chemoradiation in locally advanced non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Gemcitabine as single agent therapy in advanced non small cell lung cancer and quality of life in the elderly.

  Panminerva medica 20010301

• Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.

  Cancer chemotherapy and pharmacology 20010301

• Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.

  Breast cancer research and treatment 20010301

• Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010301

• Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010215

• Gemcitabine and cisplatin for advanced, metastatic bladder cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010215

• End-joining deficiency and radiosensitization induced by gemcitabine.

  Cancer research 20010215

• Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201

• S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine.

  Cancer research 20010201

• The clinical implications of gemcitabine radiosensitization.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010201

• The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010201

• Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study.

  Pharmacological research 20010201

• Gemcitabine as single-agent therapy in the management of advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• Treatment of advanced breast cancer with gemcitabine and vinorelbine.

  Oncology (Williston Park, N.Y.) 20010201

• Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• Gemcitabine and paclitaxel as salvage therapy in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• Gemcitabine plus cisplatin in breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• Gemcitabine and Pemetrexed disodium in treating breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer.

  Oncology (Williston Park, N.Y.) 20010201

• Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial.

  Oncology (Williston Park, N.Y.) 20010201

• [Palliative therapy of pancreatic adenocarcinoma].

  Zeitschrift fur Gastroenterologie 20010201

• Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.

  Seminars in oncology 20010201

• Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010201

• Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study.

  Cancer 20010115

• The role of laparoscopy in second-look evaluations for ovarian cancer.

  Gynecologic oncology 20010101

• Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs.

  British journal of cancer 20010101

• Gemcitabine: progress in the treatment of pancreatic cancer.

  Oncology 20010101

• Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer.

  Oncology 20010101

• Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer.

  Oncology 20010101

• Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer.

  Japanese journal of cancer research : Gann 20010101

• Options in advanced non-small cell lung cancer: a review and report on a phase II study of vinorelbine plus gemcitabine.

  The oncologist 20010101

• Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer.

  The oncologist 20010101

• [Refractory non-small-cell lung cancer responding to combination chemotherapy with docetaxel, gemcitabine and cisplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010101

• Docetaxel followed by gemcitabine and irinotecan in solid tumors.

  Oncology (Williston Park, N.Y.) 20010101

• Chemoradiation in locally advanced non-small cell lung cancer.

  Cancer treatment and research 20010101

• Lung cancer: therapeutic options for stage IV and recurrent NSCLC.

  Cancer treatment and research 20010101

• Treatment of extensive stage small cell lung cancer.

  Cancer treatment and research 20010101

• Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• Phase I trial of gemcitabine in patients with advanced pancreatic cancer.

  Japanese journal of clinical oncology 20010101

• Recent advances in bladder cancer chemotherapy.

  Cancer investigation 20010101

• Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine.

  Investigational new drugs 20010101

• Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.

  Investigational new drugs 20010101

• Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings.

  Magnetic resonance imaging 20010101

• Combined use of gemcitabine and radiation in mice.

  Anticancer research 20010101

• Treatment of classical Kaposi's sarcoma with gemcitabine.

  Dermatology (Basel, Switzerland) 20010101

• Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20010101

• The evolving role of gemcitabine in the management of breast cancer.

  Oncology 20010101

• Novel approaches to postoperative chemoradiation therapy in pancreatic cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20010101

• Preliminary evaluation of influence of gemcitabine (Gemzar) on proliferation and neuroendocrine activity of human TT cell line: immunocytochemical investigations.

  Folia histochemica et cytobiologica 20010101

• Current options for palliative treatment in patients with pancreatic cancer.

  Digestive diseases (Basel, Switzerland) 20010101

• Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.

  Cancer investigation 20010101

• Single-agent gemcitabine is active in previously treated metastatic breast cancer.

  Oncology 20010101

• Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine.

  Oncology 20010101

• Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas.

  Oncology 20010101

• Novel clinical strategies for the treatment of pancreatic carcinoma.

  Trends in molecular medicine 20010101

• Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• A systematic overview of chemotherapy effects in pancreatic cancer.

  Acta oncologica (Stockholm, Sweden) 20010101

• A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3).

  Cancer investigation 20010101

• Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas.

  Hepato-gastroenterology 20010101

• Linear immunoglobulin A bullous dermatosis induced by gemcitabine.

  The Annals of pharmacotherapy 20010101

• Gemcitabine in the treatment of ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• Developmental chemotherapy in advanced ovarian cancer: incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.

  In vivo (Athens, Greece) 20010101

• Gemcitabine plus epirubicin in advanced pancreatic cancer: a phase II multicenter trial.

  Oncology reports 20010101

• Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Radiation recall reaction following gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20010101

• WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment.

  International journal of pancreatology : official journal of the International Association of Pancreatology 20010101

• Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.

  International journal of pancreatology : official journal of the International Association of Pancreatology 20010101

• Combined-modality therapy in pancreatic cancer: current status and future directions.

  Cancer journal (Sudbury, Mass.) 20010101

• Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.

  Investigational new drugs 20010101

• Personal experience in advanced pancreatic cancer: retrospective analysis on the use of 5-fluorouracil or gemcitabine.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010101

• Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer.

  Neoplasma 20010101

• New combinations with Herceptin in metastatic breast cancer.

  Oncology 20010101

• A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.

  Health technology assessment (Winchester, England) 20010101

• An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

  Anticancer research 20010101

• Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.

  The oncologist 20010101

• Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20010101

• [Results of phase II clinical trial of cycloplatam in refractory solid tumors].

  Voprosy onkologii 20010101

• Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.

  Anticancer research 20010101

• Gemcitabine-induced acute lipodermatosclerosis-like reaction.

  Acta dermato-venereologica 20010101

• Compassionate use of Gemzar in advanced pancreatic cancer: a Belgian experience.

  Acta gastro-enterologica Belgica 20010101

• Gemcitabine hydrochloride.

  Clinical journal of oncology nursing 20010101

• Oily chemoembolization of pancreatic head adenocarcinoma.

  Cardiovascular and interventional radiology 20010101

• Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance.

  Cytogenetics and cell genetics 20010101

• Gemcitabine-induced radiation recall dermatitis: case report.

  Tumori 20010101

• [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer].

  Tumori 20010101

• A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

  Health technology assessment (Winchester, England) 20010101

• Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.

  International journal of gastrointestinal cancer 20010101

• Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.

  Cancer 20001215

• Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.

  American journal of clinical oncology 20000801

• [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].

  Zeitschrift fur Gastroenterologie 20000701

• Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity.

  Annals of oncology : official journal of the European Society for Medical Oncology 20000401

• A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20000101

• Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1.

  Nucleosides, nucleotides & nucleic acids 20000101

• Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer.

  Anticancer research 20000101

• Effects of gemcitabine on cell proliferation and apoptosis in non-small-cell lung cancer (NSCLC) cell lines.

  Cancer chemotherapy and pharmacology 20000101

• Acute myocardial infarction following gemcitabine therapy--a case report.

  Angiology 19991201

• Severe non-haematological toxicity after treatment with gemcitabine.

  Journal of cancer research and clinical oncology 19991101

• Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.

  Journal of the National Cancer Institute 19991020

• Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group.

  Cancer 19991015

• Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19991001

• Hemolytic-uremic syndrome caused by gemcitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 19981201

• Gemcitabine-associated autonomic neuropathy.

  Lancet (London, England) 19980227

• Gemcitabine induces programmed cell death and activates protein kinase C in BG-1 human ovarian cancer cells.

  Cancer chemotherapy and pharmacology 19980101

• Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19970501

• Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model.

  Radiation oncology investigations 19970101

• Inhibition of ribonucleotide reductase by 2'-substituted deoxycytidine analogs: possible application in AIDS treatment.

  Proceedings of the National Academy of Sciences of the United States of America 19940830

• Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.

  Molecular pharmacology 19901001